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Abstract 
The concept of de novo metabolic engineering through novel synthetic pathways 
offers new directions for multi-step enzymatic synthesis of complex molecules. 
This has been complemented by recent progress in performing enzymatic reactions 
using immobilised enzyme microreactors (IEMR). This work is concerned with the 
construction of de novo designed enzyme pathways in a microreactor synthesising a 
chiral molecule. An interesting compound, commonly used as the building block in 
several pharmaceutical syntheses, is a single diastereoisomer of 2-amino-1,3,4-
butanetriol (ABT). This chiral amino alcohol can be synthesised from simple achiral 
substrates using two enzymes, transketolase (TK) and !-transaminase (TAm). 
 
This project involves the design and the development of an IEMR using His6-tagged 
TK and TAm immobilised onto Ni-NTA agarose beads and packed into tubes to 
enable multi-step enzyme reactions. The IEMR was first characterised based on the 
operational and storage stability. Furthermore, kinetic parameters of both enzymes 
were determined using single IEMRs evaluated by a kinetic model developed for 
packed bed reactors.  
 
For the multi-step enzyme reaction, two model systems were investigated. The first 
model investigated was the dual TK (pQR 791)-TAm (pQR 801) reaction. With 
initial 60 mM (HPA and GA each) and 6 mM (MBA) substrate concentration 
mixture, the coupled reaction reached approximately 83% conversion in 20 minutes 
at the lowest flow rate. On the other hand, the second model reaction comprises of 
three sequential enzyme reaction, TAm (pQR 1021)-TK (pQR 791)-TAm (pQR 
1021). A 6% yield of ABT was produced from initial substrate mixture of 100 mM 
serine and 40 mM GA at flow rate of 0.5 µL/min. 
 
Further considerations to improve the system would allow for better yield of the 
target product and potentially make this IEMR system a powerful tool for 
construction and evaluation of de novo pathways as well as for rapid determination 
of various enzymes kinetics. 
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1 Introduction 
1.1 Microfluidics and its Characteristic features 
Microfluidic is the field that studies and exploits the behavior of fluids confined to 
small channels with dimensions of ten to hundreds of micrometers (Folch, 2013; 
Whitesides, 2006). This technology originated from microanalytical methods that 
used electrophoresis back in 1940s by J. St. L. Philpot, a biochemist from Oxford 
University (Folch, 2013). Later in 1990, Manz et al. (1990) invented the first HPLC 
microfluidic device. After decade of development, microfluidics have shown to 
advance in many areas including analytical chemistry, biology, diagnostics and 
biomedical research inline with novel microfabrication techniques. As the 
microfluidic applications expand, several microfluidic structures, such as 
microvalves, micropumps and micromixers (Beebe et al., 2002; Laser & Santiago, 
2004; Oh & Ahn, 2006; Zhang et al., 2007) are being developed. Integration of 
these different functional components give rise to the new emerging technology that 
is called micro total analysis systems (#-TAS) or also known as lab-on-a-chip. 
 
Owing to their miniature size, microfluidic system requires only a small volume of 
reagent, shorter processing time and can be parallelized using lab-on-a-chip 
technology (Chow & Hong, 2002; Edel & DeMello, 2009). In addition, a small 
quantity of processing volume allows for the precise control of reaction variables, 
such as reagent mixing, flow rates, reaction time, and heat and mass transfer 
(Schmid et al., 2001; Hong et al., 2009; Mark et al., 2010).  It is a perfect alternative 
for direct synthesis on demand production in small-scale plant (Maehara et al., 
2008). In contrast with conventional procedures, microreactors are easily scalable, 
rendering a device capable of both analytical and semi-preparative scales of 
production. Finally, the microreactor format is amenable to automation of reaction 
optimization (Quiram et al., 2007). 
 
This technology is being developed by taking advantage of the same 
microfabrication techniques used to pattern integrated circuits on silicon wafers, 
with incorporation of the design and development of miniaturized fluidic devices 
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that manipulate samples at nanolitres volumes (Breslauer et al., 2006). Detection 
systems for product analysis is now accessible not only using fluorescence but also 
newly introduced techniques; optical methods of chemiluminescence, refraction and 
thermooptics, as well as the electrochemical methods of amperometry, 
conductimetry and potentiometry (Schwarz & Hauser, 2001). The application of 
microfluidic devices has been extensively increased over the years especially for 
conditions screening purpose. With the miniaturisation concept, multiple samples of 
biochemical, genetic, proteomic data can be processed, thus high-throughput 
screening (HTS) technology has emerged to meet the demand (Hsieh et al., 1998; 
Wu et al., 2003; Hong et al., 2009; Cho et al., 2011).  
 
Furthermore, the microfluidic market was estimated to worth £1 billion in 2011 
with an average of 19% annual growth (Frédéric, 2011). The demand for 
microfluidics devices for research in pharmaceuticals and life sciences is expected 
to thrive in the coming years with projection of 23% growth in 2016, pushing the 
sector to almost £2.5 billion sales (Frédéric, 2011). Despite the rapid development, 
commercialisation is still a major challenge of this technology. High initial 
investments and running fabrication cost are among the hurdles of market entry. 
Mark et al. (2010) proposed the concept of a well-defined microfluidic platform, 
whereby combining individual microfluidic unit operations within a consistent 
fabrication technology may results in lower production cost and less financial risks. 
 
1.2 Application of Microfluidics  
We have seen rapid developments on microfluidics technology in the recent years. 
Annual numbers of publication on the topic of microfluidics increases dramatically 
over the last 10 years, whereby 10,000 of journal papers have been published and 
this number continue to proliferate (Mark et al., 2010). The main driving force 
behind the fast growth of this technology is due to its potential to be exploited for a 
wide range of biological applications such as high-throughput screening in drug 
development (Pihl et al., 2005; Dittrich & Manz, 2006; Lombardi & Dittrich, 2010), 
bioanalyses (Huh et al., 2005; Breslauer et al., 2006), single cell and molecule 
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studies (Wheeler et al., 2003; Lemke et al., 2009), drug delivery and advanced 
therapeutics (Pihl et al., 2005; Dittrich & Manz, 2006; Lombardi & Dittrich, 2010),  
and point of care diagnostics (Lee & Lee, 2004; Whitesides, 2006; Mark et al., 
2010).  
 
1.2.1 Micro Total Analysis System (µTAS) 
Term micro total analysis system (µ-TAS) was first coined in the early 1990s by  
Manz et al. (1990) on their miniature system of the wet chemical and electrical 
detection for chemical sensing. This term was gradually expanded to lab-on-a-chip 
(LOC) with increasing application in tissue engineering and cell biology studies 
(Folch, 2013). An important aspect of µ-TAS is the ability to perform complete an 
analytical microsystem in a single device. The various functional units usually 
include sample acquisition, pretreatment, separation, post-treatment and a detection 
system (Lee & Lee, 2004) (Figure 1.1). 
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Figure 1.1: Schematic diagram of micro-Total Analysis System (#-TAS). Key technologies and units 
that need to be incorporated into #-TAS. Image reproduced from (Lee & Lee, 2004). 
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Development of miniaturised protein analysis is progressing and it is more likely to 
be used widely in the near future. With the low sample requirement feature, a 
microfluidic approach appears to be an attractive choice to overcome the limited 
protein sample problem compared with DNA, which can be amplified by PCR. The 
advantages offered by microfluidic system will allow for high-throughput 
processing of multiple samples in an integrated microfluidic system for proteome 
analysis. High-sensitivity peptide mapping was developed that used micro-column 
high-performance liquid chromatography (HPLC) and capillary zone 
electrophoresis (CZE) separations (Cobb & Novotny, 1989). In this work, 
separations of 100 ng (4 pmol) of tryptic digest samples of &-casein were achieved 
with micro-column HPLC, while separations of approximately 2 ng (80 fmol) of &-
casein tryptic digest (from a total sample size of 50 ng) were possible with CZE. 
Integration of on-line coupling with MALDI (matrix assisted laser 
desorption/ionization) has become one of the alternatives for mass spectrometric 
analysis as it offers an extended range of mass limit for biomolecules over 300,000 
Da (Ekström et al., 2000). They devised a platform, which integrates automated 
sampling pretreatment, microchip IMER, microdispenser for sample deposition and 
automated MALDI-TOF-MS system analysis as shown in Figure 1.2. 
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Figure 1.2: Integration of on-line coupling with matrix assisted laser desorption/ionization (MALDI). 
Total analysis system and its different parts; (A) automated sample pretreatment and injection; (B) 
microchip IMER (the photo inset shows a SEM picture of the lamella structure with the porous 
layer; (C) the microdispenser used to deposit sample into microvials, (D) shallow nanovials on the 
MALDI target plate; and (E) automated MALDI-TOF MS analysis. Image reproduced from 
(Ekström et al., 2000). 
 
µ-TAS in DNA application has progressed rapidly since the completion of the 
human genome project in 2003. New platforms are being developed to enhance 
speed, sensitivity and high-throughput of the DNA analysis systems. DNA 
microchip for genomic analysis was developed for gene sequencing (Fodor et al., 
1991) which then has been commercialized by Affymetrix. This technique used 
light to micropattern the chemical synthesis of oligonucleotides. Fan et al. (1999) 
demonstrated the use of paramagnetic beads for gene expression analysis in a 
microfluidic chip that takes a few seconds for the hybridization process to complete. 
An advanced integrated microfluidic device that allows for automated multistep 
genetic assays was developed by Anderson et al. (2000). This sophisticated device 
was tested for the detection of mutations in a 1.6 kb region of the HIV genome from 
serum samples. It has the ability to perform various analysis processes, which 
include microliter chemical amplification, serial enzymatic reactions, metering 
mixing and nucleic acid hybridization. With plastic as the fabricated material, this 
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system could be applied for low cost portable DNA analysis instruments for many 
different applications.  
 
As the utilization of microreactors for bioassays becomes widely used, system 
integration and design complexity are expected to increase dramatically. 
Automation offers great benefits in terms of reducing human effort, enable high-
volume production, ease in optimization, time saving and provide safer operations. 
Chakrabarty & Zeng (2005) described different actuation mechanisms for 
microfluidics-based biochips, as well as associated design automation trends and 
challenges. A microreactor system for gas-phase catalysed reactions was coupled 
with an automation system that employed process logic controller with a human-
machine interface for display of sensors and monitoring of process control loops 
(Quiram et al., 2007). This system was able to operate at 500 Hz with all 24 
microreactor heaters being under closed-loop PID control.  
 
Thorsen et al. (2002) innovated large-scale integration of microfluidic chips that 
contain micro-pumps, micro-valves, and micro-channels, which exploits the usage 
of fluidic multiplexor to run the network. Pollack et al. (2002) superseded the use of 
conventional pumps, valves or channels with manipulation of discrete droplets. This 
system based upon direct electrical control of the surface tension or also known as 
electrowetting allowed the experiment to successfully transferred droplets of 0.7 – 
1.0 l of 100 mM KCl solution between adjacent electrodes at voltages of 40 – 80 V. 
The switching rate of the electrode up to 20 Hz and average velocities of 30 mm/s 
was achieved and this illustrates nearly 100-fold increase compared to the previous 
electrical methods.  
 
1.3 Materials and Microfabrication 
1.3.1 Construction materials  
There are many options on the type of material used to fabricate the microreactors, 
but it is all dependent on the application desired. Most common materials used in 
microfluidic systems are silicon, polymer, glass and metal. Silicon and glass were 
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widely used in the earliest development of microfluidic as the fabrication method 
was adopted from the micromechanical systems (MEMS). These materials are often 
not the ideal material for microfluidic applications due to the expensive fabricating 
cost, difficulty in component integration and surface characteristics (especially 
permeability to gases) that are not well suited to biological applications (Beebe et 
al., 2002; Verpoorte & Rooij, 2003). Moreover silicon is opaque to visible and 
ultraviolet light that make it impractical for optical method detection. Nonetheless, 
silicon and glass would be a perfect candidate for the material used in chemistry 
applications that require strong solvents, high temperatures or chemically stable 
surfaces (Woolley & Mathies, 1994; Mellors et al., 2008).  
 
The trend of using a polymer as the material for microfluidic devices has increased 
tremendously in recent years. The most widespread used polymer is PDMS 
(polydimethylsiloxane). PDMS exhibits excellent attributes that make it suitable for 
the current microfluidic devices, that include inexpensive cost, optical transparency, 
low toxicity and permeability to gases (Verpoorte & Rooij 2003; Whitesides 2006;  
Hong et al. 2009). This elastomer is easy to handle and being used extensively for 
creation of prototype devices under non-clean room conditions. Integration of 
valves, pumps and mixer in the system is possible by using multilayer soft 
lithography (Hong et al. 2009). However, this material is prone to swelling in the 
presence of organic solvent. 
 
1.3.2 Microfabrication methods  
In the early development of microfluidic devices, fabrication was performed 
through a micromachining process where silicon was used as the fabricating 
material. This method can be divided into two types, which are bulk 
micromachining and surface micromachining. Bulk micromachining refers to those 
processes that lead to structures in the single-crystal wafer, whereas surface 
micromachining results in structures located on the wafer surface (Verpoorte & 
Rooij, 2003). These methods offer high precision quality for the devices. However, 
most of the microfluidic devices do not require the precision that micromachining 
offers. This fabrication method appears to be less adopted in many microfluidic 
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devices as it is time consuming, expensive, labor intensive and requires highly 
specialized skills and facilities (Beebe et al., 2002; Malek, 2006). 
 
The need for flexible and rapid processes is increasing in all fields of microsystem 
technologies. Rapid prototyping becomes more appealing as to promote the usage 
of microfluidic devices. A simple method for fabrication has been introduced that is 
called soft lithography. The process involves the casting of solution (polymer), 
typically PDMS into the master that has been structured for specific design. The 
master can be moulded by using micromachining or photolithography techniques. 
The application of soft lithography has been reported extensively by many recent 
works. Park et al. (2010) used a micro-macro hybrid soft-lithography master 
(MMHSM) fabrication technique to create a PDMS microdevice having two 
integrated macroscale reservoirs and 40 fluidic interfaces. Li et al. (2005) 
demonstrated the multiple replication of the PMMA master for PDMS-based 
devices, which contain normal deep microfluidic channels and a much deeper 
optical fiber channel, and allows for laser-induced fluorescence (LIF) detection. A 
multidimensional layer of microfluidic devices has been fabricated by Anderson et 
al. (2000) using the membrane sandwich method. This method combines a 
convenient process for microfabrications rapid prototyping based on high resolution 
printings with multilevel photolithography, replica molding, and supported 
membrane transfer. The simplicity and flexibility that this method offers make it 
practical for prototyping microfluidic devices. 
 
Injection moulding could also be used in fabrication of microfluidic devices for 
polymers. It was widely used in macroworld fabrication before it is been introduced 
in microfluidic system. Typically the polymer material is heated up at a certain 
glass transition temperature and injected with high pressure into the mould. Rapid 
cooling will take place as the mould is maintained at lower temperature and the 
moulded part is ready within a few minutes. The advantage of this technique is the 
ability to form three-dimensional objects in particular, the integration of fluidic 
interconnects (Gärtner et al., 2007). Furthermore, this process is preferable over the 
hot embossing technique with regard to the fabrication time and relatively cheap for 
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high volume manufacturing. However, this method requires complicated moulding 
tools that can withstand the operation conditions and imposes limitation on the 
resolution and material choices (Becker & Gärtner, 2008). 
 
Another method for rapid prototyping for microfluidic devices is laser ablation. 
This technique involves directing laser pulses at the plastic surface in defined 
regions, which causes degradation of the plastic at those spots as a consequence of a 
combination of photochemical and photothermal degradation processes (Verpoorte 
& Rooij, 2003). Yin et al. (2005) presented a microfabricated approach to a nano 
liquid chromatography system by employing the laser ablation method to produce 
channels, ports, and frit structures on the chip. Furthermore, the laser ablation 
technique can be further used to modify surface charge on specific surfaces within a 
preformed plastic microchannel. This results in better control, adjustment, and 
modulation of the electroosmotic flow without using wall coatings or changing the 
geometry of the channel to achieve the desired flow profile (Johnson et al., 2001). 
Roberts et al. (1997) demonstrated fabrication of a miniaturized liquid-handling 
systems on polymer substrate chips using the same technique. Efficient sealing was 
obtained, while photoablated surfaces showed an increase in their hydrophilicity 
and rugosity, which indicates a correlation between the ablative changes in surface 
conditions and the resulting electroosmotic flow. All in all, the laser ablation 
method offers a highly precise, fast and contactless alternative to classic machining. 
Malek (2006) has discussed in detail the use of laser processing for microfluidics 
application. 
 
1.4 Microreactors 
Microreactor technology has immense potential to notably improve chemical and 
biological analyses as well as abundant applications in medical diagnostics and 
therapeutic devices. Microreactors have been developed to facilitate work in 
chemical and biochemical analysis as well as being integrated as parts of the lab-on-
a-chip and µTAS (Urban et al., 2006). Owing to their miniature size, microreactors 
offer many advantages to the industry especially in organic synthesis which include; 
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improved selectivity and reliability, faster speed to market, safety, cost savings and 
easier scale-up (Ehrfeld et al., 2000). 
 
The application of microreactors in fine-chemical industries is driven by the ability 
of the technology to ease the practical difficulties related to performing the 
chemical reactions using traditional methods (Haswell & Skelton, 2000). A high 
level of safety issue which include explosive, toxic and hazardous materials are the 
most common bottleneck presence in the conventional chemical reaction method. 
This safety aspect was addressed successfully in the production of organic 
peroxides from acid chlorides (Srinivasan et al., 1997), synthesis of hydrogen 
cyanide (Ehrfeld, 1999) and fluorine-containing organic compounds (Chambers & 
Spink, 1999) performed on a microreactor platform. 
 
Besides that, many works have been demonstrated in enzyme microreactors 
applications. These cover the area in protein and peptide mapping analysis (Ekström 
et al., 2000; Guo et al., 2003; Kato et al., 2004), nucleic acids (Zhang & Yeung, 
1998; Lee et al., 2000; Ke et al., 2004) and model enzymatic systems (Koh & 
Pishko, 2005; Hickey et al., 2007, 2009; Ngamsom et al., 2010; Alam et al., 2011; 
Matsuura et al., 2011). The incorporation of the enzyme may be either in 
immobilised (heterogeneous) form or in solutions (homogeneous biocatalysis). 
However, most of the reported works were based on immobilised enzymes due to 
its ability to be recycled, therefore reducing the operational cost. The applications of 
immobilised microfluidic enzymatic reactors were discussed in detail by Matosevic 
et al. (2011) and Nidetzky (2013). 
 
1.4.1 Biocatalyst in microreactors 
Biocatalysis posseses very compelling features that make it as one of the important 
tools in bioprocess industry especially in the biotechnology applications. This is 
mainly due to the ability of the biocatalyst to perform complex chemical 
conversions under mild environmental conditions with high specificity and 
efficiency (Christen & Metzler, 2005; Pollard & Woodley, 2006). Moreover, the 
continuing progress in medical research, genomics, proteomics and related 
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emerging biotechnology fields also lead to the exponential growth of the application 
of biocatalysis. The potential that biocatalysis has, makes it a perfect alternative to 
chemical processes particularly the exquisite regioselective and stereoselective 
properties that enable rather difficult syntheses to be performed with fewer steps 
and more benign conditions (Figure 1.3). 
 
32 
 
  
Figure 1.3: Complex drug compounds with multiple chiral centres and the biocatalytic step(s) 
associated with the development of each synthetic route. Image reproduced from Pollard & Woodley 
(2007). References: [17] (Buckland et al., 1999), [22] (Pollard et al., 2006), [59] (DeSantis et al., 
2003), [83] (Roth, 2002), [84] (Yasohara et al., 1999), [85] (Greenberg et al., 2004), [86] (Lin et al., 
2002), [87] (Brands et al., 2003), [88] (Federspiel et al., 1999), [89] (Guo & Frost 2004), [90] 
(Blacklock, 1993), [91] (Holt, 1996). 
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With the increasing demand from the industry to seek new routes to produce 
complex molecules, there is a need to have a system or tools as a platform to guide 
the development of new biocatalytic processes. Where typically, large scales incur 
higher expenses, there are other much lower-scale devices that can be used. One 
such technology are microreactors as they allow a reaction to be conducted which 
only requires a small volume of reagent, short processing time, and most of all, the 
ability to be integrated with various analytical system.  
 
1.4.2 Batch and continuous microreactors 
One of the important factors affecting bioreactor performance is the mode of 
operation. The most common modes of bioreactor operation are batch and 
continuous. The choice of operating mode has a significant effect on the substrate 
conversion, product concentration, susceptibility to contamination and process 
reliability (Doran, 2013). A batch reactor measures the rate of substrate conversion 
to product as a function of time. Whereas, in a continuous flow reaction, they 
operate at steady state and remain unchanged for as long as the flow rates are kept 
constant (Denbigh, 1944). In industry, a large number of processes in the 
production of polymers, specialty and fine chemicals as well as pharmaceuticals are 
operated in batch (Friedrich & Perne, 1995). While many chemical processes are 
produced in batch reactors, the direction in process industries is moving towards 
continuous reactors for commercial manufacture. A defining feature of continuous 
flow systems is continuous flow processing, which further brings inherent safety 
and economical advantage to the process (Watts, 2004). Moreover, the scale-up 
difficulties commonly occur in batch reactors can be improved in continuous flow 
reactors (Anderson, 2001; Brivio et al., 2006). 
 
In addition, a batch microreactor is commonly associated with its limitation on the 
reagents mixing time (Gleason & Carbeck, 2004). With a small dimension of the 
microreactor, the Reynolds numbers are usually small and flow is laminar, whereby 
the mixing is dependent almost completely on diffusion (Jähnisch et al., 2004). The 
characteristic time for diffusive mixing is given by the following equation: 
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where x is distance travelled and t is time for the reagents to mix, and D is the 
diffusion coefficient. 
 
Therefore, batch reactors are characterised by a “dead time”. This is the time it 
takes for the reactants to mix before kinetic data can be collected. Based on the 
equation, the dead time is estimated to be on the order of seconds in a micrometer-
sized batch reactor (Gleason & Carbeck, 2004). This would account for a significant 
loss that could prevent the study of fast enzyme kinetics when operated in batch 
mode.  
  
Numerous studies have been demonstrated with an immobilised biocatalyst run in 
continuous flow mode. The operation can be performed advantageously due to the 
shorter average residence time spent by the substrate molecules within the reactor. 
This results in a far greater productivity from a fixed amount of enzyme than is 
achieved in batch process as well as minimizing dead time operation. This type of 
operation was demonstrated in many microreactors application, whereby the 
reactions provide improved yields and selectivity when performed in a continuous 
manner at the microscale as compared to the batch process (Greenway et al., 2000; 
Wilson & McCreedy, 2000; Kobayashi et al., 2004). In addition the yield of a 
reaction could be improved dramatically by removing the inhibitory product by 
performing the reaction in a continuous flow mode (Shin & Kim, 1999; Andri' et 
al., 2010).  
 
1.4.3 Kinetic analysis 
Another application of microreactors is as a platform for analysing kinetic 
parameters of particular enzyme. Utilising the attributes of this system allows the 
study of enzyme kinetics in a simpler manner where hundreds of enzyme reactions 
can be conducted simultaneously with minimal amount of material at very short 
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time. Besides that, immobilisation of enzyme permits the device to be reused again 
while preserving the stability of the enzyme. Nonetheless, study of enzyme kinetics 
plays a very important role in developing new biocatalysts that could be used for a 
wide range of applications.  
 
The ability of enzymes to speed up the rate of reaction by many orders of 
magnitude, and the selectivity towards substrate make it as a valuable element in 
biochemical reactions. With the study of enzyme reactions, one can explain 
mechanisms of enzyme catalysis and regulation. Enzyme kinetics deals with time-
dependent enzyme reaction outside equilibrium. The reactions usually follow the 
well-known Michaelis-Menten kinetics under steady state conditions. Besides that, 
there are several factors that affect the kinetics of the enzyme that include, 
temperature, pH, enzyme and substrate concentration. Most enzymes work at 
optimum pH and temperature at which the activity is the greatest. 
 
Kinetic data for the enzyme is important to study specific reactions catalysed by the 
enzyme. One of the models to study the kinetics is that of Michaelis–Menten 
(Michaelis et al., 1913). The Michaelis–Menten equation relates the initial reaction 
rate, v to the substrate concentration, [S]. The corresponding graph is a rectangular 
hyperbolic function and the maximum rate is described as Vmax (Eq 1.1) 
 
(1.1) 
This equation can be rearranged to obtain linear relationships, which permit more 
precise fitting to the experimental data, and estimation of the values of Km and Vmax. 
There are several linear regression methods that can be used to fit to the Michaelis 
Menten model. This includes Lineweaver"Burke (Lineweaver & Burk, 1934), 
Eadie"Hofstee (Eadie, 1942; Hofstee, 1952) and Hanes"Woolf (Hanes, 1932). The 
Lineweaver-Burk double reciprocal plot rearranges the Michaelis-Menten equation 
as: 
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(1.2) 
However, this double reciprocal plot is prone to errors inherent in all inverse plots. 
Moreover often most points on the plot are found far to the right of the y-axis where 
the concentration of the substrate is lower. These are the points at which the 
precision of determining the rate of reaction is lowest, because the smallest amount 
of product has been formed. Alternatively, the Eadie-Hofstee plot (Eq. 1.3) can be 
used for the linear regression plot. This plot reduces the error of the undue weight 
given to points at low substrate concentration. Nevertheless, both axes of the plot 
use dependent variables, which increase the errors in estimating the kinetics value.  
 
(1.3) 
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1.5 Immobilised Enzyme Microreactors (IEMRs) 
1.5.1 Overview of Enzyme Immobilisation 
The integration of an immobilised biocatalyst in a microreactor expands the 
application of this system especially in the production of many biotechnological 
products with applications in biosensor, diagnostics and therapeutics (Guilbault et 
al., 1991; Lombardi & Dittrich, 2010; Yeo et al., 2011). The main feature of the 
enzyme immobilisation is the ability to reuse the enzyme, separation from the 
solvent system and extensive use over a longer period of time (Tischer & Kasche, 
1999; Pollard & Woodley, 2007). The biocatalyst can be immobilised either using 
the isolated enzymes or the whole cells. Moreover, it can be coenzyme dependent or 
coenzyme independent. For coenzyme dependent, employment of whole cells is 
more desirable. This approach enables the cell to regenerate the cofactor internally 
so that no external addition is necessary (Stewart, 2001). Despite of the efficient 
way for the cofactor regeneration in situ, whole cells are not able to tolerate high 
substrate or product concentration (>1g/L), restricted use with organic solvents and 
generation of unwanted side products (multiple enzyme reaction) are other issues to 
consider (Pollard & Woodley, 2007).   
 
In spite of the advantages that enzyme immobilisation brings, experimental 
investigations have revealed unfavorable results, such as significant reduction in 
enzyme activity compared with soluble enzymes (Mao et al., 2002; Gleason & 
Carbeck, 2004; Delouise & Miller, 2005; Kerby et al., 2006). They suggested that 
the loss of activity of the immobilised enzyme might due to the mass transfer effect, 
altered conformation of enzyme and steric hindrance. However, improved stability 
under working conditions and the reusability factor can compensate for such 
drawbacks, resulting in an overall benefit. 
 
Several changes can be made in practice to mitigate the problems present in enzyme 
immobilisation. Mass transfer effect can be reduced by decreasing the particle size 
of the carriers (<100 µm), reducing the enzyme loading for enzymes with high 
specific activity and opting for preferential binding at the outer shell of carrier 
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materials (Tischer & Kasche, 1999). Spacer molecule can be introduced to the 
larger proteins to improve steric accessibility to the active sites (Nouaimi et al., 
2001). 
 
While the cost of enzyme is rather high, the implementation of immobilised enzyme 
can reduce the operational costs. With the possibility of the enzyme to be reused 
and separation from the solvent system, the cost saving can only be achieved by the 
repeated or prolonged use of the immobilised enzyme (Figure 1.4). 
 
 
Figure 1.4: Manufacturing cost for immobilised enzymes (price per gram enzyme) are reduced as 
their annual production increases, roughly along a straight line when plotted on a logarithmic scale. 
Image reproduced from (Tischer & Kasche, 1999). 
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1.5.2 Choice of supports  
The characteristics of the matrix are of paramount importance in determining the 
performance of the immobilised enzyme system. The ideal matrix for the 
immobilisation process should have the following characteristics: (i) large surface 
area, (ii) permeability, (iii) hydrophilic character, (iv) insolubility, (v) chemical, 
mechanical and thermal stability, (iv) high rigidity, (vii) chemical reactivity for 
coupling of the ligands, and (viii) resistance to microbial and enzymatic attack 
(Krenková & Foret, 2004). There are many types of supports available 
commercially that can be classified as organic and inorganic according to their 
chemical composition (Table 1.1)  
 
Table 1.1: Classification of supports 
Organic 
Natural polymers 
• Polysaccharides: cellulose, dextrans, agar, agarose, chitin, alginate 
• Proteins: collagen, albumin 
• Carbon 
Synthetic polymers 
• Polystrene 
• Other polymers: polyacrylate, polymethylacrylates, polyacrylamide, 
polyamides, vinyl and allyl-polymers 
Inorganic 
Natural minerals: bentonite, silica 
Processed materials: glass (nonporous and controlled pore), metals, controlled pore 
metal oxides 
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1.5.3 Methods of Immobilisation 
Several methods are available for enzyme immobilisation. Miyazaki & Maeda 
(2006) have summarized typical techniques for preparation of immobilised enzyme 
microreactor (IEMR) as shown in Table 1.2. These techniques include particle 
entrapment, surface modification and membranes using various types of media. 
Advantages of IEMR are discussed in the next section. 
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Table 1.2: Typical techniques for preparation of immobilised enzyme microreactor 
Technique Media Immobilisation method Immobilised enzyme Reference 
Xanthine oxidase  Glass Cross-linking (3-aminopropylsilane 
glutaraldehyde) 
Horseradish peroxidase 
(Richter et al., 
2002) 
Polystylene Biotin-Avidin (avidin- coated beads 
were used) 
Horseradish peroxidase (Seong & 
Crooks, 2002) 
Agarose Complex formation (Ni-NTA and His 
tag) 
Bacterial P450 (Srinivasan et 
al., 2004) 
Magnetic 
beads 
Cross-linking (3-aminopropylsilane 
glutaraldehyde) 
Glucose oxidase (Nomura et al., 
2004) 
Polymer 
monolith 
Entrapment (2-vinyl-4-4-
dimethylazlactone, ethylene 
dimethacrylate, 2-hydroxyethyl 
methaacrylate, acrylamide) 
Trypsin (Sakai-Kato et 
al., 2004) 
Trypsin (Sakai-Kato et 
al., 2003) 
Silica 
monolith 
Entrapment within porous silica 
Protease P (Kawakami et 
al., 2004) 
Particle 
Entrapment 
Aluminium 
oxide 
Cross-linking (3-aminopropylsilane 
glutaraldehyde) 
Horseradish peroxidase (Heule et al., 
2003) 
SiO2 surface Physical adsorption of biotinylated 
polylysine/biotin avidin 
Alkaline phosphatase (Gleason & 
Carbeck, 2004) 
PDMS (O2 
plasma 
treated) 
Physical adsorption of lipid 
bilayer/biotin avidin 
Alkaline phosphatase (Mao et al., 
2002) 
PDMS Physical adsorption of 
fibrinogen/photochemical reaction of 
fluorescein-biotin 
Alkaline phosphatase (Holden et al., 
2004) 
Surface 
Modification 
Silicon Cross-linking (3-aminopropylsilane Trypsin (Ekström et al., 
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glutaraldehyde) 2000) 
Cucumisin (Miyazaki et al., 
2003) 
Lipase (Miyazaki et al., 
2004) 
Fused silica 
(sol-gel 
modified) 
Cross-linking (3-aminopropylsilane 
succinate) 
L-lactic dehydrogenase (Miyazaki et al., 
2005) 
PMMA-
modified 
with butyl 
methacrylate
and/(methyl
acryloy 
propyltrimet
hoysilicane 
Cross-linking (Si-O bond between 
modified surface and silica monolyth) 
Trypsin (Qu et al., 2004) 
PDMS (O2 
plasma 
treated) 
Cross-linking (Si-O or Si-O-Al bond 
between titaniaor alumina monolyth) 
Trypsin (Wu et al., 2004) 
Fused silica Cross-linking between physically 
immobilised silica particle (3-
aminopropylsilane/succinate) 
Lipase (Nakamura, 
2004) 
Alkaline phosphotase 
 
PDMS Entrapment within hydrogel formed 
on the surface 
Urease 
(Koh & Pishko, 
2005) 
PDMS/Glass Place PVDF membrane which adsorb 
enzymes 
Trypsin (Gao et al., 
2001) 
Glass Covalent cross-linking with Nylon 
membrane formed at liquid-liquid 
interface (glutaraldehyde) 
Horseradish peroxidase  (Hisamoto et al., 
2003) 
Chimotrypsin 
Membrane 
PTFE Enzyme-embedded membrane 
formation using 
glutaraldehyde/paraformaldehyde Trypsin 
(Honda et al., 
2005) 
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1.5.4  Characteristic Features of IEMRs 
 
1.5.4.1 Enhanced Stability of the enzyme 
Generally enzymes in solution are not stable for extended time and lose their 
activity during storage. However, immobilisation of enzymes can overcome these 
problems by facilitating their application under harsh environmental conditions of 
temperature, pH and organic solvents (Sakai-Kato et al., 2002; Nomura et al., 
2004). Immobilised enzymes also reduce the risk of autolysis and can be recycled 
(Fernandes, 2010). Sakai-Kato et al. (2002) immobilised trypsin via encapsulation 
by sol-gel method, which was conducted under mild conditions. This technique is 
required to maintain the enzyme catalytic activity and the encapsulated trypsin 
displayed increased stability during prolonged use compared to that in free solution.  
 
In the work described by Srinivasan et al. (2004), nickel-nitrilotriacetic (Ni-NTA) 
agarose beads were used to immobilised PikC hydroxylase into a microfluidic 
biochip. The high enzyme loading enabled the rapid hydroxylation of the macrolide 
YC-17 to methymycin and neomethymycin in about equal amounts with a 
conversion of >90% at a flow rate of 70 nL/min. Nevertheless, stability of the 
enzyme was enhanced which enables the half-life of the enzyme to be extended 
from 3 hours in free solution to 9 hours in the immobilised form.  
 
Magnetic microbeads were also used in a microreactor where it can be readily 
injected into the flow analysis, and the retention takes place within the flow line by 
a small permanent magnet located near the detector (Nomura et al., 2004). The 
immobilised enzymes were shown to be stable and active for more than 8 months 
when stored at 10°C. Utilization of silica-based particles has been recognized to be 
highly effective as the scaffold for enzyme immobilisation. As reported by Berne et 
al. (2006), polyethyleneimine (PEI)-mediated silica encapsulation showed 
improvement in mechanical properties of the immobilised enzyme and excellent 
operational stability. More than 90% conversion of nitrobenzene was observed 
during continuous use for more than 3 days at room temperature and a flow rate of 5 
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µL/min.  
 
1.5.4.2 Improved Reaction Efficiency 
One of the main applications of IEMR is the protein digestion for peptide mapping. 
This process consumes immense time with manual sampling system and extended 
proteolytic digestion. Efficient protein or peptide digestion can be carried out 
through enzymes immobilisation. The feature of this method permits high 
concentration of enzymes to be immobilised onto the surface and finally results in 
rapid catalytic turnover. Ekström et al. (2000) described their work on 
immobilisation of protease enzymes on µ-chip IEMR by following the standard 
procedures for enzyme coupling to silica matrixes. Larger surface area was obtained 
by treating the silicon with anodization in an HF/ethanol solution, yielding a thin, 
porous surface layer on the channel walls. This resulted in significant increase in the 
speed of the digested protein, which was 200-1000 faster than in solution digestion. 
Furthermore, the immobilised protease prevents autolytic interferences from the 
proteolytic enzyme in the mass spectra.  
 
In the work by Miyazaki et al. (2005), His-tagged dehydrogenase enzyme was 
immobilised onto a microchannel surface through Ni-complex. High concentration 
of immobilised enzymes were achieved as a result of multilayer binding of the 
enzymes on the surface and higher performance of the microreactor was reported 
compared to free enzyme reaction. A layer-by layer self-assembly technique onto 
silicon was introduced by Jones et al. (2004) where urease enzyme was 
incorporated into microchannels of a polymeric matrix of polydimethylsiloxane 
(PDMS). The multilayers comprise of polydimethyldiallyl ammonium chloride 
(PDDA) and polystyrene sulfonate (PSS) to which urease enzyme was attached. 
This method displayed greater stability of the enzyme than those entrapped in 
PDMS and obtained high conversion of urea with a proportional increase in 
residence time and enzyme loading. 
 
 
45 
1.5.4.3 Utilisation of Crude Enzyme 
Generally, high purity of enzyme is used for the immobilisation of biocatalyst to 
ensure high-throughput analysis. However, researchers have to bear the cost 
incurred for the purification of the enzymes. Miyazaki et al. (2005) incorporated 
crude cell extracts for the immobilisation of enzyme. Supernatant of cell lysate of 
BL21 (DE3) cells expressing L-lactic dehydrogenase was immobilised in the same 
way as performed for the purified sample. The same amount of protein was 
immobilised and the performance of the microreactor indicated the same results as 
the purified protein. This technique may create a new route for simplification of 
protein purification whereby enabling integration of purification and immobilisation 
of enzymes in one step.  
 
1.5.5 Enzyme Immobilisation Through His-Tag 
Perhaps the most general approach for the immobilisation of oriented protein 
molecules is the use of recombinant tags, particularly poly histidine (His-tag). This 
technique is stemmed from immobilised metal ion affinity chromatography (IMAC) 
and has been applied extensively to protein immobilisation (Block et al., 2009; 
Cheung et al., 2012). In this method, a chelate group (iminodiaacetic acid (IDA) or 
nitrolotriacetic acid (NTA)) is attached to a solid support which then can bind 
strongly to a metal ion such as Ni2+ or Cu2+ via three or four binding sites, leaving 
three or two vacant sites for coordination to imidazole group of polyhistidine units 
on the tagged protein molecule. Complex formation between Ni-NTA and His-tag 
renders stability for the immobilisation and the interaction can be easily uncoupled 
through incorporation of imidazole or EDTA.  
 
With the advent of recombinant protein technology, the incorporation of His-tag to 
either C-terminus or N-terminus to the target protein becomes feasible. Roche 
obtained patents on the use of nitrilotriacetic acid (NTA) as a ligand for 
immobilizing metals in affinity chromatography and for the incorporation of 
histidine affinity tags into recombinant proteins, whilst QIAGEN is the distributor 
for the expression vectors, Ni-NTA purification matrices, and the EasyXpress 
Protein Synthesis system. This elegant technique offers fast and specific binding 
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and allows protein immobilisation without pre-purification steps. Moreover, the 
His-tag does not usually interfere with the structure or function of proteins and does 
not affect the secretion, compartmentalization, or folding of fusion proteins within 
cells (Cha et al., 2004). The tag also allows for purifying recombinant proteins in 
denaturing conditions because its mode of action is dependent only on the primary 
structure of proteins.   
 
Application of the immobilisation of protein molecules via a His-tag has been 
successfully demonstrated. Site-specific immobilisation which orientates all 
proteins uniformly was performed by Abad et al. (2005), where His-tagged of 
horseradish peroxidase and ferredoxin- NADP+ reductase, confirmed the full 
functional attachment of the protein to the NTA-Co(II)-platform. These 
functionalized nano particles thus represent an attractive ready-to-use tool for 
protein immobilisation on nanoparticles. Besides that, immobilisation of His-tagged 
Rhodotorula gracilis D-amino acid oxidase (RgDAO) on Ni-NTA magnetic beads 
was demonstrated by Kuan et al. (2008). The immobilisation of RgDAO enhanced 
its stability against thermal inactivation where the relative activity of the 
immobilised enzyme was 56% while the free enzyme was completely inactivated 
after incubation at 50°C for 1 h. The residual activity and the storage stability were 
also improved in the immobilised form of the enzyme. Cha et al. (2005) described 
that enzymes immobilised through poly His-tag exhibits similar activities as in the 
free solution as a result of highly specific orientation offered by the His-tag linkage.  
 
1.5.6 Enzyme Immobilisation in Fused-Silica Microcapillary  
Microcapillaries are originally used as analytical columns in gas chromatography 
(GC) analysis. A glass capillary was first used before it was replaced by a fused 
silica capillary in the early 1980s, which the application then has been extended in 
many other miniaturized analytical columns in various separation techniques. The 
fused-silica capillary is now widely available, relatively cheap and easy to handle. It 
also allows UV and fluorescence detection to be performed directly on the capillary. 
The fused-silica capillary is available in several different dimensions with internal 
diameter typically between 1 and 700 µm and outer diameter between 150 and 850 
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µm. 
 
In order to take full advantage of the fused-silica capillary, and to extend the range 
of its application, it is necessary to treat the surface of the capillary to suit the 
application of interest. Miyazaki et al. (2003) developed a simple method to form a 
nanostructure suitable for catalyst immobilisation on a fused-silica capillary surface 
by a solution of 3-aminopropylsilane (Figure 1.5). They applied the sol–gel 
procedure, which has been utilized for porous structure preparation in batch 
systems. After treatment of the surface modification, the serine protease cucumicin 
was successfully immobilised as multilayers on the surface and the activity of the 
enzyme was demonstrated. This work was further studied (Miyazaki et al., 2004), 
where the cucumisin-immobilised microreactor showed high efficiency that enabled 
hydrolysis of substrate within 2 seconds. Moreover, the system was improved with 
a reversible immobilisation method that allowed denatured enzyme to be replaced. 
In addition, Amankwa & Kuhr (1992) demonstrated the immobilisation of trypsin 
via a biotin-avidin-biotin couple onto surface of a fused-silica capillary. The strong 
coupling method produces a highly stable and reusable catalytic active capillary. 
Matosevic et al. (2009) performed quantification of immobilised transketolase 
kinetics based on the reversible immobilisation of His6-tagged enzymes via the Ni-
NTA linkage to surface derivatised silica. The capillary derivatisation protocol was 
adopted from Miyazaki et al. (2005). The kinetics data obtained was comparable 
with reaction in free solution indicating that the microreactor is a powerful tool for 
enzyme kinetic parameter quantification. 
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Figure 1.5: Surface modification process for reversible immobilisation of proteins. The fused silica 
surface was modified with a mixture of 3-aminopropyltriethoxysilane/methyltriethoxysilane prior to 
the above treatment. (Miyazaki et al., 2005) 
 
1.6 Multi-Step Enzyme Reactions in Microreactors 
 
1.6.1 Enzymes to be studied  
1.6.1.1 Transketolase Enzyme and Reaction 
Transketolase (TK) (EC 2.2.1.1) is an important enzyme that is responsible for the 
reversible transfer of a two-carbon ketol moiety from a ketose to an aldose in a key 
step of the pentose phosphate pathway (Meining et al., 2000; Chen et al., 2007). It 
does also catalyze a reaction in the Calvin cycle in photosynthesis process (Henkes 
et al., 2001). Transketolase can be isolated from many sources which include, yeast 
(Effenberger et al., 1992; Kobori et al., 1992) , spinach (Demuynck et al., 1991; 
Dalmas & Demuynck, 1993) and recombinant Escherichia coli strains (Hobbs et 
al., 1993; Sprenger et al., 1995). Over expressed TK in E coli can be optimised to 
 
49 
get higher level of TK expression up to 4 kg of enzyme from a 1000-L glycerol-fed 
fermentation (French & Ward, 1996) with TK represented around 35% of the 
intracellular protein expressed by the cell. 
 
The functional form of the enzyme is homodimer with a subunit molecular weight 
of 74,200 Da, with both active sites having equal catalytic activity (Meining et al., 
2000). Each monomer comprising a pyrophosphate (PP)-binding, pyridinium (Pyr)-
binding, and C-terminal domain (Figure 1.6). For TK to become fully functional, it 
requires reconstitution of cofactors which are magnesium (II) ions and thiamine 
diphosphate (TPP) (Kochetov, 1982; Aucamp et al., 2008). TPP binds at the 
interface between the subunits and interacts with residues from both subunits and it 
is regenerated in each cycle of the reaction. The cofactor is noncovalently bound to 
the enzyme in the less energetically favorable but activated ‘‘V’’ conformation 
(Muller et al., 1993). The apoenzyme form of TK turns to completely functional 
form of holoenzyme with the binding of cofactors.  
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Figure 1.6: Structure of E. coli holo-transketolase (holo-TK). The homodimer is highlighted with 
chain A dark and chain B light, the domains coloured as PP (red), Pyr (green), and C-terminal (blue), 
the two TPP cofactors as violet spheres, and two Mg
2+
 ions as cyan spheres. Image reproduced from 
Jahromi et al., 2011. 
 
 
The potential substrates for this enzyme are D-xylulose-5-phosphate, D-fructose -6-
phosphate, D-sedoheptulose-7-phosphate and hydroxypyruvate (HPA) as donors of 
the transferred glycolaldehyde (GA) group (Sevostyanova et al., 2004). As acceptor 
substrates, it catalyses D-ribose-5-phosphate, D-glyceraldehyde-3-phosphate, D-
erythrose-4-phosphate, and glycolaldehyde (Sevostyanova et al., 2004). In vivo, the 
reaction remains reversible, however with HPA as a ketol donor, the reaction 
renders irreversible, with the release of CO2 and formation of a compound 
containing a new carbon-carbon bond and a chiral hydroxy group (French & Ward, 
1996). Figure 1.7 shows the TK reaction catalysed the carbon-carbon bond 
formation using HPA and GA. Many works involving glycolaldehyde as the 
aldehyde acceptor were demonstrated which produces erythrulose and CO2 with 
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HPA as the ketol donor (Lilly et al., 1996; Mitra et al., 1998). Moreover, the assay 
for this reaction can be easily carried out using HPLC (Mitra & Woodley, 1996) or 
a colorimetric assay (Smith et al., 2006) that allows for simple and rapid 
measurement and kinetic study of TK. 
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Figure 1.7: (a) General reaction scheme of TK mediated carbon–carbon bond formation using 
hydroxypyruvate as ketol donor, (b) Transketolase-mediated erythrulose (ERY) synthesis via-
hydroxypyruvate (HPA) and glycolaldehyde (GA) reaction. 
 
TK used in this study is originating from E. coli, whereby the TK coding gene has 
been engineered into high copy number plasmid pQR791 (Martinez-Torres et al., 
2007) to increase expression and has been tagged with six histidine residues to 
facilitate rapid purification and facile immobilisation process. This enzyme has 
been extensively studied in both purified and lysate forms (Matosevic et al., 2009; 
Jahromi et al., 2011; Rios-Solis et al., 2011; Payongsri et al., 2012). In this work, 
the HPA and GA substrate model system was used. The optimum conditions and 
kinetic analysis for TK-catalysed reaction for the model system of HPA and GA 
was discussed in details by Matosevic et al. (2009) in batch reaction as well as in 
continuous flow reaction. TK was found to be relatively stable at ambient 
temperature and neutral pH. Moreover, TK kinetics parameters evaluated based on 
a Michaelis-Menten model, in the IEMR were shown to be comparable to those 
measured in free solution (Matosevic et al., 2009). 
 
1.6.1.2  " -Transaminase Enzyme and Reaction 
Transaminase (TAm) (EC 2.6.1) falls under transferases group that catalyses a type 
of reaction between an amino acid and $-keto acid. This high stereoselectivity 
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enzyme converts a carbonyl group to an amino group to form chiral amino alcohols, 
but would need a broad specificity to accept substrates other than keto acids or 
ketones (Kaulmann et al., 2007). Figure 1.8 shows the general reaction catalyses the 
transfer of an amine and ketose substrate using pyridoxal-5’-phosphate (PLP) as the 
cofactor. Other enzymes that exhibit the same characteristics as TAm are acid 
dehydrogenases and amine dehydrogenases (Crump & Rozzell, 1992; Brunhuber & 
Blanchard, 1994). In contrast to the amino dehydrogenase reaction, TAm does not 
require cofactor recycling which makes it the perfect choice for industrial processes 
(Kaulmann et al., 2007). 
 
 
 
Figure 1.8: General scheme of transaminase catalysed reaction. TAm catalyses the transfer of an 
amine functionality between an amine and a ketose substrate in a reaction requiring a pyridoxal 
phosphate (PLP) cofactor. 
 
Transaminases can be categorized into four subgroups based on their mutual 
primary structure, and also correspond to the specialization of the enzymes for 
substrate specificity within subgroups (Mehta et al., 1993). !-TAms fall under 
group III as defined by Pfam while $"TAms are classified under group I, II, IV and 
V (Punta et al., 2012). Distinct feature of !-TAms as compared to $"TAms is on 
the ability of !-TAms to accept substrates that do not contain $-amino acid or $-
keto acid, which is required for $"TAms. The TAm used in this work was isolated 
from Chromobacterium violaceum, which was first reported by Kaulman et al. 
(2007). Apart from this, many other sources of ! -TAms from different 
microorganisms have been studied. Among them are Klebsiella pneumoniae JS2F, 
Bacillus thuringiensis JS64 and Vibrio fluvialis JS17 (Shin et al., 2003; Mishra et 
al., 2007). These strains showed high enantioselectivity (E>50) towards (S)-$-
Methylbenzylamine (MBA) and catalyse the amination of keto acids, aldehyde and 
ketone (Shin & Kim, 2002). The studies concluded that among the three strains, V. 
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fluvialis JS17 displayed the best in kinetic resolution and asymmetric synthesis to 
produce enantiomerically pure chiral amines (Cho et al., 2003; Yun et al., 2005). 
 
The CV-!TAm is a homodimer with a molecular mass of ~100 kDa. Each 
monomer has an active site at the dimeric interface that involves amino acid 
residues from both subunits. The active site contains a PLP-binding pocket and a 
substrate-binding region. In the holo form, pyridoxal 5)-phosphate (PLP) is joined 
by a covalent Schiff base linkage to the *-amino group of the catalytic lysine. The 
TAm enzymatic reaction can be described by a ping-pong bi-bi mechanism 
(Christen & Metzler, 1985) (Figure 1.9). In the first half-reaction, the donor binds to 
the enzyme, the PLP coenzyme is aminated to pyridoxamine 5)-phosphate (EPMP) 
and the respective keto product is released. The transamination cycle is completed 
by transferring the amino group from enzyme-bound (EPMP) to the acceptor and 
regenerates the co-factor (EPLP).  
 
 
Figure 1.9: Structure of C. violaceum holo-!-transaminase (dimer) The large domains are coloured 
light red and blue respectively, and the small domains are coloured dark red and blue respectively, 
PLP is shown as spheres. 
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Figure 1.10: Schematic representation of the ping-pong bi-bi ordered reaction mechanism of ! -
TAm. 
 
 
Despite many advantages that !-TAms can offer, the industrial use of these 
enzymes have been limited mainly due to the low equilibrium constants in the 
reactions (Shin & Kim, 2002). Moreover, severe substrate and product inhibition 
was also observed which further hampered the use of high concentration of amine 
substrate (Shin & Kim, 1999; Mishra et al., 2007). 
 
The substrate spectrum with different amine donors and pyruvate was investigated 
with C. violaceum, TAm CV2025 (Kaulmann et al., 2007). CV2025 !-TAm 
showed high activities towards aromatic (S)-amines such as MBA and (S)-
aminoindane and the three most efficient amine donors were 1- aminoindane, 1-
methyl-3-phenylpropylamine and benzylamine. The amination of pyruvate by MBA 
as the amino donor displayed high conversion reaction with almost complete 
conversion to acetophenone and alanine (Figure 1.10). Glyoxylate proved to be the 
best acceptor and aliphatic and aromatic aldehydes were both readily converted. 
This study also managed to demonstrate the amination of aromatic 2-keto-1,3-diols 
that was later quantified. 
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Figure 1.11: Reaction scheme of the transamination between (S)-$-Methylbenzylamine and pyruvate 
to synthesise acetophenone and L-Ala 
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Table 1.3: Specificity of CV2025 ! -TAm towards various amino donors. Table reproduced from 
(Kaulmann et al., 2007). 
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Table 1.4: Specificity of CV2025 !-TAm towards ketoacids and aldehyde acceptors. Table 
reproduced from (Kaulmann et al., 2007). 
 
 
59 
Further study on substrate specificity was carried out by Ingram et al. (2007) using 
&"alanine: pyruvate transaminase (&-A:P TAm) from Pseudomonas aeruginosa 
PAO1. In this work, (S)-$-MBA and erythrulose was used to produce acetophenone 
(AP) and the chiral amino alcohol, 2-amino-1,3,4-butanetriol (ABT) (Figure 1.11). 
They demonstrated a de novo TK-TAm pathway where L"erythrulose, product of 
the TK"catalysed reaction was aminated by &-A:P TAm producing 2-amino-1,3,4-
butanetriol (ABT) from achiral substrates glycolaldehyde (GA) and &-
hydroxypyruvate (HPA) (Figure 1.12). This novel synthetic pathway offers new 
directions for multi-step enzymatic synthesis of complex molecules. The resulting 
product from this pathway contains both a chiral aldehyde group and a chiral amine 
group making an excellent industrial synthon (Section 1.6.2). 
 
 
 
Figure 1.12: Reaction scheme of the transamination between (S)-$-methylbenzylamine and 
erythrulose to synthesise acetophenone and 2-amino-1,3,4-butanetriol (ABT). 
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Figure 1.13: The synthesis of chiral amino alcohol 2"amino1,3,4"butanetriol from achiral substrates 
glycolaldehyde and hydroxypyruvate using a TK"TAm pathway. 
 
1.6.2 Aminodiol synthesis  
Chiral aminodiols play significant roles in production of many pharmaceutical 
products. These molecules are important synthons for the production of a wide 
range of chiral chemicals. Moreover, the increasing size and complexity of these 
molecules frequently results in multiple chiral centers that can be exploited for 
extensive use in many complex chemicals syntheses.  
 
Wang et al. (1995) synthesised an aminodiol that act as HIV protease inhibitor. 
Optically pure aminodiols are also used as chiral ligands for asymmetric syntheses 
such as in the enantioselective addition of diethylzinc to aromatic aldehydes 
(Szakonyi, 2008) and as an intermediate compound in the synthesis of detoxinine, 
an agent used to reduce the toxicity of an antibiotic treatment for rice blast disease 
(Monache et al., 1999). Moreover, chiral aminodiols are also opted as the starting 
materials for the syntheses of oxazines or oxazolidines, which are compounds that 
exert potent antibacterial properties (Mishra et al., 2007).  
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1.6.3 De-novo pathway engineering  
The rapid growth of the pharmaceutical industry requires more sophisticated, facile, 
and uncomplicated ways of synthesising complex compounds with high optical 
purity that are superior compared to the conventional chemical synthesis. Academic 
researchers and industry have shown great interest in the idea of de novo pathway 
engineering as one of the alternative to improve efficiency and productivity in 
pharmaceutical syntheses. De novo pathway engineering through integration of 
multi-step enzyme reactions provides an attractive alternative for the creation of 
molecules with increased complexity and has been complemented by recent 
progress in performing enzymatic reactions on chips using IEMRs. There were 
several studies conducted where various enzymes have been immobilised within 
microchannels. Worth noting here that, the main target of multienzyme reaction is 
the ability to perform in vitro metabolic pathway manipulation for high-throughput 
biotransformations. To attain this goal, multiple enzymes that function in series 
must be functional on the microfluidic chip, wherein the product of one reaction 
acts as the substrate for the subsequent reaction and so forth.  
 
Babich and co-workers (2012) demonstrated the synthesis of a complex chiral 
carbohydrate analogue in a three-step cascade reaction consisted of immobilised 
acid phosphatase, fructose-1,6-diphosphatase aldolase and acid phosphatase in a 
packed bed system reactor. This flow system was able to synthesise a yield of 0.6 g 
of D-fagomine precursor product. Moreover, a seven continuous flow enzymatic 
reaction was established by Liu et al. (2002) to produce uridine diphosphate 
galactose (UDP-galactose). All of the enzymes were immobilised individually on 
Ni-NTA agarose bead, which was packed into a column. The synthesis was 
performed in three main pathways, i) main pathway to form UDP-galactose from 
galactose, ii) the uridine triphosphate supply pathway and, iii) the adenosine 
triphospahte (ATP) regeneration pathway. The authors achieved 50% conversion of 
UMP into UDP-galactose in 48 hours and the stability of the immobilised enzyme 
was also improved compared to the enzyme in solution. 
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Multiple reactions in one pot mode are also an attractive option in organic synthesis. 
This mode of operation is usually associated with the benefits of improved yield, 
enhanced reaction rates, the ability to shift reaction equilibria, overcoming of 
inhibition effect and solubility problems (Ricca et al., 2011). This method is well 
exploited in the case of compounds with similar structures, conversion and 
selectivity >99% are desired in industry because product separation can heavily 
affect the overall costs (Goldberg et al., 2006). Several successful studies were 
reported that utilized the one-pot reactions. For example, pure D-xylulose-5-
phosphate was prepared in gram quantities (>82% overall yield) by the multi-
enzymatic one pot procedure (Zimmermann et al., 1999). Schoevaart et al. (2000) 
demonstrated a four-step enzymatic reaction for the one-pot synthesis of non-
natural carbohydrates from glycerol. The production of N-acetyl-D-neuraminic acid 
(Neu5Ac) was conducted by Tao et al. (2011). This important pharmaceutical 
compound was synthesised by utilizing a robust engineered whole-cell catalyst, 
which was integrated in the process for the one-pot synthesis of Neu5Ac in a safe 
and economic manner. On the other hand, the one-pot mode poses some 
disadvantages that include non-agreeable optimal conditions among the multiple 
reactions, the presence of side reactions and enzyme inhibition (Ricca et al., 2011). 
The optimal conditions for the one-pot system however can be predicted by 
conducting a mathematical modeling (Chen et al., 2006). 
 
A chemoenzymatic microfluidic reactor was developed by Luckarift et al. (2007) 
that merged a single chemical reaction with a multi-step enzymes reaction. 
Individual microfluidic chips containing metallic zinc, silica-immobilised 
hydroxylaminobenzene (HAB) mutase and silica-immobilised soybean peroxidase 
(SBP) were connected in series to produce 2-aminophenoxazin-3-one (APO), an 
intermediate in the synthesis of anti-fungal compound known as antinomycins. In 
the first step, nitrobenzene was reduced by immobilised metallic zinc to HAB, 
subsequently HAB was converted into 2-aminopenol (2-AP) by HAB mutase that 
was also immobilised in the microchannel. The final stage involved immobilised 
SBP, which catalysed the conversion of 2-AP to 2-aminophenoxazin-3-one (APO). 
However, the results showed a decrease in efficiency that was down to 19% of the 
overall conversion compared to 52% conversion with only HAB and SBP catalysed 
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reactions. This percentage however could be improved by optimizing the zinc 
conversion step.  
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1.7 Aim and Objectives of the Project 
Microreactor technology has immense potential to notably improve chemical and 
biological analyses as well as abundant applications in medical diagnostics and 
therapeutic devices. Owing to their miniature size, they require only a small volume 
of reagent, shorter processing time and can be parallelized using lab-on-a-chip 
technology (Hong et al., 2009; Mark et al., 2010) Moreover, the integration of 
immobilised enzymes in microreactor systems has great impact in many emerging 
technologies employing biocatalytic and biorecognition events. Several reports 
show that a microreactor can be an ideal platform for enzyme reactions (Hickey et 
al., 2007, 2009; Ngamsom et al., 2010; Alam et al., 2011; Matsuura et al., 2011). 
Rapid screening can be done with the capacity of multiple usage of the immobilised 
enzyme (Forsberg et al., 2004; Matosevic et al., 2011). In addition to that, enzymes 
are found to gain higher stability facilitating their application under harsh 
environmental conditions of temperature, pH and organic solvents (Sakai-Kato et 
al., 2002; Nomura et al., 2004; Berne et al., 2006) .  
 
There are many applications of IEMRs available for biocatalysis reported to date 
(Section 1.5). Different types of technique and method for enzyme immobilisation 
were introduced (Table 1.2). A variety of methods of the immobilisation of protein 
have been demonstrated, such as non-specific physical adsorption of trypsin on N-
vinyl-2-pyrrolidinone matrix (Jiang et al., 2012), affinity-based adsorption of 
alkaline phosphotase immobilised in a microchannel (Mao et al., 2002), covalent 
attachment of ribonuclease A to macroporous methacrylate-based monolith supports 
(Ponomareva et al., 2012) and hydrophobic adsorption of monoamine oxidase 
(MAO) on an immobilised artificial membrane (IAM) liquid chromatographic 
stationary phase (Markoglou et al., 2004). Most of these types of immobilisation 
were found to affect the intrinsic properties of the enzyme, which in turn altered the 
catalytic activity. The catalytic modification may be caused by the changes in the 
three-dimensional conformation of the protein especially if the functional groups of 
the enzyme involved in the binding linkage to the support (Krenková & Foret, 
2004). This non-orientated immobilisation may impose a critical effect on the 
enzymatic activity and therefore would compromise the observed kinetic 
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performance of these systems (Kerby et al., 2006). 
  
In contrast to more complex attachment chemistries, reversible immobilisation of 
oriented protein molecules through affinity interactions, His6-tag is considered 
simpler and highly selective. This elegant technique offers fast and specific binding 
and allows protein immobilisation without pre-purification steps. Moreover, the 
His6-tag does not interfere with the structure or function of proteins and does not 
affect the secretion, compartmentalization, or folding of fusion proteins within cells 
(Cha et al., 2004). The use of His6-tag for the applications of IEMR has been widely 
demonstrated to study the kinetics performance of enzyme systems. However, only 
a few studies were conducted that used fused silica capillary and Ni-NTA beads as 
the solid support. These studies also lacked a thorough quantification in kinetic 
studies and the enzymatic behavior inside the IEMR needs further consideration. 
Ultimately, different enzymes combinations could be incorporated in the IEMR to 
synthesise optically pure compounds.  
 
The aim of this project is to design and characterise a novel microscale reactor 
based on the reversible immobilisation of His6-tagged enzymes. The versatility of 
the immobilisation method makes the system amenable to a wide range of 
biocatalysts to be integrated in order to create a variety of synthetic pathways for 
rapid synthesis and screening purposes. 
 
The specific objectives are: 
• Chapter 3: To gather baseline data of enzymatic activity in a batch solution. In 
this chapter, two enzymes, i.e. transketolase and transaminase will be first 
characterised by looking at several parameters, which include storage 
stability, effect of different co-factor concentration and kinetic parameters. 
Additionally, preparation and purification of the enzyme catalyst in pure form 
will be studied with respect to its activity and compared to the crude form. 
The validated data from the batch solution reactions will be used for further 
investigation of enzymatic activity in IEMR. 
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• Chapter 4: To design and construct a reversible immobilised enzyme 
microreactor (IEMR). In the first part of the chapter, two types of solid 
support will be investigated for the construction of the IEMR, which are the 
functionalised microbeads and derivatised surface silica capillary. The 
feasibility of both methods will be compared and one method will be chosen 
for further study of the IEMR. The IEMR will be further characterised based 
on the operational enzymatic activity, storage and reusability for both 
enzymes. Besides that, an online UV detection system using the Actipix 
instrument will be incorporated with the IEMR and this system will be tested 
on one of the enzyme model system as a proof of concept.  
 
• Chapter 5: Having established the IEMR prototype with known enzymatic 
conversions, the IEMR will be used for the kinetic evaluation of the 
transketolase (TK)-catalysed production of L-erythrulose (ERY) from 
hydroxypyruvate (HPA) and glycolaldehdye (GA) as substrates, and the 
second enzyme !-transaminase (TAm)-catalysed reaction between S-
methylbenzylamine (MBA) and ERY to produce 2-amino-1,3,4-butanetriol 
(ABT) and acetophenone (AP). This chapter will investigate the kinetic 
performance of both enzymes in continuous flow reaction using Lilly-Hornby 
(Lilly et al. 1966) kinetics model. 
 
• Chapter 6: This final results chapter will demonstrate the versatility of the 
IEMR in the multistep enzymatic reaction to synthesise a complex chiral 
aminodiol. In this chapter two model systems will be studied. The first one is 
a two-step TK-TAm catalysed reaction and the second one is a three-step 
TAm-TK-TAm catalysed reaction. Single IEMRs will be arranged in series 
whereby the product of the first reaction will be the substrate of the 
subsequent step. Furthermore, the best matching enzyme combinations will be 
identified allowing high conversion for production of the chiral aminodiol. 
Actipix online detection will be also integrated into the three-step enzymatic 
system to enable direct quantification of the bioconversions. This in vitro 
study of the multi-step enzymatic reaction will provide insight into the 
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behaviour of de novo engineered pathway prior to cloning them into 
engineered whole cell biocatalysts. 
 
• Chapter 7: This chapter will give a summary of the main findings and 
conclusions of the study as well as suggestions for future work. 
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2 Materials and Methods 
2.1 Reagents and chemicals 
All reagents were of analytical grade and were obtained from Sigma-Aldrich 
(Gillingham, UK) unless stated otherwise. Reverse osmosis (RO) water was used in 
all of the experiments. 
 
2.2 Biocatalyst production  
2.2.1 Enzyme production 
Stocks of E.coli BL21gold (DE3) containing plasmid pQR791 (His6-TK) 
(Martinez-Torres et al., 2007) or pQR801 (His6-TAm) (Kaulmann et al., 2007) 
(previously cloned from expression constructs provided by Prof. John Ward, 
Department of Biochemical Engineering, UCL) were used. Cells were grown for 16 
hours at 37 °C on agar plate containing LB-glycerol nutrient broth (yeast extract 5 
g/L, tryptone 10 g/L, NaCl 10 g/L, glycerol 10 g/L), 15 g/L agar and 0.15 g/L 
selection antibiotic ampicillin (TK cultures) or kanamycin (TAm cultures). A single 
colony was inoculated into a sterile 250 mL shake flask containing 20 mL of the 
LB-glycerol medium and grown on an orbital shaker (Stuart Scientific, Redhill, 
UK) at 250 rpm for 12-16 hours at 37°C.  
 
20 mL of inoculum prepared earlier was transferred into 2 L shake flask containing 
180 mL of LB-glycerol with 0.15 g/L antibiotic. The culture was incubated for 7-8 
hours at 37°C and 250 rpm on an orbital shaker. For TAm production isopropyl &-
D-1-thiogalactopyranoside (IPTG) of 0.2 mM was added after 3 hours of 
fermentation at optical density (OD): 0.6. The OD600nm of the solution was measured 
every hour to check bacterial growth until it reached stationary phase. 0.2 mM of 
pyridoxal-5’-phosphate (PLP) was added to the transaminase cells upon harvesting. 
Following the fermentation, culture broth was centrifuged at 4000 rpm for 10 
minutes at 4°C. The supernatant was discarded and the pellets were stored at –20ºC. 
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For plasmid pQR1021 (His6-TAm), the overnight cultures were prepared in 2XYT 
(tryptone 16 g/L, yeast extract 10 g/L, NaCl 5 g/L, glycerol 20 g/L) with 0.15 g/L 
kanamycin. Cells were subcultured using 1% v/v inoculum in 2 L shake flasks 
containing 500 mL of the same supplemented broth at 37°C and 250 rpm. 
Transaminase was induced with 1 mM of IPTG when growing in early exponential 
phase (OD600 = 0.7), and temperature was dropped to 30°C until harvesting. Cells 
were harvested by centrifugation after 5 hours of induction. 0.2 mM of pyridoxal-
5’-phosphate (PLP) was added to the cells upon harvesting. The culture broth was 
centrifuged at 4000 rpm for 10 minutes at 4°C. The supernatant was discarded and 
the pellets were stored at –20ºC. 
 
2.2.2 Optical Density (OD) measurement 
The optical density (OD) of liquid cultures was measured in triplicate at every hour 
by absorbance at 600 nm using a ATI Unicam UV/VIS spectrophotometer 
(Spectronic, Leeds, UK). The OD was measured by diluting the fermentation 
samples with fresh LB medium in order to keep the value between 0.1–0.9 
 
2.2.3 Quantification of protein concentration   
 
2.2.3.1 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) and densitometry analysis  
Pre-cast gels (1.0 mm x 12 wells) of SDS 12% Tris-Glycine (Novex, Paisley, UK) 
were used for SDS-PAGE protein analysis as described by King and Laemmli 
(King & Laemmli, 1971). Gels were run in Tris-Glycine buffer (Novex, Paisley, 
UK) using a Mini-155 Protean II system (Bio-Rad Laboratories Inc., Hemel 
Hempstead, UK) at a power of 80-150 V for about 90 minutes. The gel was then 
rinsed twice for 5 minutes with 100 mL of RO water. Next, the gel was stained with 
sufficient SimplyBlue SafeStain (~20 mL) (Novex, Paisley, UK) to cover the gel for 
1 hour at room temperature with gentle shaking. Then the gel was de-stained with 
de-staining buffer (40% v/v methanol, 10% v/v acetic acid and 50% v/v RO water) 
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for 2-3 hours. Finally, the mini gel was washed with 100 mL of RO water for 1-3 
hours.  
 
All gels were visualized and quantified on a Gel-Doc-it bioimaging system with 
Labworks 4.5 software (Bioimaging systems, Cambridge). 
 
2.2.3.2 Protein concentration determination  
Quantification of protein was carried out by UV absorbance of the purified enzyme 
at 280 nm using ATI Unicam UV/VIS spectrophotometer (Spectronic, Leeds, UK). 
Absorbance measurements were converted to protein concentration using the Beer-
Lambert law: 
A = "&c 
Where A = absorbance at 280 nm, " = extinction coefficient (for transketolase 
93,905 M.cm
-1
 and transaminase 78,000 M.cm
-1
), & = path length (1 cm), and c = 
protein concentration (mol. L
-1
). 
 
Quantification of the enzyme concentration in crude and purified form were carried 
out using a Bradford Assay based on the method of Bradford (Bradford, 1976). 
Bradford Reagent was used with bovine serum albumin (BSA) as the standard 
protein. Absorbance measurements at 595 nm were carried out on an ATI Unicam 
UV/VIS spectrophotometer (Spectronic, Leeds, UK). Crude extracts enzyme was 
quantified using Bradford assay as it contains contaminants such as nucleic acids 
that have absorption maxima near 260 nm with considerabe absorption extending to 
280 nm. 
  
2.3 Preparation of enzyme lysate for activity analysis 
Frozen cell pellets from the fermentation were thawed at room temperature. The 
pellet was resuspended in a small quantity of 50 mM Tris-HCl at pH 7.0 (TK) or 
7.5 (TAm) (1:25 v/v) and vortexed. The suspension was sonicated on ice using a 
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Soniprep 150 sonicator (MSE, Sanyo, Japan, 10 cycles of 10 seconds ON, 10 
seconds OFF). The solution was centrifuged using a Hettich Universal 320R mid-
bench centrifuge (DJB Labcare, Newport Pagnell, UK) for 10 minutes at 4000 rpm 
and 4°C. The supernatant was decanted and the pellets were discarded. The 
supernatant was filtered using a 0.2 #m pore filter (GE Healthcare, 
Buckinghamshire, UK). The clarified lysates was stored in the freezer at  -20°C. 
 
2.4 Purification of His6-tagged enzymes 
Frozen cell pellets from the fermentation were thawed at room temperature. The 
pellet was resuspended in a small quantity of 50 mM Tris-HCl at pH 7.0 (TK) or 
7.5 (TAm) (1:25 v/v) and vortexed. The suspension was sonicated on ice using a 
Soniprep 150 sonicator (MSE, Sanyo, Japan, 10 cycles of 10 seconds ON, 10 
seconds OFF). The solution was centrifuged using a Hettich Universal 320R mid-
bench centrifuge (DJB Labcare, Newport Pagnell, UK) for 10 minutes at 4000 rpm 
and 4°C. The supernatant was decanted and the pellets were discarded. The 
supernatant was filtered using a 0.2 #m pore filter (GE Healthcare, 
Buckinghamshire, UK). Purification of His6-tagged enzymes was performed using 
Ni-NTA superflow cartridges (Qiagen, Sussex, UK). The cartridge was equilibrated 
with 10 mL of binding buffer (pH 8.0) (50 mM NaH2PO4, 300 mM NaCl and 10 
mM imidazole). The clarified lysate was loaded into the cartridge and subsequently 
washed with 20 mL of wash buffer (pH 8.0) (50 mM NaH2PO4, 300 mM NaCl and 
20 mM imidazole). The enzyme was eluted with 2.5 mL of elution buffer (pH 8.0) 
(50 mM NaH2PO4, 300 mM NaCl and 250 mM imidazole). 
 
2.5 Dialysis of His6-tagged enzymes 
The purified enzyme contains imidazole in the solution due to the presence of this 
compound in the buffers. To remove this, 50 mM of Tris-HCl at pH 7 (for TK) and 
pH 7.5 (for TAm) was added to 0.5 L of water (0.2 mM of PLP was added to the 
buffer for TAm). The purified enzyme-imidazole solution was placed inside a 
dialysis semi-permeable membrane with a MWCO of 14,000 Da (BioDesign, 
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Carmel, NY, USA) and this was positioned in a beaker containing the prepared 
buffer with gentle magnetic stirring. By stirring this at 4°C overnight the imidazole 
moves out of the dialysis membrane leaving pure enzyme. 100 µL of pure enzyme 
was taken for SDS-PAGE analysis. The dialysed enzyme solution was stored in the 
fridge at 4°C. This enzyme solution was used throughout this work.   
 
2.6 Desalting of His6-tagged enzymes 
The purified enzyme contains imidazole in the solution due to the presence of this 
compound in the purification buffers. PD-10 desalting column (GE Healthcare, 
Buckinghamshire, UK) with a MWCO of 5,000 Da was used to remove the 
imidazole. The column storage solution was removed by taking off the seal at the 
bottom. Next, the column was filled up with 25 mL of 50 mM Tris-HCl at pH 7 (for 
TK) and pH 7.5 (for TAm) (0.2 mM of PLP was added to the buffer for TAm) and 
the flow-through solution was discarded. 2.5 mL of purified enzyme sample was 
added to the column and the flow-through was discarded. Elution was carried out by 
adding 3.5 mL of 50 mM Tris-HCl at pH 7 (for TK) and pH 7.5 (for TAm) (0.2 mM 
PLP was added to the buffer for TAm) to the column and the eluate was collected in 
a universal tube. The desalted enzyme was stored in the fridge at 4°C. This enzyme 
solution was used throughout this work. 
 
2.7 Standard enzyme activity in solution  
2.7.1 Assay for TK activity in microwells 
The enzyme activity assay was carried out at room temperature in 50 mM Tris-HCl 
buffer (pH 7.0). One unit of TK enzyme was defined as the amount that catalyses 
the formation of 1 #mol of erythrulose (ERY) per minute using 50 mM of 
glycolaldehyde (GA) and lithium-hydroxypyruvate (HPA) at pH 7.0. TK reactions 
were conducted using model substrates, 50 mM HPA and 50 mM GA unless stated 
otherwise. The enzyme was incubated with cofactors, 2.4 mM thiamine 
pyrophosphate (TPP) and 9 mM MgCl2 of for 30 minutes to reconstitute the 
holoenzyme. Substrate solutions of HPA and GA were added to make the total 
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reaction volume of 300 #L. 20 µL of samples were taken from this reaction mixture 
and 180 µL of 0.1% TFA was added to the sample to stop the TK activity at certain 
time interval. Reactions were monitored for HPA depletion and ERY production by 
HPLC assay. 
2.7.2 Assay for !-TAm (pQR 801) activity in glass vials 
The enzyme activity assay was carried out at room temperature in 50 mM Tris-HCl 
buffer (pH 7.5). One unit of TAm enzyme was defined as the amount that catalyses 
the production of 1 #mol of acetophenone (AP) per minute using 100 mM ERY and 
10 mM (S)-$-methylbenzylamine (MBA) at pH 7.5. TAm reactions were conducted 
using 10 mM of MBA and 100 mM of ERY unless stated otherwise. Substrate 
solutions of MBA and ERY and 0.2 mM cofactor pyridoxal-5’-phosphate (PLP) 
were added to the enzyme solution to make the total reaction volume of 300 #L. 20 
µL of samples were taken from this reaction mixture and 280 µL of 0.1% TFA was 
added to the sample to stop the TAm activity at certain time interval. Reactions 
were monitored for MBA depletion and AP production by HPLC assay. 
 
2.7.3 Assay for !-TAm (pQR 1021) activity in glass vials 
The enzyme activity assay was carried out at room temperature in 50 mM Tris-HCl 
buffer (pH 7.5). One unit of TAm enzyme was defined as the amount that catalyses 
the production of 1 #mol of HPA per minute using 100 mM L-serine (SER) and 10 
mM GA at pH 7.5. Substrate solutions of SER and GA and 0.2 mM PLP were 
added to the enzyme solution to make the total reaction volume of 300 #L. 20 µL of 
samples were taken from this reaction mixture and 280 µL of 0.1% TFA was added 
to the sample to stop the TAm activity at certain time interval. Reactions were 
monitored for HPA production by HPLC assay. 
 
2.7.4 TK kinetics in solution 
TK kinetics parameter was determined by following a modified assay for TK 
activity (Section 2.7.1). The enzyme was incubated with cofactors, 2.4 mM TPP 
and 9 mM MgCl2 for 30 minutes to reconstitute the holoenzyme. Substrate solutions 
of HPA and GA (Table 2.1) were added to make the total reaction volume of 300 
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#L. 20 µL of samples were taken from this reaction mixture and 180 µL of 0.1% 
TFA was added to the sample to stop the TK activity at certain time interval. 
Reactions were monitored for ERY production by HPLC assay. 
 
2.7.5 TAm kinetics in solution 
TAm kinetics parameter was determined by following a modified assay for TAm 
activity (Section 2.7.2). Substrate solutions of MBA and ERY (Table 2.1) and 0.2 
mM PLP were added to the enzyme solution to make the total reaction volume of 
300 #L. 20 µL of samples were taken from this reaction mixture and 280 µL of 
0.1% TFA was added to the sample to stop the TAm activity at certain time 
interval. Reactions were monitored for AP production by HPLC assay. 
 
Table 2.1: Compositions of substrate solutions for TK and TAm kinetics in solution 
TK TAm 
HPA 
(mM) 
GA 
(mM) 
GA 
(mM) 
HPA 
(mM) 
ERY 
(mM) 
MBA 
(mM) 
MBA 
(mM) 
ERY 
(mM) 
100 10 100 10 100 1 10 50 
100 25 100 25 100 5 10 100 
100 50 100 50 100 7.5 10 200 
100 100 100 100 100 10 10 300 
 
2.8 HPLC analysis 
HPLC analysis was conducted using a microbore HPLC system (Dionex, Surrey, 
UK) controlled by Chromeleon 6.8 software with a multiwell plate autosampler 
(Spark, Emmen, Holland). HPA and ERY were analysed using an Aminex 87H 
column (Bio-Rad, Hertfordshire, UK) and analysis were conducted at 60°C using a 
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mobile phase of 0.1% (v/v) TFA in water at 0.6 mL/min. Detection was at 210 nm 
and the retention time was around 8.8 and 11.5 minutes for HPA and ERY 
respectively.  
 
AP and ABT were analyzed using an ACE5 C18 reverse phase column (150x4.6 
mm, Advanced Chromatography Technologies, Aberdeen, UK) on the Dionex 
HPLC system. The mobile phase for AP detection comprised of 0.1% TFA at 1.0 
mL/min with a gradient of acetonitrile from 15% to 72% over 9 minutes. The 
gradient was followed by a 2 minute equilibration. UV detection was carried out at 
250 nm with retention time for AP was around 7.3 minutes. For ABT analysis, the 
samples were derivatised by addition of an excess of 6-aminoquinolyl-N-
hydroxysuccinimidyl carbamate (AQC). The derivatising reagent was made in 
house based on Cohen and Michaud (1993) protocol and the HPLC method reported 
by Ingram et al. (2007) was used. AQC powder was added in dry acetonitrile and 
heated at 55°C until the powder dissolves. The samples were mixed with borate 
buffer and the AQC solution. This mixture was then vortexed for few seconds prior 
to transfer to HPLC vial. The retention time of derivatised ABT was around 8.9 
minutes. 
 
2.8.1 Quantification of HPLC standard 
Standard calibration curves were used to quantify the absorbance responses for the 
reaction substrates and products from the HPLC assay. Standard ERY, HPA, MBA, 
AP and ABT were prepared separately with a known concentration and analysed 
with the HPLC. Example of chromatogram for each compound can be found in 
Appendix 1. 
 
2.9 Synthesis of derivatising reagent 
The derivatising reagent AQC was made in house based on Cohen and Michaud 
(Cohen and Michaud, 1993) protocol. Di (N-succinimidyl) carbamate (3 g, 6 mmol) 
was dissolved in 100 mL of dry acetonitrile and heated to reflux. Dropwise addition 
of a 6-aminoquinoline (1.5 g, 10 mmol) solution in dry acetonitrile was carried out 
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over 45 min. Following a further 30 min reflux, the reaction mixture was 
concentrated to about half of the original volume by rotary evaporation. The 
solution was stored at 4°C overnight. The crystals were then filtered off and stored 
in a desiccator. 
2.10 Immobilised Enzyme Microreactor (IEMR) setup 
2.10.1 Derivatised fused silica capillary 
2.10.1.1  Microreactor setup 
The microreactor system setup consists of fused silica capillary microreactor that 
was connected to KDS100 syringe pump (KD Scientific, Holliston, MA, USA) 
(Figure 2.1). The NanoTight fittings (Presearch Ltd, UK) were used to connect the 
capillary tubing into standard 10-32 threaded, coned ports (Quick Connect Luer 
adapter) (Presearch Ltd, UK) which then joined to the syringe. These are made of 
chemically inert PEEK™ polymer nuts with a high-pressure ferrule. The 1.6” long 
NanoTight sleeves are manufactured from fluoropolymer (FEP) and can withstand 
up to 50˚C. The sample of bioconversion was collected at the other end of the 
capillary.  
 
 
Figure 2.1: Stop flow microreactor setup. Photos showing the setup of the derivatised fused silica 
capillary. The microreactor consists of capillary with I.D of 200 #m and total reaction volume of ~13 
#L.  
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2.10.1.2 Microcapillary surface derivatisation 
A fused silica capillary with I.D of 200 #m was used for the microcapillary reactor. 
Derivatisation protocol was conducted under laboratory safety hood in room 
temperature. The immobilisation procedure was adopted from previous work 
(Miyazaki et al., 2005). A new, untreated capillary was treated with a 3:1 (v/v) 
piranha solution (H2SO4 and 30% H2O2) at a flow rate of 1 #L/min overnight to 
strip the inner surface from any organic residues prior to chemical treatment, 
followed by washing with 150 #L ultrapure water at a flow rate of 5 #L/min. The 
capillary was then reacted with a 30% of 1:1 v/v solution of 3- 
aminopropyltriethoxysilane and methyltriethoxysilane in 97% ethanol in water for 1 
hour and left to incubate for an additional hour. After washing with low volume 
ethanol (1:1 v/v), the capillary was heated to 115˚C for 1 hour. This caused 
polymerisation of the silanes on the surface and resulted in a visible white layer 
forming inside. The amino functionalized microcapillary prepared above was 
treated with 20 mM solution of succinic anhydride in dimethylformamide (DMF) 
for 2 hour at room temperature at a flow rate of 5 #L/min to create the carboxyl 
function. After washing with DMF, the resulting carboxyl group was reacted with 1 
M solution of 1"Ethyl"3"(3"dimethylaminopropyl) carbodiimide hydrochloride 
(WSCI"HCl) and N-hydroxysuccinimide (NHS) in DMF for 1 hour, followed by 
washing with DMF. The nickel-nitrilotriacetic acid (Ni-NTA) chemistry could now 
be complexed to the surface. A 250 mM DMF solution of N$-N$-
bis(carboxymethyl)-l-lysine hydrate in water was loaded to the capillary and reacted 
for 4-6 h at a flow rate of 5 µl/.min and left to incubate overnight. AB-NTA forms 
white solid deposits on the surface. Nickel was then complexed to the surface by 
incubation with 40 mM Ni2SO4 solution for 12 hours. The derivatised capillary was 
stored at 4°C. The chemistry immobilisation diagram is shown in Figure 1.5. 
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2.10.1.3 Enzyme immobilisation and elution  
Enzyme immobilisation was carried out at room temperature. An AB-NTA 
derivatised microcapillary was treated with a 40 mM aqueous solution of nickel 
sulphate for 6 hours at a flow rate of 5 #L/min. Incubation of nickel was for an 
additional 6 hours in stop-flow mode. After washing with 50 mM Tris-HCl, the 
enzyme solution (~0.2-0.3 mg/mL) in 50 mM Tris-HCl containing 5 mM imidazole 
was loaded into the capillary at a flow rate of 5 µL/min. The enzyme was left to 
incubate for an additional 2 hours following immobilisation and later washed with 
50 mM Tris-HCl (with 5 mM imidazole) to remove unbound enzyme. 
 
Enzyme was removed by treating the capillary with a 50 mM solution of EDTA (pH 
8.0) at 5 µL/min. The amount of EDTA used did not exceed 100 #L. The collected 
solution was analysed for protein content by SDS-PAGE or absorbance at 280 nm. 
When absorbance was measured, the readings were blanked with EDTA buffer to 
minimise background absorbance.  
 
2.10.1.4  Transketolase reaction in microcapillary  
TK activity in microcapillary was conducted based on modified procedures in 
microwells using similar model substrates, HPA and GA. One unit of TK enzyme 
was defined as the amount that catalyses the formation of 1 #mol of ERY per 
minute using 50 mM GA and 50 mM HPA at pH 7.0. Cofactors of TPP, 2.4 mM 
and MgCl2, 9 mM was loaded at 5 #L/min in the immobilised TK capillary for 30 
minutes to reconstitute the holoenzyme. Solution substrates of 50 mM HPA and 50 
mM GA were loaded at 5 #L/min and left incubated at certain residence time. 
Samples were taken from this reaction mixture and 0.1% TFA was added to the 
sample to stop the TK activity. Reactions were monitored for HPA depletion and 
ERY production by the HPLC assay (Section 2.8). 
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2.10.2  Packed tube IEMR  
2.10.2.1 Packing of a FEP tube with microbeads 
HIS-Select Nickel Affinity agarose beads (45-165 #m) were used as the packing 
material. They were first washed with 50 mM of Tris-HCl and left in suspension in 
the same buffer. A Nanobaume (Presearch Ltd, UK) pressurised container was used 
to pack the beads in the tube (Figure 2.2). The bead slurry containing 5% (v/v) 
beads was placed in a glass vial. A stir bar was put in the vial and the vial was 
placed into the pressurized container. The container was then set on top of a 
magnetic stirrer. The fluorinated ethylene propylene (FEP) tube (500 #m ID, 
Presearch Ltd, UK) was attached to the container while a microfilter assembly (2 
#m, Presearch Ltd, UK) was connected at the end of the tube. A two-way valve was 
connected to the pressurised container while the other end was connected to a 
nitrogen gas cylinder. A pressure of 5 bar was applied to the system and the 
pressure drop was monitored by the pressure gauge installed. The packing took 5-10 
minutes.  
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Figure 2.2: A schematic of the nanobaume pressurized container: The nitrogen gas source was 
compressed into the system through the 3 way valve at 5 bar. A bead slurry of 5% (v/v) was 
continuously stirred in the glass vial and then packed into the fluorinated ethylene propylene (FEP) 
tube (500 #m ID) by positive pressure. Excess liquid left through the filter while the beads were 
retained inside the FEP tube.  
 
2.10.2.2  Enzyme immobilisation and elution 
The packed tube IEMR was first equilibrated with binding buffer (500 mM NaCl, 
20 mM Tris-HCl, 5 mM imidazole; pH 7.0 or 7.5) at 5 #L/min for 15 minutes. 
Enzyme concentrations used were 0.05-2.0 mg/mL. The purified enzyme (100 #L) 
was loaded into the tube at 5 #L/min and was left to incubate for an additional 1 
hour following immobilisation. Non-specific binding of the enzyme on the beads 
was removed by treating the tube with washing buffer (50 mM Tris-HCl; pH 7.0 or 
7.5) at 25 #L/min for 20 minutes. Bound enzyme was removed by treating the tube 
with elution buffer (1 M imidazole, 500 mM NaCl and 20 mM Tris-HCl; pH 7.0 or 
7.5) at 5 #L/min for 10 minutes. 
 
2.10.2.3 Transketolase reaction in packed tube IEMR 
The packed tube IEMR (5 cm length) was connected to a KDS100 syringe pump 
(KD Scientific, Holliston, MA, USA) on one end and connected to a microfilter 
assembly (2 #m, Presearch Ltd, UK) at the outlet. The enzyme activity assay was 
carried out at room temperature in 50 mM Tris-HCl buffer (pH 7.0). One unit of TK 
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enzyme was defined as the amount that catalyses the formation of 1 #mol of ERY 
per minute using 50 mM GA and 50 mM HPA at pH 7.0. TK reactions were 
conducted using model substrates, 50 mM HPA and 50 mM GA unless stated 
otherwise. The enzyme was incubated with cofactors, 2.4 mM TPP and 9 mM 
MgCl2  at 5 #L/min for 30 minutes to reconstitute the holoenzyme. Substrate 
solutions of HPA and GA with the cofactors were loaded continuously at various 
flow rates and 20 #L samples were taken from the outlet of the tube at regular time 
intervals. The samples were quenched with 0.1% TFA and analysed by HPLC. 
Reactions were monitored for ERY production by HPLC assay (Section 2.8). 
 
2.10.2.4 Transaminase reaction in IEMR 
The enzyme activity assay was carried out at room temperature in 50 mM Tris-HCl 
buffer (pH 7.5). One unit of TAm enzyme was defined as the amount that catalyses 
the production of 1 #mol of AP per minute using 100 mM Ery and 10 mM MBA at 
pH 7.5. TAm reactions were conducted using model substrates, 10 mM of MBA 
and 100 mM of ERY unless stated otherwise. Substrate solutions of MBA and ERY 
and 0.2 mM PLP were loaded continuously at various flow rates and 20 #L samples 
were taken from the outlet of the tube at regular time intervals. The samples were 
quenched with 0.1% TFA and analysed by HPLC. Reactions were monitored for 
AP production by HPLC assay (Section 2.8). 
 
82 
 
Table 2.2: Flow rates used in the continuous flow reaction corresponding to the residence times in 
the packed tube IEMR. The residence times were based on the 5 cm IEMR with total volume of 10 
#L  
Flow rate (#L/min) Residence Time (min) 
0.5 20 
1 10 
2 5 
5 2 
10 1 
20 0.5 
30 0.33 
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2.10.3 Actipix online detection system 
Actipix D100 was integrated in the IEMR system to monitor the product 
conversion in a real-time. This detector has been designed for use in a variety 
of applications in research by providing quantitative imaging in the UV 
region. The Actipix D100 consists of a control box and a capillary cartridge 
with a miniature size detector (6.5 cm x 5.5 cm x 11.5 cm) (Figure 2.3). This 
system allows for wide range of UV detection by using different types of filter 
corresponding to the specific wavelength. Detection was performed at two 
different wavelengths. The first one was at 210 nm for the detection of product 
formation of HPA in the multi steps enzymatic reaction. And the second filter 
was at 280 nm for the detection of product formation of AP in the single TAm 
enzymatic reaction. Light was delivered via a fibre optic coupled light source. 
Readout of signals on the active pixel sensor and absorbance calculations were 
carried out at MHz rates, with all processing done in hardware on custom 
electronic assemblies. Processed data was output in real-time to a computer 
using a high-speed serial data or USB link. Paraytec data acquisition software 
was set up for data collection and output signal analysis. 
 
2.10.4  Integration of Actipix online detection system in IEMR  
The packed tube IEMR was connected to a KDS100 syringe pump on one end and 
connected to a microfilter assembly at the outlet. The Actipix detector capillary was 
joined at the outlet by connecting the outlet tube with a sleeve that allow for direct 
flow of the bioconversion mixture to flow through the detector. Substrate solution 
was loaded at flow rates ranging from 1-30 µL/min, with detection taking place in 
real time through the Actipix cartridge window and data was recorded as .cvs files 
via the propriety software. 
 
2.10.5  Quantification of Actipix standards 
Standard calibration curves were used to quantify the absorbance responses for the 
product formation from the Actipix online detection system. Standard HPA and AP 
were prepared separately with a known concentration and run through the Actipix. 
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Figure 2.3: Continuous flow microreactor setup with Actipix detector. Photos showing the setup of 
the continuous flow microreactor coupled with Actipix (Paraytec, York) capillary detection system 
consisting of a capillary-holding sensor head (1) and the control box (2). Data is collected and 
processed through a computer interface (3). 
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2.11 Enzyme kinetics in IEMR 
 
2.11.1 TK kinetics in IEMR 
TK kinetics in the IEMR was determined by following a modified assay for TK 
activity as described in Section 2.10.2.3. The enzyme was first incubated with 
cofactors, 2.4 mM TPP and 9mM MgCl2  at 5 #L/min for 30 minutes to reconstitute 
the holoenzyme. Substrate solutions (Table 2.3) were loaded continuously at flow 
rates ranging from 2-30 #L/min and 20 #L samples were collected from the outlet 
of the tube. The samples were quenched with 0.1% TFA and analysed by HPLC. 
Reactions were monitored for ERY production by HPLC assay (Section 2.8). 
 
2.11.2 TAm kinetics in IEMR 
TAm kinetics in the IEMR was determined by following a modified assay for TAm 
activity as described in Section 2.10.2.4. Substrate solutions (Table 2.3) and 0.2 
mM PLP were loaded continuously at flow rates ranging from 2-30 #L/min and 20 
#L samples were collected from the outlet of the tube. The samples were quenched 
with 0.1% TFA and analysed by HPLC. Reactions were monitored for AP 
production by HPLC assay (Section 2.8). 
 
86 
 
Table 2.3: Substrate composition for TK and TAm kinetics  
 
2.12 Multi-step enzymatic reaction in IEMR 
 
2.12.1 Two step enzymatic reaction  
The set-up of the IEMR cascade is shown in Figure 2.4. The enzyme 
immobilisation of individual IEMRs was conducted separately before assembly. 
Two separate (2x5 cm) of the packed tube IEMR were connected in series where 
the beads were retained using a microfilter assembly (2 #m, Presearch Ltd, UK). 
The second packed tube IEMR was connected to the first using a microferrule 
(Presearch Ltd). The two-tube system was connected to a KDS100 syringe pump 
(KD Scientific, Holliston, MA, USA) so that the inlet of the first tube was directly 
connected to the pump while its outlet was used to collect the samples for further 
off-line HPLC analysis. Coupled reactions were carried out using the TK (pQR 
791)-TAm (pQR 801) model reaction. Solution substrates of GA, HPA and MBA at 
desired concentrations and cofactors for both enzymes at pH 7.5 were loaded 
together into the first tube containing packed beads immobilised with TK. The 
erythrulose required by the immobilised TAm was provided by the TK reaction 
step. The reaction was carried out continuously at flow rates between 1-30 #L/min. 
TK TAm 
HPA (mM) GA (mM) MBA (mM) Ery (mM) 
100 10 10 50 
100 15 10 100 
100 25 10 200 
100 50 10 300 
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20 #L samples were taken at different time intervals and quenched with 0.1% TFA. 
Reactions were monitored for ABT and AP production by HPLC assay (Section 
2.8). 
 
 
Figure 2.4: Schematic illustration of the IEMR used for analysis of TK-TAm reaction. An IEMR 
with ID of 500 #m and length of 5 cm gives a total reaction volume of ~10 #L. The prototype 
consisted of single IEMRs that were cascaded in series to allow multi-step enzymatic reaction. TK 
catalysed the reaction of hydroxypyruvate (HPA) and glycoaldehyde (GA) to L-erythrulose (ERY), 
and the second unit of the IEMR with immobilised TAm converted ERY into 2-amino-1,3,4-
butanetriol (ABT) using (S)-$-methylbenzylamine (MBA) as amine donor. 
 
 
2.12.2 Three step enzymatic reaction 
The set-up of the IEMR cascade is shown in Figure 2.5. The enzyme 
immobilisation of individual IEMRs was conducted separately before assembly. 
Three separate (2x10 cm and 1x5 cm) of the packed tube IEMR were connected in 
series where the beads were retained using a microfilter assembly (2 #m, Presearch 
Ltd, UK). The second and third packed tube IEMR was connected to the first using 
a microferrule (Presearch Ltd). The three-tube system was connected to a KDS100 
syringe pump (KD Scientific, Holliston, MA, USA) so that the inlet of the first tube 
was directly connected to the pump while its outlet was used to collect the samples 
for further off-line HPLC analysis. Coupled reactions were carried out using the 
TAm (pQR 1021)-TK (pQR 791)-TAm (pQR 1021) model reaction. Solution 
substrates of SER and GA at desired concentrations and cofactors for both enzymes 
at pH 7.5 were loaded together into the first tube containing packed beads 
immobilised with TAm. The HPA required by the immobilised TK was provided by 
the first TAm reaction step which then reacted with GA in the second step reaction 
to produce ERY (substrate used in the third step). The reaction was carried out 
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continuously at flow rates between 0.5-10 #L/min. 20 #L samples were taken at 
different time intervals and quenched with 0.1% TFA. Reactions were monitored 
for HPA production in the first step of TAm reaction through Actipix online 
detection whilst ABT and HPA production in the final step by HPLC assay (Section 
2.8). 
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Figure 2.5: Schematic illustration of the IEMR used for analysis of TAm-TK-TAm reaction. Three 
IEMR with ID of 500 #m (2x10 cm and 1x5 cm) gives a total reaction volume of ~20 #L and ~10 
#L respectively. The prototype consisted of single IEMRs that were cascaded in series to allow 
multi-step enzymatic reaction. TAm catalysed the reaction of Serine (SER) and glycolaldehyde (GA) 
to hydroxypyruvate (HPA) which was used in the second unit of the IEMR. Immobilised TK 
converted the reaction between HPA and GA to erythrulose (ERY) and this product was 
subsequently reacted with SER for the formation of 2-amino-1,3,4-butanetriol (ABT). 
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3 Characterisation of Transketolase and Transaminase in 
solution phase 
 
3.1 Introduction 
As described in Section 1.6.1.1, transketolase (TK) is an important enzyme that 
catalyses the transfer of a two-carbon ketol group to an aldose to form asymmetric 
carbon-carbon bond. Given the importance of this reaction in the synthesis of a 
wide range of molecules, interest on TK has been growing in recent years. TK 
applications have been widely reported, owing to its broad substrate tolerance 
(Takayama et al., 1997; Turner, 2000; Fessner & Helaine, 2001). To date, the most 
rapid TK reaction using HPA as a ketol donor is in the production of erythrulose 
(ERY) from glycolaldehyde (GA), which releases carbon dioxide as a by-product 
(Bolte et al., 1987; Dalmas & Demuynck, 1993) (Figure 1.7b). The assay for this 
reaction can be easily analysed using HPLC (Mitra & Woodley, 1996) that allows 
for simple and rapid measurement and kinetic study of TK. This model system has 
been extensively studied for investigating transketolase-catalysed reaction. Details 
of biotransformation characterisation of TK was reported by Mitra et al. (1998) and 
kinetic measurements was performed by Gyamerah et al. (1997) and Chen et al. 
(2007). Guidelines for reactor design and operation condition was also 
demonstrated (Woodley et al., 1996) and in situ product removal (ISPR) of 
erythrulose from the bioconversion was developed (Chauhan et al., 1997).  
 
Apart from transketolase enzyme, transaminase is also among the frequently studied 
enzymes due to its potential in the production of amino acids and chiral amines ( 
Taylor et al., 1998; Chao et al., 1999). In this research, CV2025 !–TAm from C. 
violaceum was used to investigate transaminase-catalysed reaction. This enzyme 
showed high activity towards (S)-'-methylbenzylamine (MBA), the amino donor 
(Kaulmann et al., 2007) and reacted with erythrulose to produce 2-amino-1,3,4-
butanetriol (ABT) and acetophenone (AP) (Figure 1.12). The ketodiol needed for 
this reaction can be synthesised via the transketolase enzyme, therefore making it a 
perfect model for investigating TAm-catalysed reaction, which can be further 
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coupled in the TK-TAm reaction for the production of chiral aminodiol (Figure 
1.13). 
 
This chapter details the characterisation of two main enzymes that were used 
throughout this project, which were transketolase (TK) and transaminase (TAm) in 
enzyme solution. A good understanding of the enzyme activity of both TK and 
TAm in solution phase is very important for effective optimisation of immobilised 
enzyme microreactor (IEMR). Key insight can be gained into the enzyme behaviour 
involved in the IEMR, which will facilitate future implementation of the 
multienzyme microreactor. The validated data will be used for further investigation 
of enzyme activity in IEMR.  
 
The key objectives of this chapter are: 
• Characterisation of His6-tagged transketolase and transaminase with respect to 
its bioconversion for purified and crude enzyme. 
• Characterisation of His6-tagged transketolase and transaminase with respect to 
its stability in different storage conditions. 
• Evaluation of kinetic parameters of the His6-tagged transketolase and 
transaminase in solution phase. 
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3.2 Characterisation of Transketolase (TK) enzyme 
 
3.2.1 Transketolase production 
3.2.1.1 Production of His6!TK by E.coli fermentation   
Stocks of E.coli BL21gold (DE3) containing plasmid pQR791 (His6-TK) 
(Martinez-Torres et al., 2007) was used. Cells were grown in a 2 L shake flask with 
a total working volume of 200 mL using LB-glycerol media. The OD600nm of the 
solution was measured every hour to check bacterial growth until it reached 
stationary phase. This data ensures that the cell is harvested at the optimum level, 
hence offers substantial amount of TK for the subsequent purification step. Figure 
3.1 shows a typical growth profile for E.coli fermentation expressing His6-tagged 
TK pQR791 as determined by OD600nm measurements. The cell reached a plateau 
after a period of approximately 7 hours. The fermentation was stopped and the cells 
were harvested. 
 
Based on the growth profile, the fermentation underwent a short lag phase which 
due to high inoculum volume 10% v/v, as well as using similar medium in the 
fermentation to the inoculum. Following the lag period, growth started in the 
exponential phase for about 7 hours before it reached stationary phase. For the 
particular fermentation data shown in Figure 3.1, the maximum specific growth rate 
was 0.73 hr
-1 
with a doubling time, td of 0.95 hr. A similar fermentation procedure 
was used throughout this project and data shown in Figure 3.1 is representative of 
each fermentation performed. Expressed His-TK constituted about 28% of the total 
cell protein as estimated by SDS-PAGE.  
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Figure 3.1: Growth of E.coli strain BL21gold (DE3) pQR791 expressing His6"TK. Cells were 
cultured in 200 mL LB glycerol media with the addition of 0.15g/L ampicillin, in a 2 L shake flask at 
37°C, 250 rpm with a 10% v/v inoculum grown overnight as previously described (Section 2.2.1). 10 
g/L of glycerol as the carbon source to the media was added to promote growth. Growth was 
monitored by OD600nm measurements (Section 2.2.2). Error bars represent one standard deviation 
about the mean (n = 3). 
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3.2.1.2 Purification of His6!tagged TK  
Characterisation and kinetics studies of His-tagged TK in solution phase and 
immobilised form were conducted using purified enzyme. Pure enzyme offers 
cleaner reaction product and easier workup when reaction is complete (Kirst et al., 
2001). In contrast to the crude form, purified enzyme enhances the enzyme 
specificity whilst minimising non-specific reactions. These features are absolutely 
paramount to the investigation of the enzyme kinetics. Instead of using crude 
enzyme for direct immobilisation with the Ni-NTA derivatised capillary and 
microbeads, the use of purified enzyme feed minimises non-specific binding during 
immobilisation and allows for improved characterisation of the enzyme behaviour. 
 
3.2.1.2.1 Ni-NTA affinity purification 
With the advent of recombinant protein technology, the incorporation of an affinity 
tag offers a feasible way for enzyme purification. Among the variety of affinity 
tags, more than 60% of the proteins produced include a polyhistidine tag 
(Derewenda, 2004), which normally results in high yields of more than 90% purity, 
making it economically favourable (Arnau et al., 2006). Numerous application of 
his-tag purification have been reported (Chaga et al., 1999; Derewenda, 2004; 
Chatterjee et al., 2005). Purification of His-tagged proteins is based on the affinity 
binding of histidine residues to several types of immobilised metal ions (Ni
2+
 or 
Cu
2+
) that is in complexed with an immobilised chelating agent (immobilised metal-
ion affinity chromatography, IMAC). Complex formation between Ni-NTA and 
His-tag renders stability for the immobilisation and the interaction can be easily 
uncoupled through incorporation of imidazole or EDTA. 
 
Purification of His-tagged TK was demonstrated successfully by Hibbert et al. 
(2007) using sepharose fast-flow Ni-NTA resin and Matosevic et al. (2009) using 
Ni
2+
 affinity cartridge. In this work, purification of His-tagged TK was performed 
using Ni-NTA superflow cartridge from Qiagen. Purification is based on the 
affinity between the neighboring histidines of the His•Tag sequence of the 
expressed TK and an immobilised metal ion (Ni2+) in the cartridge. The cartridge 
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was first loaded with equilibration buffer before the crude TK was loaded through 
the cartridge. Any non-specific protein binding was removed by washing buffer and 
the target protein was recovered in the elution buffer (Section 2.4). This procedure 
produced high purity of TK (>90%) as indicated by the band appeared in the SDS-
PAGE gel in Figure 3.2. The Ni-NTA superflow cartridge was used up to ten times 
without any major enzyme loss before being discarded. In addition, the Ni-NTA 
superflow cartridge can also be used for purifying proteins in an automated 
procedure, which was successfully demonstrated by using the syringe pump. 
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Figure 3.2: Purification of His6"tagged transketolase. His6"tagged TK was purified from 200 mL 
culture scale on Ni-NTA superflow cartridge. The TK band in each lane at 72 kDa corresponds to 
the monomeric form of the enzyme. Lane (1) protein marker, (2) E.coli lysate obtained by 
sonication, (3) supernatant following sonication and centrifugation, (4) purified His6-TK eluted with 
a 250 mM solution of imidazole, (5) purified His6-TK following removal of imidazole by desalting 
method. His6-TK was determined to make up about 28% of the total cell protein. Purification 
performed as described in Section 2.4 
kDa 
170 
130 
100 
70 
55 
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3.2.1.2.2 Removal of imidazole from purified His6-TK 
Imidazole was added during the purification process to allow for the recovery of the 
purified His6-TK from the purification column (Section 2.4). Imidazole was passed 
in excess through the column to displace the His6-TK from nickel co-ordination, 
and freeing the enzyme. No more than 250 mM is suggested for the elution buffer 
since many proteins will elute with imidazole levels as low as 100-200 mM. Free 
imidazole can be removed from the eluted sample by dialysis, desalting column or 
gel filtration. Alternatively, EDTA can be used to elute His6-TK from the column. 
However, the downside of this method is that EDTA strips nickel ions from the 
resin, which limits the reusability of the purification column.  
 
Two methods were tested to demonstrate the removal of imidazole from purified 
His6-TK. Dialysis works by separating molecules in solution by the difference in 
their rates of diffusion through a semi-permeable membrane. The TK-imidazole 
solution was placed inside a dialysis semi-permeable membrane with MWCO of 
14,000 Da and incubated in 50 mM Tris-HCl at pH 7 (Section 2.5). By stirring this 
at 4°C overnight (14-16 hours) the imidazole moves out of the dialysis membrane 
leaving pure transketolase. The pore size is significantly lower than the size of the 
enzyme molecule (~144,000 Da), thus minimising losses that might occur during 
the process.  
 
The second method was by using the desalting column with a MWCO of 5,000 Da 
(Section 2.6). This method allows for rapid group separation of salts and other 
impurities from the high molecular weight substances of interest. The sensitivity of 
this column was even higher and the desalting process took less than one hour to 
perform. The desalted sample however was diluted by more than 30% from the 
initial enzyme feed. Samples from both methods were quantified and run on SDS-
PAGE (Figure 3.3). The quality and band size of both samples, as visualized from 
the gel were similar. Quantification of the enzyme concentration was carried out to 
support this data. After normalising the final volume of the samples, the 
concentration of purified His6-TK from dialysis was 2.38±0.055 mg/mL while 
sample from desalting column was 2.44±0.056 mg/mL. This result suggests that no 
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significant leakage of enzyme occurred during the dialysis process compared to the 
desalting method, despite the long hours process. 
 
Based on the information acquired from this study, desalting method appeared to be 
more favourable compared to the dialysis method. While both methods showed 
almost similar results, desalting method was chosen due to its simpler protocol and 
shorter processing time. In addition, the desalting method was found to be relatively 
cheap as the desalting column could be recycled up to ten times before discarding. 
Therefore, desalting method was used for further post purification process for 
removal of imidazole. The effect of dialysis and desalting process on the His6-TK 
activity was further investigated in Section 3.2.4. 
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Figure 3.3: SDS PAGE for dialysis and desalting process sample of purified His6-TK. (1) Protein 
marker, (2 and 5) Purified His6-TK prior to removal of imidazole, (3 and 6) Purified His6-TK after 
dialysis, (4 and 7) Purified His6-TK after desalting process. Dialysis of His6-TK was performed as 
described in Section 2.5 and desalting process in Section 2.6.  
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3.2.1.3 Quantification of His6!tagged TK 
The quantification of His6-TK concentration was conducted after the purification 
process using three techniques, which were absorbance by spectrophotometer, SDS-
PAGE and Bradford assay. Protein concentration was determined at 280 nm with an 
extinction coefficient (") of 93905 L mol-1 (Martinez-Torres et al., 2007). This 
measurement is based on the content of Trp, Tyr and cystine (disulfide bonds) (Pace 
et al., 1995). The relationship of absorbance to protein is linear. Using the known " 
value, the concentration of the TK was calculated using Beer-Lambert equation 
(Section 2.2.3.2). 
 
The concentration of purified TK was measured to be 1.58±0.19 mg/mL. The 
variability of the TK concentration might be due to the OD measurement of the 
fermentation and the recovery process of the protein, which includes the sonication 
process and purification.  
 
From the SDS-PAGE analysis, the recovery process of the purified TK was 
demonstrated. A significant loss of TK was observed during centrifugation process 
whereby about 10-15% of protein was lost based on the band compared to that of 
the sonicated sample. This fraction of protein loss was the inclusion bodies that 
were formed during the high-level expression of E.coli cells. The removal of this 
aggregated protein will ensure there is no misfolded protein presence in the purified 
TK. The centrifugation processes were carried out twice with the first step was the 
recovery of the pellet after the fermentation. The purity of His-tagged purified TK 
was consistently high (>90%) indicating that the purification process with Ni-NTA 
superflow cartridge was effective in removing the vast majority of the 
contaminants. 
 
Finally, the Bradford assay (Section 2.2.3) was used to validate the results obtained 
by the other methods. This simple technique relies on the binding of the dye 
Coomassie Blue G250 to protein. Bovine serum albumin (BSA) was used for 
constructing the calibration curve and the absorbance was taken at 595 nm. Results 
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were found to be in agreement with slight variation in values with this method 
compared to the previous method. The difference may be subject to variation in 
sensitivity between individual proteins and impurities presence in the sample 
(Hammond and Kruger, 1988). Unless the protein is free of other compunds that 
absorb light at 280 nm, the results will be inaccurate. For example, nucleic acids 
contain purine and pyrimidine rings that have absorption maxima near 260 nm with 
considerabe absorption extending to 280 nm. In addition, the variability in the 
values could also be due to other factors arising from SDS-PAGE preparation, such 
as the reducing agent used and staining and the staining and destaining processes 
(Neuhoff et al., 1985). 
 
3.2.2 Investigation of activity of His6-TK in solution 
The standard activity of TK was conducted in 96-SRW microwell with total 
reaction volume of 300 µL (Section 2.7.1). A comparison of activity of purified TK 
and TK in lysate form was performed for a period of two hours (Figure 3.4). The 
activity of TK lysate reached 80% after one hour reaction compared to purified TK 
that only achieved 64% conversion. The concentration of enzyme used in the 
reaction was 0.1 mg/mL and 0.05 mg/mL for lysate and purified TK respectively. 
When normalised by the corresponding amount of enzyme, the specific activity of 
erythrulose formation were 19 ± 0.25 µmol.min-1.mg-1 (lysate) and 23± 0.13 
µmol.min
-1
.mg
-1 
(purified His6-TK). 
 
These results indicate that productivity per unit of enzyme of purified His6-TK was 
higher than lysate, which was likely due to less competing side reactions present. 
Despite losing some enzyme during the purification, this data suggests that the 
purification procedure had no detrimental effect on the His6-TK enzyme activity. 
Therefore, further bioconversion studies were performed using the His6-TK in 
purified form. 
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(a) 
 
(b) 
 
Figure 3.4: Activity profile of pure and crude form of His6-TK. Comparison of purified His6-TK 
with His6-TK in lysate form. (a) The TK reaction profile with model substrate of 50 mM 
hydroxypyruvate (HPA) and 50 mM glycolaldehyde (GA) in 50 mM Tris"HCl buffer, pH 7.0 with 
cofactors thiamine pyrophosphate (TPP), 2.4 mM and MgCl2, 9 mM at room temperature (Section 
2.7.1). Concentration of enzyme used for purified TK was 0.05 mg/mL and lysate was 0.1 mg/mL in 
300 µL total volume reaction. (b) Initial reaction rates of purified and lysate His6-TK. Error bars 
represent one standard deviation about the mean (n = 2) 
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3.2.3 Investigation of His6-TK storage stability 
Understanding the stability of an enzyme is paramount to both commercial and 
scientific interest. There are several parameters that can be studied to determine the 
stability of an enzyme such as temperature, pH, oxidative stress, solvent used and 
presence of surfactant (Eijsink et al., 2005). Mitra et al. (1998) evaluated the 
stability of TK based on the effect of pH and substrates, while Jahromi et al. (2011) 
further investigated the effect of organic solvents, extreme pH and high temperature 
on the activity and stability of TK. To date there is no reported data on TK stability 
at different storage conditions. The viability and activity of TK over time is very 
important to ensure the enzyme does not degrade nor destabilise during 
investigation. Any reduction in enzyme activity would compromise the evaluation 
of the enzymatic behaviour.  
 
Effect of storage at three different temperatures on enzyme stability was 
investigated. The temperatures selected were 4°C, -20°C and room temperature 
(22°C). The effect of storage on the stability of TK in the fridge at 4°C was minimal 
for a period of up to 15 days with average specific activity of 21± 2.16 µmol.min-
1
.mg
-1 
(Figure 3.5). Significant loss of enzyme activity was observed with only 58% 
of TK activity was retained after 30 days of storage. For prolonged use of purified 
TK, the enzyme was best stored in -20°C. The activity of the purified TK was 
almost constant for up to 30 days and a minimal loss (15%) of activity was 
observed after 60 days (Figure 3.6). This data suggests that the enzyme is stable for 
longer period of time, which minimises the number of purifications required to 
obtain sufficient enzyme for TK activity assays. 
 
Stability of purified TK was evaluated during the first 24 hours at room 
temperature. Reduced activity was noticed whereby about 22% of enzyme activity 
loss was observed (Figure 3.7). This assessment is important, as the enzyme will be 
immobilised in the IEMR for a period of up to 24 hours. However, the evaluation of 
TK stability in IEMR is not conclusive based on this finding. As the reaction was 
conducted in solution phase, they were likely to be less representative of the 
immobilised TK. Significant improvements are usually observed with immobilised 
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enzyme in storage and operational stability as well as decreased autolysis reaction 
(Sakai-Kato et al., 2002; Nomura et al., 2004; Fernandes, 2010). 
 
Enhanced stability of immobilised TK on derivatised surface capillary was reported 
by Matosevic et al. (2009) with constant activity up to 96 hours. Moreover, the 
stability of TK immobilised on different resins were studied, where Eupergit-C( 
matrix (Brocklebank et al., 1996) showed to be stable for up to 5 hours reaction 
while immobilisation on Sepharose 4B matrix (Kochetov & Solocbeva, 1977) was 
reported to retain 50% of its specific activity compared to the free enzyme. While 
some immobilisation proved to increase the enzyme stability, the type of 
immobilisation or matrixes used plays an important role in determining the stability 
of an enzyme.   
 
105 
(a) 
 
 
(b) 
 
Figure 3.5: Stability of His6-TK upon storage at 4°C. (a) Graph showing the production of 
erythrulose by purified His6-TK assessed at different time. (b) Specific activity of His6-TK measured 
over a period of 30 days. The assays were conducted with 50 mM HPA and GA (Section 2.7.1) with 
enzyme concentration of 0.05 mg/mL. Error bars represent one standard deviation about the mean (n 
= 2) 
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(a) 
 
 (b)  
 
Figure 3.6: Stability of His6-TK upon storage at -20°C. (a) Graph showing the production of 
erythrulose by purified His6-TK assessed at different time. (b) Specific activity of His6-TK measured 
over a period of 60 days. The assays were conducted with 50 mM HPA and GA (Section 2.7.1) with 
enzyme concentration of 0.05 mg/mL. Error bars represent one standard deviation about the mean (n 
= 2) 
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(a) 
 
(b) 
 
Figure 3.7: Stability of His6-TK upon storage at room temperature. (a) Graph showing the 
production of erythrulose by purified His6-TK assessed at different time. (b) Specific activity of 
His6-TK measured over a period of 7 days. The assays were conducted with 50 mM HPA and GA 
(Section 2.7.1) with enzyme concentration of 0.05 mg/mL. Error bars represent one standard 
deviation about the mean (n = 2) 
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3.2.4 Effect of dialysis and desalting on the activity of His6-TK form  
Further investigation on the effect of dialysis and desalting on the TK activity in 
solution was carried out using the standard protocol for TK activity assay (Section 
2.7.1). The activity of His6-TK showed to be comparable for both methods with 
initial rates of 1.015±0.13 mM/min and 1.02±0.14 mM/min for dialysis and 
desalting column, respectively (Figure 3.8). However, the desalting column 
appeared to be more preferable due to its simpler protocol and high efficiency in 
removing imidazole. This method was adopted for the post purification process. 
 
 
 
Figure 3.8: Activity of purified His6-TK following dialysis and desalting process. Dialysis (Section 
2.5) and desalting process (Section 2.6) were carried out for post purification process for the removal 
of imidazole. The assay was conducted with 50 mM HPA and GA (Section 2.7.1) with enzyme 
concentration of 0.05mg/mL. Error bars represent one standard deviation about the mean (n = 2) 
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3.2.5 Kinetic data of purified His6-TK in solution phase 
Determination of kinetic data is important in order to quantify and predict specific 
chemical reactions catalysed by the enzyme. The most common model to study the 
kinetics is Michaelis–Menten model (Michaelis & Menten, 1913). The Michaelis–
Menten equation (Eq. 3.1) relates the initial reaction rate v to the substrate 
concentration [S]. The corresponding graph is a rectangular hyperbolic function 
(Figure 3.9); the maximum rate is described as Vmax. 
 
 
          (3.1) 
 
Where Km = Michaelis Menten constant, [S] = substrate concentration, v = initial 
rate of product formation, and Vmax = maximum reaction rate of product formation. 
 
The Michaelis constant is an approximation of the affinity of the enzyme for the 
substrate based on the rate constants within the reaction, which is equivalent to the 
substrate concentration when the rate of conversion is half of Vmax. Smaller Km 
value indicates higher affinity towards the enzyme, hence will approach Vmax more 
quicker. Very high [S] values are required to approach Vmax, which is reached only 
when [S] is high enough to saturate the enzyme.  
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Figure 3.9: Michaelis-Menten representation of enzyme activity data. V represents the initial 
velocity rate of a given enzyme reaction and is calculated from the initial portion of the measurement 
as depicted in the inset. S is the limiting substrate concentration for each rate experiment. Image 
reproduced from (Cooney, 2011). 
Product  
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In order to evaluate the His6-TK enzyme kinetics, the reaction rates were first 
measured at different substrate concentrations (Figure 3.10). These data were used 
to construct Lineweaver-Burk and Eadie-Hofstee plots. Enzyme kinetics was shown 
to have no significant inhibition by the products within the substrates concentration 
range studied. The Km and Vmax values estimated from both plots showed to be in 
agreement with slight difference in their estimation of kinetic parameters for His6-
TK (Table 3.1). The Michaelis constant for GA of 37 mM obtained in this study 
was of the same magnitude as the value of 16 mM (Chen et al., 2009), 16.1 mM 
(Gyamerah et al., 1997) and 14 mM (Sprenger et al., 1995) reported in previous 
studies. 
 
Comparable Michaelis constant value was also obtained for HPA which was 21 
mM as compared to 18 mM (Chen et al., 2009), 13.2 mM (Gyamerah et al., 1997) 
and 18 mM (Sprenger et al., 1995) reported from the same studies. The difference 
in values may be accounted for the fact that our assays were performed using a 
purified His6-TK compared to lysate in the described studies. Variation of pH, 
temperature and the way the assay was conducted could also have contributed to the 
variation in the results produced. Data of the kinetic parameters in various studies 
was summarized in Table 3.2. 
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(a) 
 
(b) 
 
Figure 3.10: Purified His6-TK activity assay at different substrate concentrations. Erythrulose 
formation over 60 min reaction with different substrate concentration. (a) Reaction with various 
glycolaldehdye (GA) concentrations (100-10 mM) when the concentration of second substrate 
hydroxypyruvate (HPA) was kept constant at 100 mM, (b) Reaction with various hydroxypyruvate 
(HPA) concentrations (100-10 mM) when the concentration of second substrate glycolaldehyde 
(GA) was kept at 100 mM. Reactions were performed as described in Section 2.7.4 and His6-TK 
concentration of 0.05 mg/mL was used. Error bars represent one standard deviation about the mean 
(n = 3). 
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(a) 
 
(b) 
 
Figure 3.11 Kinetic analysis of purified His6-TK in solution phase. (a) Lineweaver-Burke and (b) 
Eadie-Hofstee plots. Initial rate data for different glycolaldehyde (GA) concentrations was used to 
obtain these plots. Km values obtained with both plots were in agreement. 
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 (a) 
 
(b) 
 
Figure 3.12: Kinetic analysis of purified His6-TK in solution phase. (a) Lineweaver-Burke and (b) 
Eadie-Hofstee plots. Initial rate data for different hydroxypyruvate (HPA) concentrations was used 
to obtain these plots. Km values obtained with both plots were in agreement. 
 
115 
  
Table 3.1: Kinetic parameters for purified His6-TK in solution phase. Comparison of kinetic 
parameters analysed using Lineweaver-Burke and Eadie-Hofstee plots (Figure 3.11 and Figure 3.12). 
Table shows mean values ± one standard deviation (n=3). 
Michaelis-Menten kinetic parameters 
 Lineweaver-Burke Eadiee-Hofstee 
 Vmax (mM/min) Km (mM) Vmax (mM/min) Km (mM) 
Glycolaldehyde (GA) 3.8±0.3 35±1 4±0.1 37±1 
Hydroxypyruvate (HPA) 3.7±0.3 21±5 3.7±0.1 21±4 
 
 
Table 3.2: Summary of kinetic parameters for transketolase reaction using HPA and GA as substrate 
model in various studies. 
Kinetic parameters This work (Chen et al., 2009) 
(Gyamerah et al., 
1997) 
(Sprenger et al., 
1995) 
Km for HPA (mM) 21 18 13.2 18 
Km for GA (mM) 37 16 16.1 16.1 
Vmax (mM/min) 4.0 - 5.3 - 
kcat (s
-1
) 95 40.7 84.6 - 
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3.3 Characterisation of Transaminase (TAm) enzyme 
3.3.1 Transaminase production  
3.3.1.1  Production of His6!TAm by E.coli fermentation  
The E.coli (containing plasmid pQR801) (Kaulmann et al., 2007) expressing !–
TAm from C. violaceum was firstly grown in a 2 L flask with working volume of 
200 mL for 7-8 hours at 37°C and 250 rpm (Section 2.2.1). Optical density (OD) of 
the solution was measured every hour at 600 nm to check for bacterial growth at 
stationary phase. 0.2 mM IPTG was added after 2 hours fermentation (early 
exponential phase). The growth of the cells begins to reach stationary phase after 
seven hours fermentation and the optical density measurement taken at eight hours 
confirmed the bacterial growth plateau. This data ensures that the bacteria culture is 
harvested at the optimum level, hence offering substantial amount of TAm for the 
subsequent purification step. Following fermentation, 0.2 mM PLP was added to 
the culture broth to stabilise the cells. 
 
Based on the growth profile, the fermentation underwent a short lag phase, due to 
the high inoculum volume 10% v/v and as a result of using similar inoculum 
medium in the fermentation. Following the lag period, growth started in the 
exponential phase for about 7 hours before it reaches stationary phase. For the 
particular fermentation data shown in Figure 3.13, the maximum specific growth 
rate was 0.84 hr
-1 
with a doubling time, td of 0.83 hr. Similar fermentation procedure 
was used throughout this project and data shown in Figure 3.13 is representative of 
each fermentation performed. The expressed His-TAm constituted about 40% of the 
total cell protein as estimated by SDS-PAGE.  
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Figure 3.13: Growth of E.coli strain BL21gold (DE3) pQR801 expressing His6"TAm. Cells were 
cultured in 200 mL LB glycerol media with the addition of 0.15g/L kanamycin, in a 2 L shake flask 
at 37°C, 250 rpm with a 10% v/v inoculum grown overnight as previously described (Section 2.2.1). 
10 g/L of glycerol as the carbon source to the media was added to promote growth. The cell was 
induced with 0.2 mM of IPTG after 2 hours of fermentation. Growth was monitored by OD600nm 
measurements (Section 2.2.2). Error bars represent one standard deviation about the mean (n = 3) 
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3.3.1.2 Purification of His6!tagged TAm  
TAm purification was conducted using Ni-NTA superflow cartridge (Qiagen) that is 
specially designed for histidine tagged protein purification. A similar protocol as the 
His6-TK purification was adopted with additional of 0.2 mM of PLP in the 
purification buffers (Section 2.4). The presence of the PLP stabilises the enzyme by 
covalently binding to the apoenzyme via internal aldimine linkage with the "-amino 
group of an active –site lysine (Shin et al. 2003). 
 
The desalting process was carried out after the purification, to remove the 
remaining imidazole (Section 2.6). The purification process was monitored and 
analysed by running some samples on the SDS-PAGE and quantification by 
Bradford assay and spectrophotometer at 280 nm.  
 
From the SDS-PAGE analysis, the recovery process of the purified His6-TAm was 
demonstrated (Figure 3.14). A significant loss of His6-TAm was seen during 
centrifugation, with about 40-50% loss based on the band compared to the sonicated 
sample. This was due to the inclusion bodies formation, which was previously 
observed by Ingram et al. (2007). The purification column produced high purity of 
His6-TAm as indicated by the band appeared in the SDS-PAGE gel with almost 
>90% purity was achieved. The concentration of His6-TAm was determined by the 
Bradford assay with an average concentration of 2.4±0.2 mg/mL. The value 
obtained was in agreement with spectrophotometer reading (Section 2.2.3.2). The 
reading was blanked with 0.2 mM PLP to reduce any background noise.  
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Figure 3.14: Purification of His6"tagged transaminase. His6"tagged TAm was purified from 200 mL 
culture scale using Ni-NTA superflow cartridge. The TAm band in each lane at 50 kDa corresponds 
to the monomeric form of the enzyme. Lane (1 and 6) protein marker, (2 and 7) E.coli lysate 
obtained by sonication, (3 and 8) supernatant following sonication and centrifugation, (4 and 9) 
purified His6-TAm eluted with a 250 mM solution of imidazole, (5 and 10) purified His6-TAm 
following removal of imidazole by desalting method. His6-TAm was determined to make up about 
40% of the total cell protein. Purification performed as described in Section 2.4. 
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3.3.2 Investigation of His6- TAm activity in solution  
His6-TAm activity was demonstrated using MBA and ERY model substrates with 
cofactor PLP to produce ABT and AP (Section 2.7.2). The formation of the second 
product (ABT) was confirmed to follow the formation of AP by derivatising the 
ABT sample (Section 2.8). This allows for the ABT to be detected through HPLC. 
The mass balance of the product was consistent, with the AP and ABT formation 
was similar within error (Figure 3.15).  
 
Similar activity of TAm from C. violaceum was reported for using MBA and ERY 
as model substrates with the enzyme in lysate (Kaulmann et al., 2007). With 0.45 
U/mL of TAm, about 3% conversion was observed after one hour of reaction. On 
the other hand, higher conversion (84% in one hour) was achieved with pyruvate as 
the amino acceptor (Kaulmann et al., 2007). The activity of enzyme in lysate 
reached 37% conversion after one hour of incubation, whereas it was 25% for the 
purified enzyme (Figure 3.16). However, when normalised by the amount of 
enzyme present in the reaction, the specific activity of enzyme in lysate (0.13±0.03 
#mol/min/mg) was slightly lower than that of the purified enzyme (0.15±0.04 
#mol/min/mg). These values suggest that purification process had no adverse effect 
on the enzyme activity. Further bioconversion studies were performed using His6-
TAm in purified form unless stated otherwise. 
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Figure 3.15: Profile of His6-TAm reaction with analysis of MBA depletion, AP and ABT formation. 
His6-TAm model reaction with 10 mM of (S)-$- methylbenzylamine (MBA) and 100 mM of 
L"erythrulose (Ery) as model substrates with 0.2 mM pyridoxal phosphate (PLP) to produce 
acetophenone (AP) and 2-amino-1,3,4-butanetriol (ABT), pH 7.5 and at room temperature (Section 
2.7.2). Reaction was monitored on the depletion of MBA and production of AP and ABT by HPLC. 
Concentration of His6-TAm used was 0.3 mg/mL in this reaction. Error bars represent one standard 
deviation about the mean (n = 3). 
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(a) 
 
(b) 
 
Figure 3.16: Activity profile of pure and crude form of His6-TAm. Comparison of purified His6-
TAm with His6-TAm in lysate form. (a) The TAm reaction profile with model substrate of 10 mM 
(S)-$- methylbenzylamine (MBA) and 100 mM L"erythrulose (ERY) in 50 mM Tris"HCl buffer, 
pH 7.5 with cofactor 0.2 mM pyridoxal phosphate (PLP) at room temperature (Section 2.7.2). 
Concentration of enzyme used for purified TAm was 0.3 mg/mL and lysate was 0.4 mg/mL in 300 
µL total volume reaction. (b) Initial reaction rates of purified and lysate His6-TAm. 
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3.3.3 Product inhibition effect on His6-TAm  
In spite of the many advantages that TAm offers, such as broad substrate 
specificity, high turnover rate and high stability, the industrial use of TAm has been 
limited, due to the low equilibrium constant of the transaminase reaction (Shin et 
al., 2003; Yun et al., 2005; Kaulmann et al., 2007). Moreover, high concentration of 
substrate in TAm bioconversion will become impractical as it would cause severe 
product inhibition (Shin & Kim, 1999). Ketone product was reported to inhibit the 
enzyme activity in !-TAm from V. fluvialis JS17 (Shin & Kim, 1999; Shin & Kim, 
2002; Shin et al., 2003). Similar inhibition was observed with !-TAm from C. 
violaceum with exception of few amine acceptors (pyruvate, glyoxylate and 
benzaldehyde) that allowed for )90% conversion (Kaulmann et al., 2007). 
 
A time course study was performed with MBA and ERY until no more conversion 
was observed. Equimolar concentration of substrate was used (50 mM MBA and 
ERY) and the reaction was monitored for 24 hours (Section 2.7.2). The reaction 
reached equilibrium after 6 hours and no increment in product formation was 
observed after 24 hours with the final reaction yield of only 17% (Figure 3.17). The 
low conversion observed here displayed the unfavourable equilibrium seen in many 
!-TAm substrates that was influenced by a strong by-product (AP) inhibition. 
Conversely, the bioconversion of 50 mM MBA and pyruvate catalysed by !-TAm 
from Bacillus thuringiensis JS64 resulted in almost 100% conversion with the 
equilibrium favouring product formation to produce L-alanine (Shin & Kim, 1998). 
 
Many studies have been done to tackle this inhibition problem. Product can be 
removed to overcome the equilibrium problem by using whole cell 
biotransformation (Chao et al., 1999). Shin & Kim (1997) demonstrated an 
extractive biphasic reaction system that reduced the inhibitory AP concentration in 
the aqueous phase. However this method may pose a solvent toxicity problem on 
the enzyme and mass transfer limitation due to the interfacial area (Shin et al., 
2001). In addition, an enriched culture method combined with random mutagenesis 
was shown to significantly reduce product inhibition by aliphatic ketones (Yun et 
al.,2005).
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Figure 3.17: Reaction profile of His6-TAm with 50 mM of MBA and 50 mM ERY. Profile of His6-
TAm reaction with analysis of MBA depletion and AP formation. Experimental conditions: 0.2 mM 
pyridoxal phosphate (PLP), pH 7.5 and at room temperature (Section 2.7.2). Concentration of His6-
TAm in lysate form used was 1.4 mg/mL. Error bars represent one standard deviation about the 
mean (n = 3). 
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3.3.4 Investigation of His6-TAm storage stability 
Enzyme stability plays a very important role due to the increasing number of 
enzyme applications. This study will help to realise the full potential of the enzyme, 
which reflects the commercial and scientific interest. The majority of enzymes on 
the market are in their native form and therefore, it is vital to the industrial 
biochemist to ensure the stability of the enzyme during storage and use. Storage 
stability of various enzymes under different storage conditions were successfully 
demonstrated (Cryer & Bartley, 1974; Jones, 1985; Hansen & Shultz, 2001). In 
general, storage stability tends to decrease significantly with increasing 
temperature. In pure aqueous solution, rapid inactivation takes place between 50-
80°C, which completely destroys the enzyme activity within one to five hours 
(Euler & Pope, 1912). Alternatively, enzymes can be stored with glycerol solution 
to enhance their stability. 
 
A similar study was conducted to evaluate the storage stability of His6-TAm at three 
different storage conditions. His6-TAm productivity dropped to ~70% after 24 
hours and was nearly inactive after seven days when stored at room temperature 
(Figure 3.18). The stability of His6-TAm was improved when stored in 4°C with 
slight decrease in productivity after three days reaction (Figure 3.19). This small 
fluctuation might be due to errors during the experiment and the HPLC analysis. 
However, a significant decline was observed on the enzyme productivity after seven 
days reaction where His6-TAm only retained 45% of its initial productivity. For 
prolonged use of purified His6-TAm, the enzyme could be stored at - 20°C for 30 
days without any substantial loss of activity (Figure 3.20).  
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(a) 
 
(b) 
 
Figure 3.18: Reaction profile of His6-TAm stored at room temperature. (a) Graph showing the 
production of acetophenone catalysed by purified His6-TAm assessed at different times. (b) 
Productivity of His6-TAm measured over a period of 15 days. The assay was conducted with 10 mM 
MBA and 100 mM ERY (Section 2.7.2) with enzyme concentration of 0.5 mg/mL. Error bars 
represent one standard deviation about the mean (n = 3). 
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(a) 
 
(b) 
 
Figure 3.19: Reaction profile of His6-TAm stored at 4°C. (a) Graph showing the production of 
acetophenone catalysed by purified His6-TAm assessed at different times. (b) Productivity of His6-
TAm measured over a period of 15 days. The assay was conducted with 10 mM MBA and 100 mM 
ERY (Section 2.7.2) with enzyme concentration of 0.5 mg/mL. Error bars represent one standard 
deviation about the mean (n = 3). 
 
128 
(a) 
 
 
(b) 
 
Figure 3.20: Reaction profile of His6-TAm stored at -20°C. (a) Graph showing the production of 
acetophenone catalysed by purified His6-TAm assessed at different times. (b) Productivity of His6-
TAm measured over a period of 60 days. The assay was conducted with 10 mM MBA and 100 mM 
ERY (Section 2.7.2) with enzyme concentration of 0.5 mg/mL. Error bars represent one standard 
deviation about the mean (n = 3). 
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3.3.5 Effect of PLP on His6-TAm enzyme activity and storage stability 
Pyridoxal-5’-phosphate (PLP) acts as a coenzyme in all transamination reactions 
and in some decarboxylation and deamination reactions of amino acids. The TAm 
enzymatic reaction demonstrates ping-pong bi-bi mechanism (Christen & Metzler, 
1985). According to this mechanism, PLP is coordinated in the active site as an 
internal aldimine formed by a covalent Schiff base linkage to the "-amino group of 
a catalytic lysine (Humble et al., 2012). The regeneration of the cofactor in situ after 
the reaction completes make it a perfect choice in industrial processes.  
 
The presence of PLP in the transaminase reaction does not only act as a cofactor but 
also as a stabilizing agent (Shin et al., 2003; Yun et al., 2004; Yun et al., 2005). To 
evaluate the PLP effect on enzyme activity, a set of standard His6-TAm activity 
assays (Section 2.7.2) were carried out using different PLP concentration (0.2-2.0 
mM). No significant change was observed on the His6-TAm activity (Figure 3.21a). 
This suggests that the range of PLP concentration used did not pose a drastic effect 
on the enzyme activity. Higher PLP concentration can be tested to see any obvious 
effect on the enzyme activity.  
 
The effect of different PLP concentration on His6-TAm storage stability was 
demonstrated. All samples were readily incubated in respective PLP concentration 
(0.2, 1.0, 2.0 and 5.0 mM) during the purification process and stored at 4°C. His6-
TAm activity was recorded over 15 days of reaction following the standard His6-
TAm assay (Section 2.7.2). Enzyme activity incubated in all of the PLP 
concentrations was quite similar for the first two days of reaction (Figure 3.21b). 
However, a more pronounced effect was observed on the enzyme activity on the 
seventh and 15th day of reaction. His6-TAm incubated with 5 mM PLP retained 
22% activity after 15 days compared to 4% activity in His6-TAm incubated with 0.2 
mM PLP. That was more than 5-fold improvement in the enzyme stability. This 
suggests that while moderate effect of PLP concentration on enzyme activity was 
observed on the early period of the experiment, the stabilizing effect at different 
PLP concentration only could be seen distinctly at a longer time period of time 
when the PLP starts to degrade.  
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Nevertheless, since the effect of the PLP concentration on the enzyme storage 
stability become apparent at longer time period, it is not necessary for the enzyme 
to be prepared at higher PLP concentration. The enzyme can be stored at 4°C with 
0.2 mM PLP without compromising kinetic data collection if the enzyme is utilised 
within the first few days. Moreover, one can opt to store the enzyme at -20°C for 
longer storage time (>30 days without substantial loss in enzyme activity) (Figure 
3.20). 
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(a) 
 
(b) 
 
Figure 3.21: Effect of pyridoxal-5’-phosphate (PLP) on enzyme stability. Reaction was carried out 
with 100 mM ERY and 10 mM MBA substrate, 50 mM Tris-HCl buffer (pH 7.5) at room 
temperature. (a) Effect of different PLP concentration on the enzyme activity using 0.4 mg/mL His6-
TAm (b) Effect of different PLP concentration (0.2-5.0 mM) incubated with TAm, stored in 4°C 
over 15 days reaction using 0.5 mg/mL His6-TAm.  
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3.3.6 Kinetic data of purified His6-TAm in solution phase 
The kinetic constants for the forward reaction between MBA and ERY were 
evaluated based on a single substrate assumption. Two sets of reaction were 
conducted, whereby in both sets, the concentration of one of the substrate was 
varied while the other substrate was kept fixed. All reactions were performed at 
room temperature and at pH 7.5 (Section 2.7.5). As expected, the reaction rates 
increase with higher substrate concentration (Figure 3.22). These data were fitted to 
a Michaelis Menten model using two plots, the Lineweaver–Burke and Eadie-
Hofstee plots to estimate the Vmax and the Km value. The Vmax for ERY and MBA 
calculated were 0.018 mM/min and 0.015 mM/min, respectively, and the Michaelis 
constant estimated for ERY was 80 mM and for MBA was 1 mM. Agreeable values 
of the kinetic parameters obtained from both plots apart from the slight different in 
Km value for ERY and the catalytic constant kcat, calculated for His6-TAm was 
0.19/s.  
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(a) 
 
(b) 
 
Figure 3.22: Activity profile of His6-TAm at different substrate concentration (Section 2.7.5). 
Reactions were set up in 50 mM Tris-HCl, pH 7.5 with total reaction volume of 300 µL. (a) ERY 
concentration was varied (50-300 mM) with MBA concentration fixed at 10 mM. (b) MBA at 
different concentrations (1-10 mM) with ERY concentration maintained at 100 mM. Error bars 
represent one standard deviation about the mean (n = 3). 
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(a) 
 
(b) 
 
Figure 3.23: Kinetic analysis of His6-TAm in solution phase. (a) Lineweaver-Burke plot and (b) 
Eadie-Hofstee plot at different ERY concentration.  
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(a) 
 
(b) 
 
 
Figure 3.24: Kinetics of His6-TAm in solution phase. (a) Lineweaver-Burke plot and (b) Eadie-
Hofstee plot at different MBA concentration.  
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3.4 Summary  
The work performed in this initial chapter demonstrated the utility of batch solution 
phase formats for the quantitative study of transketolase and transaminase 
bioconversion kinetics. The preliminary data gathered here provides a basis for 
studies in the subsequent chapter of the thesis. 
 
The comparison of the enzyme activity in crude and purified form was investigated 
and the results showed the productivity per unit of purified enzyme was higher than 
lysate, which was likely due to less competing side reactions present (Section 3.2.2 
and Section 3.3.2). Besides that, the characterisation of both enzymes in regards to 
its storage stability showed that the enzymes are best stored at -20°C for prolonged 
use of 30 days without showing any significant loss in enzyme activity (Section 
3.2.3 and Section 3.3.4).  
 
As for transaminase enzyme, the presence of PLP showed to have a significant 
effect not only as a cofactor but also as the enzyme stabiliser. Concentration of 0.2 
mM of PLP stored in 4°C was chosen to be used in the TAm-catalysed reaction 
without compromising kinetic data collection provided that the enzyme is utilised 
within the first few days (Section 3.3.5). In addition, the activity of TAm reaction 
was found to be greatly inhibited by the by-product, acetophenone. The maximum 
product formed after 24 hrs reaction was ~9 mM (Section 3.3.3).  
 
Finally, the specific activity for both enzymes showed that the conversion rate of 
TAm (Section 3.3.2) was relatively slower (~150x) compared to TK (Section 3.2.2) 
based on the investigated conditions. This preliminary data highlights the 
importance of matching the rates of the two enzymes to achieve optimal conversion 
rates in the multi-step enzymatic reactions (Chapter 6). 
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4 Development and Characterisation of Immobilised 
Enzyme Microreator (IEMR) 
 
4.1 Introduction 
The application of biocatalysts in microfluidic systems have attracted huge attention 
in recent years due to their potential for creating microscale analytical tools with 
minute volumes, high-throughput and attractive prospect for mass replication 
(Section 1.1). The aim of this research is to design and characterise a novel 
microscale reactor based on the reversible immobilisation of His6-tagged enzymes. 
The flexibility of this microreactor allows for the system to be applied to a wide 
range of enzyme-catalysed bioconversions. Two reactors system were considered in 
this study, which were the derivatised fused-silica capillary and packed tube reactor 
as outlined in Section 2.10.1 and Section 2.10.2 respectively.  
 
The fused silica capillary was commonly used in capillary electrophoresis but has 
progressed into capillary HPLC and electrochromatography (Wen et al., 1990). 
Series of chemical processes will be conducted in the capillary to create the desired 
functional group on the surface that allows for the immobilisation of an enzyme 
(Miyazaki et al., 2004). In the second system, a packed tube microreactor was 
employed. The microbeads, which were used as the solid support for the enzyme 
immobilisation, will be packed in the FEP tube that works as a packed bed reactor. 
These microreactors were based on the affinity-based attachment of the enzymes on 
the surface of a microchannel or microbeads employing His6-Ni affinity. The 
reversible immobilisation of the His-tagged enzymes shows the versatility of these 
reactors that reflects the practicality and commercial interest of these systems. 
 
Furthermore, there is a great need for the development of a microreactor that allows 
for rapid screening of biocatalytic conversion and kinetic determination. 
Conventionally, bioconversions are performed in a microwell system that requires a 
minimum volume of 100-300 µL. For this purpose, it is indispensable to provide 
 
138 
hydroxypyruvate, a rather expensive substrate in large quantities. On the other hand, 
immobilised enzyme microreactor (IEMR) is able to tackle this issue and other 
limitations presence in a microwell system such as shorter processing time, lower 
cost, better enzyme stability and potential of reusability of the reactor.  
 
In this chapter, the prototype of the immobilised enzyme microreactor was 
developed. Both systems were constructed and the feasibility and efficiency of the 
system were investigated. The selected IEMR was further characterised in details 
for both TK and TAm enzymes. By knowing the behaviour of each single enzyme 
in the IEMR, key insight can be gained into the physics and chemistry involved 
during the bioconversion which will facilitate future implementation of the 
multienzyme reactor. Finally, the Actipix online detection system was incorporated 
into the microreactor system to allow for direct quantification of the product of 
interest. 
The key objectives of this chapter are: 
• Development of the reversible immobilisation of His6-tagged enzymes 
microreactor. 
• Characterisation of the IEMR using transketolase and transaminase enzymes 
with respect to its operational and storage stability.  
• Investigation of the reusability of the IEMR 
• Implementation of a continuous flow, UV-based online detection system for 
monitoring and evaluating immobilised enzyme reactions.  
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4.2 Construction of the immobilised enzyme microreactor 
 
4.2.1 Derivatised fused silica capillary 
4.2.1.1 Setup of the microreactor system 
The setup of the microreactor was described in Section 2.10.1.1. As shown in 
Figure 2.1, the stopped-flow microreactor comprises of three main units, (1) inlet, 
(2) microreactor and (3) outlet/sample collector. With length of 40 cm and ID of 
200 #m, the total reaction volume of the microcapillary was  ~13 #L.  
 
 
Figure 4.1: Fused silica capillary for the construction of the immobilised enzyme capillary reactor.  
 
4.2.1.2 Microreactor preparation 
A number of microreactors using fused silica capillaries have been demonstrated 
(Section 1.5.6). In this work, the surface of fused silica capillary was first treated to 
create the Ni-NTA group on the surface to allow the binding of His-tagged enzyme. 
The derivatisation method was adopted with slight modification based on Miyazaki 
et al. (2003). The protocol (Section 2.10.1.2) describes immobilisation method of 
His-tagged enzymes onto a microchannel surface. 
 
The protocol involved several steps using different chemical reagents to create Ni-
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NTA group on the capillary surface (Figure 1.5). The capillary surface was first 
modified using silanes mixtures to generate an amino group on the surface. Then 
the amino group formed was modified with succinic anhydride, followed by active 
ester formation by WSCI/NHS solution. This active ester was reacted with AB-
NTA to enable the formation of a complex with Ni
2+ 
ions. The capillary was ready 
for immobilisation of His-tagged enzymes after incubation of the Ni2SO4 solution. 
Incubating the capillary with Ni2SO4 solution can regenerate the derivatised 
capillary and a new batch of enzyme is ready to be immobilised. 
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 (a) 
 
(b)                (c) 
 
 
Figure 4.2: Field emission (FE)-SEM images of the inner surface of a fused silica capillary; (a) 3700 
magnification cross-section of 200 µm ID untreated capillary; (b) untreated capillary shows an 
entirely smooth inner surface at a 33,000 magnification; (c) 33,000 magnification of capillary 
surface treated with a solution of AB-NTA ready for enzyme immobilisation showing a rough inner 
topography. Image reproduced from (Matosevic et al., 2009) . 
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4.2.1.3 His6-Transketolase immobilisation and elution 
The immobilisation of His-tagged TK was carried out following the procedure in 
Section 2.10.1.3. Enzyme solution (~0.25-0.3 mg/mL) in 50 mM Tris-HCl (pH: 7.0) 
was loaded into the capillary at a flow rate of 5 µL/min. Theoretically, the 
immobilisation of His6-TK is dependent on the concentration of amino group 
attached to the capillary surface as a result of the chemical derivatisation (Miyazaki 
et al., 2003). The functionalised Ni-NTA groups are proportional to the number of 
amino residues on the surface and in turn drive the binding between poly-histidine 
tags on the protein molecule. 
 
Based on the dimension of the capillary reactor used (ID 200 µm and 40 cm length), 
the surface area available was 250 mm
2
,, which can accommodate about 1.3 #g of 
His6-TK. This estimation was based on the saturated binding of His6-TK on the 
inner surface of a fused silica capillary that forms a monolayer of spherical protein 
molecules. The quantity immobilised can be estimated based on the size of the 
protein and its density. The density of the enzyme was estimated to be 
approximately 1.3 g.cm
-3
 (Fischer et al. 2004). The full calculation is shown in the 
Appendix 2. The immobilisation of TK resulted in complete single layer coverage 
based on the quantification of the eluted enzyme sample, 0.018 mg/mL of His6-TK 
concentration that was approximately equal to 1.8 #g. Samples from the 
immobilisation process were run on SDS-PAGE (Figure 4.3). Significant portion of 
the initial enzyme feed was not bound on the surface and can be easily removed 
after the washing step. Based on the measured concentration of the bound His6-TK 
enzyme following the immobilisation and washing steps, the binding of His6-TK 
was confirmed to be a complete single layer surface coverage.  
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Figure 4.3: Immobilisation of His6-TK inside microcapillary. SDS PAGE of enzyme immobilisation 
within the Ni-NTA derivatised fused silica capillary. (1) The purified His6-TK feed, (2) His-TK 
remaining in solution after one pass through the microreactor, (3) His6-TK remaining in solution 
after two additional passes through the microreactor. Immobilisation performed as described in 
Section 2.10.1.3.  
72 kDa 
     (1)            (2)              (3) 
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4.2.1.4 His6-TK microcapillary reaction 
A standard assay of His6-TK was conducted in the derivatised microcapillary 
following the immobilisation process. The same procedure was adopted as in the 
microwell with slight modification (Section 2.10.1.4). Initial substrate concentration 
of 50 mM of HPA and GA and cofactors were loaded at 5 #L/min and left 
incubated at room temperature. The stop-flow reaction was carried out at different 
residence times and the samples of the reaction were analysed using HPLC.  
 
Based on Figure 4.4, the conversion yield of His6-TK increased over time and after 
12 hours reaction, His6-TK catalysed approximately 50% conversion of the 
substrates. With length of 40 cm and ID of 200 #m the total reaction volume of the 
microcapillary was ~13 #L. This was still significantly below that of a standard 
reaction performed in the microwell (300 #L) scale. At this volume, the 
microreactor is characterised by laminar flow with a parabolic velocity profile, 
whereby the mixing is dependent almost completely on diffusion (Jähnisch et al., 
2004). A number of stop-flow reaction kinetics have been demonstrated (Delouise 
& Miller 2005; Matosevic et al., 2009). In this system, diffusion is enhanced by an 
increase in residence time of the reaction mixture to allow longer contact between 
the substrate and the immobilised enzyme (Amankwa & Kuhr, 1992). In addition to 
that, immobilisation may result in some changes in enzymatic activity, optimum pH 
or the affinity with the substrate (Krenkova & Foret, 2004). Problems related to 
mass transfer and long diffusion times also contribute to the lower conversion in the 
microcapillary compared to the reaction in the microwell that has a homogenous 
reaction mixture.  
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Figure 4.4: Reaction profile of His6-TK in  the microcapillary. The reaction was carried out using 50 
mM of hydroxypyruvate (HPA) and glycolaldehdye (GA) in 50 mM Tris-HCl buffer at pH 7.0 in 
room temperature with 0.018 mg/mL of His6-TK. The reaction was performed in stop-flow mode. 
Samples were removed at different residence time and the capillary was filled with new substrate for 
the next sampling. The reaction was performed as described in Section 2.10.1.4. Error bars represent 
one standard deviation about the mean (n = 3). 
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4.2.2 Packed tube microreactor 
4.2.2.1 Setup of the microreactor system 
A schematic illustration of the packed tube microreactor is shown in Figure 4.5b. 
The construction of the reactor was carried out using a transparent fluorinated 
ethylene propylene (FEP) tube that was packed with microbeads. A 500 µm FEP 
tube was chosen, as it allows at least five bead layers of packing while the length of 
the reactor was 5 cm. Packing of the tube was carried out using a Nanobaume 
pressurised container (Section 2.10.2.1). This method produced consistent and 
reproducible packed tubes according to the images produced from the microscope 
(Figure 4.6). The microfilter at the end of the capillary retained the microbeads and 
released excess liquid during packing. The dense packing in the tube was formed as 
a result of the compressibility property of the agarose beads used.  
 
Besides the FEP tube, a fused silica capillary can also be employed for the reactor. 
However, the practicality of using the capillary was found to be more complicated. 
With the naturally bend coil characteristic, the capillary tends to break when packed 
with the beads and was extremely fragile especially when the top microfilter was 
applied. On the other hand, the FEP tube is more flexible and with the transparent 
tube, the progress of the packing can be monitored to avoid over compression 
during the packing process. 
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(a) 
 
(b) 
 
 
Figure 4.5: Schematic illustration of the packed tube reactor used for analysis of His6-TK and His6-
TAm reactions. (a) A fluorinated ethylene propylene (FEP) tube used as the packing tube. The 
characteristics of this tube include high durability, low permeability, inert material and compatible 
with biological application. (b) A packed tube IEMR with ID of 500 #m and length of 5 cm gives a 
total reaction volume of ~10 #L. 
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(a) 
 
 
(b) 
 
 
Figure 4.6: Microscope images of tube packing process. (a) Image of FEP tube with diameter of 500 
#m, prior to the tube packing process. (b) Image of dense beads packing in the FEP tube using a 
Nanobaume pressurized container. HIS-Select Nickel Affinity agarose beads (45-165 #m diameter) 
were used as the packing material. Photos taken using standard light microscope (Leica microscope) 
with 5x magnification. 
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4.2.2.2 Enzyme immobilisation and elution 
Purified enzymes were used in all immobilisation processes. Samples collected 
from the feed and elution steps were ran on SDS-PAGE and quantified (Section 
2.2.3). The eluted enzyme purity was >90%, observed as a single band on the gel 
for TK and TAm (Figure 4.7). Following immobilisation of 0.2 mg/mL of the 
enzyme feed, 0.1± 0.01 mg/mL (10 #g) of the enzyme was recovered during the 
elution process. This showed approximately 50% of the feed was retained inside the 
microreactor while the remaining proportion was removed during the washing 
process. In order to test if the maximum enzyme loading capacity was reached the 
concentration of TAm in the feed was increased to 1.9 mg/mL, which resulted in a 
10-fold increase of immobilised enzyme in the microreactor (1.1 ± 0.15 mg/mL). 
This suggests that enzyme loading increases gradually with higher enzyme 
concentration in the feed until it reaches the maximum capacity of the beads. The 
IEMR with higher TAm loading was later used in the dual enzyme reaction. In 
addition, no adsorption of protein on the surface of the FEP tube was detected when 
a similar immobilisation- washing- elution process was conducted on an empty 
tube. This eliminates any errors that might mask the actual enzyme activity in the 
packed tube IEMR.  
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Figure 4.7: SDS-PAGE gel of enzyme immobilisation-elution process in a packed tube IEMR. The 
immobilisation- elution process was conducted as described in Section 2.10.2.2. (1) Purified TK (0.2 
mg/mL) (2) Flow through from the IEMR, (3) Eluted TK (0.1 mg/mL) (4) Purified TAm (0.2 
mg/mL) (5) Flow through from the IEMR (6) Eluted TAm (0.1 mg/mL), (7) Purified TAm (1.9 
mg/mL), (8) Flow through from the IEMR, (9) Eluted TAm (1.1 mg/mL). 
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4.2.2.3 His6-TK enzyme activity in packed tube reactor 
The standard activity assay of His6-TK was performed as described in Section 
2.10.2.3. In a continuous flow reaction, the residence time needs to be adjusted to 
allow sufficient time for the bioconversion to occur at a detectable level. Due to the 
small dimension of a microreactor, the Reynolds number (Re) is usually between 
~0.1 and 100 (Adeosun & Lawal, 2009). This indicates flow to be in a laminar 
regime. At this level, the flow can only rely on molecular diffusion, which is known 
to be very slow compared to convection. At such a low Re number, the flow is 
dominated by the balance between viscous stress and pressure gradient and the flow 
enfolding necessary for effective mixing is weak (MacInnes et al., 2005).  
 
At a concentration of 0.2 mg/mL of His6-TK, the conversion yield of the enzyme 
reached >90% after 10 minutes reaction (Figure 4.8). The highest activity was 
observed at the lowest flow rate (1 #L/min), which had longer residence time. 
Moreover, the conversion reached ~20% in less than one minute at the highest flow 
rate. This showed that the mass transfer effect was improved which is normally 
observed in a continuous flow mode reaction (Chen & Chen, 1998). Furthermore, 
the physical attribute of microbeads that were used as packing material enhanced 
the surface-to-volume ratio while reducing the long diffusion times present in a 
laminar flow condition (Krenková & Foret, 2004). Therefore shorter analysis time 
can be achieved.  
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Figure 4.8: Reaction profile of His6-TK in packed tube reactor. The reaction was carried with the 
model substrates of 50 mM hydroxypyruvate (HPA) and 50 mM glycolaldehyde (GA) in 50 mM 
Tris"HCl buffer, pH 7.0 with cofactors thiamine pyrophosphate (TPP), 2.4 mM and 9 mM MgCl2 at 
room temperature. The reaction was performed in continuous flow mode. The substrate was loaded 
continuously at different flow rates (1-30 µL/min). The reaction was performed as described in 
Section 2.10.2.3. The concentration of immobilised TK was ~0.16 mg/mL. Error bars represent one 
standard deviation about the mean (n = 3). 
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4.2.3 Summary of microreactor evaluation 
Both microreactor systems were investigated previously (Section 4.2.1 and Section 
4.2.2). In the preliminary study, the development of a derivatised fused silica 
capillary and packed tube reactor were demonstrated. The first method requires a lot 
of preparation in terms of time (~ two days), effort and large amounts of reagents 
for every step. In contrast, the latter method appeared to be more facile and 
relatively inexpensive to prepare.  
 
The activity assay of immobilised His6-TK was performed following the 
immobilisation process. The conversion yield of His6-TK immobilised on the 
surface of the microcapillary tube achieved approximately 11% completion in 40 
min while 92% in 10 min for the packed tube reactor. When normalised by the 
corresponding amount of enzyme, the specific activity of His6-TK for erythrulose 
formation in the microcapillary was lower than in packed tube reactor, which was 
0.6 #mol/min/mg and 7.8. #mol/min/mg respectively. The low activity observed in 
the microcapillary was most likely due to the nature of the reaction (stop-flow 
mode) as well as a mass transfer issue that might affect it. Long diffusion time and 
small surface-to-volume ratio issues that is common among the open tubular IEMR 
was improved in the packed tube reactor system. Similar studies that utilised resins 
as packing material have been demonstrated elsewhere (Cobb & Novotny 1989; 
Wang et al., 2000; Seong & Crooks 2002). 
 
Furthermore, the capacity of immobilised enzyme for both systems were also 
demonstrated. The packed tube reactor was able to accommodate a much higher 
enzyme concentration, which helps to speed up the reaction despite of having lower 
reactor volume than the microcapillary reactor. With a simple microreactor setup, 
higher enzyme capacity and improved mass transfer in the packed tube reactor, this 
system is ideal for the design and development of the multienzyme reactor that will 
be discussed in Chapter 6. Therefore, the packed tube microreactor was chosen for 
further enzyme kinetics investigation in IEMR. 
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4.3 Characterisation of packed tube IEMR 
4.3.1 Pressure drop across the packed tube IEMR 
The ability to determine pressure drop in packed bed system is of importance for the 
design of the reactor especially for the pump and column specification. The 
pressure drop of packed bed has been studied in details whereby the pressure drop is 
known to be dependent on the particle Reynolds number, the mean void fraction, 
the particle geometry and the particle size distribution (Eisfeld & Schnitzlein, 
2001). To calculate the pressure drop value, the friction factor is considered which 
is attributed to Ergun equation. The Ergun equation that is commonly employed is 
given below: 
 
 
Here the friction factor fp for the packed bed and Reynolds number Rep are defined 
as follows: 
    
 
%p: pressure drop 
L: length of the bed 
Dp: spherical diameter of the particle (1.05x10
-4
m) 
#: density of the fluid (1000 kg.m-3) 
µ: dynamic viscosity of the fluid (1x10
-3
kg.m
-1
.s
-1
) 
Vs: superficial velocity  
": void fraction of the bed (0.3) 
 
In the case of the continuous flow reaction, the packed tube IEMR is subjected to a 
constant flow of the substrates-cofactor mixture that creates a pressure drop within 
the packed tube reactor. With a compressible resin used as the packing material, the 
maximum flow rate through the reactor is limited by the collapse of the resin due to 
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compressive stresses imposed by the fluid flowing through it (Tran et al., 2007). 
Therefore, it is very important to estimate the range of working flow rate that will 
suit the design and dimension of the reactor as well as the capacity of the pump. 
Due to the small dimension of the microreactor, the Re number of the fluid flow is 
less than 1, which corresponds to the laminar flow regime. At this condition, the 
velocity of a particle in a fluid stream is not a random function of time and any 
streams flowing in contact with each other will not mix except by diffusion (Beebe 
et al., 2002). It was reported that the pressure drop in a column is directly 
proportional to the velocity when the flow is laminar (Joye, 2003). The pressure 
drop calculated for the packed bed tube IEMR (Figure 4.5b) for a flow rate of 30 
µL/min is ~790 Pa and this data was used to evaluate the maximum force, Fmax of 
the microreactor. 
 
where As: syringe surface area  
 
Based on this data, the maximum force estimated was still very low compared to the 
maximum force capacity of the syringe pump (Fpump > Fmax)(~80 N). Therefore, the 
current working flow rates and the microreactor dimension do not impose any 
critical risk on the packed tube reactor operation. This would allow for further 
modification on the operating condition as well as the reactor dimension. 
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(a) 
 
(b) 
 
Figure 4.9: Reactor profile on the effect of flow rate and reactor diameter based on theoretical 
calculation. (a) Plot of Fmax as a function of flow rate. The theoretical values of Fmax calculated are 
much lower than the capacity of the maximum capacity of syringe pump (~80N). The reactor 
dimension as in Figure 4.5b was used in the calculation. (b) Plot of pressure drop as a function of 
reactor diameter. A pronounced effect was observed as the reactor diameter increases  
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4.3.2 Operational and storage stability study 
One of the most important properties of an immobilised enzyme is its storage and 
operational stability (Krenková & Foret, 2004). Unless it is stable, it cannot be used 
over a prolonged period. The most realistic way to test storage and operational 
stability is by periodic measurement of the residual activity. Enhanced stability of 
immobilised enzyme is usually observed compared to their soluble form.  
 
The operational stability of the immobilised His6-TK was evaluated continuously 
for 48 hours at a flow rate of 1 #L/min. Samples were taken every 12 hours to 
measure the conversion of HPA and GA to ERY product. Immobilised His6-TK was 
found to remain stable during the first 12 hours of reaction with 100% productivity 
(Figure 4.10a). However the productivity dropped to 76% after 48 hours of reaction. 
A similar test was performed with immobilised His6-TAm where the productivity 
was determined continuously every hour at 1 #L/min. In contrast to TK, after only 8 
hours of continuous reaction, the productivity of the immobilised His6-TAm was 
reduced to 60% (Figure 4.10b).  
 
The storage stability of immobilised TK in the packed tube stored at 4°C in 50 mM 
of Tris-HCl was measured over a period of 16 days. Immobilised TK retained 
almost 100% productivity after 16 days, when compared to the first day of reaction 
(Figure 4.11a). This consistency in activity of the immobilised TK enzyme, proved 
the high stability of TK in the immobilised form whilst ~7% of activity drop was 
observed with free enzyme (Figure 3.5). By contrast, immobilised TAm only 
retained ~7% of its initial productivity after 5 days (Figure 4.11b) compared to 
~45% residual activity after 7 days in free enzyme (Figure 3.19). The sharp 
decrease in productivity showed that immobilisation significantly affect enzyme 
stability (Krenková & Foret, 2004; Ladero et al., 2006). This low catalytic stability 
of TAm was most likely due to the alteration in the three-dimensional conformation 
of the protein upon immobilisation, which led to rapid inactivation of TAm after 
repeated use. In addition, it was reported that CV2025 TAm has flexible structure 
and requires a large loop movement during the catalytic activity cycle (Sayer et al., 
2013). This might now be restricted upon immobilisation. Besides that, the stability 
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of an enzyme was found to be highly dependent on the type of immobilisation 
support used. !-TAm from V. fluvialis immobilised on chitosan beads exhibited 
higher stability compared to Eupergit
 
C, whereby 70% of residual activity was 
retained after 3.5 weeks and only 10% for the latter one (Yi et al., 2007).  
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(a) 
 
(b) 
 
Figure 4.10: Operational stability of TK and TAm in IEMR. The productivity is defined as the 
amount of product generated over 12 h (TK) or 1 h (TAm) (per amount of enzyme) divided by the 
product formed of the starting enzyme activity determined in the same way. A productivity of 100% 
indicates no deactivation and degradation of the immobilised enzyme in the reactor. (a) Continuous 
reaction of TK in packed tube IEMR at 1 #L/min for 48 hours. (b) Continuous reaction of TAm in 
packed tube IEMR at 1 #L/min for 8 hours. Error bars represent one standard deviation about the 
mean (n = 3). 
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(a) 
 
(b) 
 
Figure 4.11: Storage stability at 4°C in 50 mM Tris-HCl of (a) TK IEMR and (b) TAm IEMR. The 
productivity of the IEMR was determined according to the standard TK and TAm assays (Section 
2.4.3 and 2.4.4). The productivity is defined as the amount of product generated (per amount of 
enzyme) divided by the product formed of the starting enzyme activity determined in the same way. 
Error bars represent one standard deviation about the mean (n = 3). 
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4.3.3 Reusability of IEMR 
The reusability of the microreactor was investigated by using the same packed tube 
reactor in seven TK immobilisation-elution processes. The activity of the 
immobilised enzyme was then tested (Section 2.10.2.2) to ensure the repeated 
immobilisation-elution process in the microreactor does not affect the activity of the 
enzyme. Based on the results shown in Figure 4.12, the productivity of the IEMR 
was retained over seven cycles of the immobilisation-elution process within a four 
week period. This is similar to the findings from work of Matosevic et al. (2009), 
however the reusability of the packed tube was made simpler compared to the 
surface derivatised capillary as it does not require a regeneration step before the 
subsequent immobilisation process. The same concentration of enzyme was used 
throughout the experiments to allow a direct comparison between each cycle of 
immobilisation-elution processes. 
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Figure 4.12: Reusability test of the IEMR. Reusability of packed tube was measured by productivity 
of the immobilised TK over seven cycles of immobilisation-enzyme reaction-elution processes using 
a single IEMR. Productivity of the IEMR was measured according to the standard TK assay (Section 
2.10.2.3) over four week period. Error bars represent one standard deviation about the mean (n = 3). 
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4.4 Integration of Actipix online detection system 
The various functional units of a microfluidic devices apart from sample 
acquisition, pretreatment, separation, post-treatment is the incorporation of an 
efficient detection system (Lee & Lee 2004). The detection system enables 
monitoring the reaction conditions in real time while reducing the processing times 
for high-throughput screening experiments. There are numerous detection methods 
available for these miniaturized systems, with the analyte of interest driving the 
choice of detection system (Baker et al., 2009). The most common detection 
systems employed are the optical (Benninger et al., 2007; Emory & Soper, 2008; 
Tong et al., 2009), electrochemical (Kim et al., 2007; Hayashi et al., 2008; Kang et 
al., 2008) and mass spectrometric method (An et al. 2008; Kim et al., 2009). 
 
The most predominant detection method in microfluidic analyses by far has been 
with optical means (Baker et al., 2009). Within this system, ultraviolet (UV) 
absorbance-based detection can be considered routine. UV detection system has 
been used in many characterisation of a diverse range of liquid samples, including 
pharmaceutical drugs, peptides, protein and DNA.  
 
The Actipix D100 detector was integrated in the IEMR system to monitor the 
product conversion in real-time. This detector has been designed for use in a variety 
of applications in research by providing quantitative measurements in the UV 
region. The Actipix D100 consists of a control box and a capillary cartridge with a 
miniature size detector (6.5 cm x 5.5 cm x 11.5 cm) (Figure 2.3). Processed data 
output was sent in real-time to a computer using a high-speed serial data or USB 
link. The Paraytec data acquisition software was set up for data collection and 
output signal analysis. The setup of the integration of the Actipix online detection 
system with the IEMR was previously described in Section 2.10.4. The absorbance 
of the analyte can be visually monitored based on the colour of the capillary image 
that corresponds to the detector output data (absorbance data) (Figure 4.13). Two 
capillaries in a cartridge were installed which allows for simultaneous multiple 
detections. However in this study only one capillary was used which correlates to 
the channel one in the detector output data. Calibration of the detector with RO 
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water through the capillary was performed and low absorbance reading (0-0.1 
mAU) was obtained indicating minimal background interference from the capillary.  
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(a) 
 
(b)  
 
 
Figure 4.13: Paraytec Actipix detection window and UV detector data output. (a) The cartridge 
consists of two capillaries with a real time visual image through a 9 x 7 mm area on the Actipix 
detector head. Flow was provided via a single syringe pump at various flow rates. Absorbance data 
was collected directly and processed using the application software via a computer connected to the 
Actipix detector (b) Detector output data as collected through the application software. Data 
acquisition begins approximately 30 s after detector start time. 
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4.4.1 Absorptivity of TAm reaction components 
The integration of the Actipix online detection in the packed tube IEMR was 
performed at detection wavelength of 280 nm. This detection system was tested on 
the TAm-catalysed reaction in the IEMR with model substrate of ERY and MBA to 
produce AP and ABT. It was previously reported that the by-product AP absorbs 
UV light at 280 nm (Fisher et al., 2001) while both of the substrates and ABT have 
negligible absorbance at the same wavelength. In order to determine the absorbance 
of the species, measurements at 280 nm were initially carried out on a bench scale 
spectrophotometer at room temperature. A solution of substrates was prepared in 50 
mM Tris-HCl (pH:7.5) and the reading confirmed low absorptivity at this 
wavelength. However, the cofactor PLP required for TAm-catalysed reaction was 
found to absorb at 280 nm. In order to eliminate background interference by PLP, 
output absorbance readings were blanked with the initial absorbance of the PLP-
substrates mixture.  
 
In order to validate the previous results, the substrates solutions were run through 
the Actipix detector and the reading was observed. The results obtained were in 
agreement as in the spectrophotometer. The detection of product through the 
Actipix detector was calibrated with solution of pure product measured at different 
concentration (Figure 4.14). This calibration curve was used to quantify the AP 
production in the TAm-catalysed reaction.  
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a) 
 
b) 
 
Figure 4.14: Actipix online detection of acetophenone at 280 nm. (a) AP absorbance at various 
concentrations (0.2-10 mM). The absorbance values were used to construct the (b) calibration curve 
for the quantification of AP product in the TAm-catalysed reaction in packed tube IEMR. 
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4.4.2 TAm-catalysed reaction with direct quantification of AP 
His6-TAm activity in the packed tube IEMR was demonstrated based on protocol 
described in Section 2.10.2.4. The setup of the experiment was described in Figure 
2.3 and performed at room temperature. The reaction was evaluated by quantifying 
the by-product of AP via an Actipix online detection system and validated by the 
off-line HPLC. 
 
The reaction profile of acetophenone production is shown in  
Figure 4.15 as a function of flow rate and residence time. As expected, the product 
formation was highest at the lowest flow rate reflecting the longer residence time 
for the reaction to occur. With enzyme concentration of 1.0 mg/mL, the 
bioconversion reached almost 40% conversion at the slowest flow rate. The 
conversion can be easily improved by running the reaction at a slower flow rate. For 
instance, at flow rate of 1 µL/min the residence time in the packed tube IEMR is 10 
minutes. The residence time can be increased up to 2 hours to get higher conversion 
without having significant effect on the stability of the His6-TAm immobilised 
enzyme (Figure 4.10). A stable biocatalyst would retain activity over a number of 
reactions thereby minimizing the need of re-immobilisation.  
 
The detection of the product was performed in a real time via the Actipix detector. 
Based on the residence time, different rates of conversion were achieved, as 
indicated by the change in the output signal response. In order to validate the data 
from the Actipix detector, the samples were run on the HPLC. The results from the 
Actipix were agreeable with the HPLC analysis with an average error of less than 
20%. This discrepancy could be due to the dilution error added during preparation 
of samples for the HPLC analysis. Ultimately, the integration of the online 
detection system in the packed tube IEMR was performed successfully. The 
efficiency of this detection system shows a great potential for the system to be 
applied to other bioconversion models especially in the multi-step enzymatic 
reaction that will be discussed in Chapter 6.  
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(a) 
 
 
(b) 
 
Figure 4.15: Continuous flow TAm-catalysed reaction integrated with Actipix online detection 
system. Profile of acetophenone (AP) formed as a function of (a) flow rate and (b) residence time. 
The reaction was carried out as described in Section 2.10.2.4 with the enzyme concentration of 1.0 
mg/mL. Reaction was analysed for acetophenone production by the UV Actipix detector and 
validated by the off-line HPLC. Error bars represent one standard deviation about the mean (n = 3). 
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4.5 Summary 
In this chapter, the implementation of a prototype enzyme microreactor based on 
the reversible immobilisation of His6-tagged enzymes was demonstrated. A packed 
tube microreactor was selected over the derivatised fused silica capillary based on 
the outcomes discussed in Section 4.2.3. The reaction of the enzyme was 
downscaled from 300 µL to 10 µL in a 500 µm-ID packed tube IEMR. With the 
microreactor format, a small quantity of processing volume would allow for the 
precise control of reaction variables, such as reagent mixing, flow rates, reaction 
time, and mass transfer. 
 
The strong coupling method of the His6-tagged enzyme produces a highly stable 
and reusable IEMR. Moreover, the capacity of the packed tube IEMR was tested 
with several batches of enzyme immobilisation and the quantitative elution of the 
immobilised enzyme was demonstrated. The operational and storage stability of 
both enzymes on the immobilised form were also evaluated and reusability of the 
microreactor was performed over several cycles of immobilisation and elution.  
 
Moreover, the integration of the UV online detection system in the packed tube 
IEMR was successfully demonstrated using the TAm model reaction. This detection 
system enables the monitoring of the reaction conditions in real time while reducing 
the sample processing time. The flexibility of this system would allow for a wide 
range of UV detection by simply changing to a different types of filter 
corresponding to the specific wavelength.  
 
Overall, the microreactor configuration enables the biocatalytic reaction to be 
conducted rapidly for various TK and TAm libraries for screening purposes. The 
facile His tag-immobilisation method provides a stable heterogeneous catalyst, 
which can be easily incorporated into a FEP tube and is cost-effective due the low 
material cost and reusability property of the IEMR. Moreover, the problem of using 
expensive substrate such as hydroxypyruvate is alleviated in the microreactor 
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system compared to the microwell format as well as other limitations that include 
limited enzyme stability and higher operation cost.  
 
Having established the IEMR prototype with known enzymatic conversions, the 
IEMR will be used for the kinetic evaluation of the transketolase (TK)-catalysed 
production of L-erythrulose (ERY) from hydroxypyruvate (HPA) and 
glycolaldehdye (GA) as substrates, and the second enzyme !-transaminase (TAm)-
catalysed reaction between S-methylbenzylamine (MBA) and ERY to produce 2-
amino-1,3,4-butanetriol (ABT) and acetophenone (AP) (Chapter 5). 
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5 Determination of continuous flow enzyme kinetics in 
packed tube IEMR 
5.1 Introduction 
Microfluidic system has been used to characterise kinetics of various biochemical 
reactions and shows a huge potential to speed up processes especially in clinical 
diagnostics and drug discovery and screening (Section 1.2). Hadd et al. (1997) 
demonstrated the first enzyme kinetics analysis performed using microfluidic 
platform. Following that, numerous studies based on enzymatic microreactors have 
been reported in analytical chemistry or biochemistry.  
 
Conventionally enzyme assays are performed based on homogenous reaction 
systems. Several reports of enzyme activity measured using microfluidic system 
have been conducted in homogenous solutions (Xue et al., 2001; Schilling et al., 
2002; Miller & Wheeler, 2008; Wang et al., 2010). Alternatively, heterogeneous 
assays using immobilised enzymes can be adopted due to the attractive benefits that 
it can offer, such as ability to reuse the enzyme, easy separation of product and 
continuous flow analysis. Hickey et al. (2009) studied the effect of immobilised (+)-
*-lactamase within a capillary column microreactor in respect to its stability, 
activity, kinetics and substrate specificity. High stability of the immobilised enzyme 
was observed with the enzyme retained 100% of its initial activity at 80°C for 6 hr 
and 52% activity after 10 hr. Moreover, the data obtained on the substrate 
specificity of the enzyme in the immobilized form was in agreement with the data in 
free enzyme. On the other hand, reduced enzyme activity by 70% was reported. It 
was suggested that the exposure of the enzyme to formaldehyde during the 
immobilisation process contributed to the loss of the immobilised enzyme activity. 
In addition, Kundu et al. (2011) demonstrated the polymerization of lactones using 
immobilised Candida antartica Lipase B in a microreactor format. The apparent 
rate constant for the microreactor recorded was at least an order of magnitude 
higher than that observed for batch reactor. The small confined volume and higher 
surface-to-volume ratio of the microreactor attributed to the improved performance 
of the immobilised enzyme. As both of these examples were performed in 
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continuous flow mode, conversions were monitored as a function of position under 
steady-state conditions. In this case, all limits of dead time and difficulties with 
mixing were improved (Section 1.4.2). 
 
In this chapter, the evaluation of enzyme kinetics in continuous flow mode was 
performed in a packed tube IEMR. Having established the IEMR prototype with 
known enzymatic conversions, the IEMR was used for the kinetic evaluation of the 
transketolase (TK)-catalysed production of L-erythrulose (ERY) from 
hydroxypyruvate (HPA) and glycolaldehdye (GA) as substrates, and the second 
enzyme !-transaminase (TAm)-catalysed reaction between S-methylbenzylamine 
(MBA) and ERY to produce 2-amino-1,3,4-butanetriol (ABT) and acetophenone 
(AP). The apparent kinetic parameters of both enzymes in continuous flow reaction 
were determined using the Lilly-Hornby (Lilly et al., 1966) kinetics model. Several 
factors that affected the kinetics of immobilised enzyme were also discussed. 
 
The key objectives of this chapter are: 
• Demonstration of TK and TAm kinetics in a packed tube IEMR operated in 
continuous flow mode. 
• Evaluation of the continuous flow kinetics using Lilly-Hornby (Lilly et al., 
1966) kinetics model. 
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5.2 Evaluation of continuous flow enzyme kinetics  
The kinetic parameters of the immobilised enzyme may result in different values 
compared to the solution-phase reaction due to conformational change of enzyme, 
partitioning effect, mass transfer restriction and enzyme deactivation. Among these, 
mass transfer limitation have been studied extensively from the viewpoint of 
heterogeneous catalysis (Kobayashi & Moo-Young, 1973; Toda, 1975; Lee et al., 
1979; Ozdural et al., 2001; Kerby et al., 2006). Under these conditions, apparent 
kinetic constants are used to evaluate the kinetics of the immobilised enzyme. The 
Lilly-Hornby (1966) model is commonly employed to determine kinetic parameters 
for continuous packed-bed reactors where a plug flow assumption is made. 
Furthermore, the model is able to account for any mass transfer effects that may be 
present and can alter the overall enzyme kinetics. Under steady state conditions the 
apparent kinetic parameters in a packed-bed enzyme reactor can be determined by 
the following equation: 
 
f[Ao] = Km (app)In(1-f) + C/Q 
 
Where f is the fraction of substrate reacted, [Ao] is the initial substrate 
concentration, Km (app) is the apparent Michaelis constant, C is the reaction capacity 
of the reactor and Q is the flow rate. 
 
If values of f are measured when various initial concentrations of substrates are 
perfused through the same reactor at identical flow rates (Q is constant), then f[Ao] 
plotted against ln(1-f) will give a straight line if Km (app)  and C are constant at this 
flow rate. The slope of the line will be equal to Km (app)  and the y-intercept will be 
equal to C/Q. Thus Km (app) and C may be determined for any flow rate of substrate 
through the reactor. 
 
The applicability of this model has been performed in many studies of enzyme 
kinetics, particularly for the packed bed microreactor (Ozdural et al., 2001; Seong et 
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al., 2003; Ozdural et al., 2001; Kerby et al., 2006). Most recently Matosevic et al. 
(2011b) demonstrated the kinetics evaluation of transketolase enzyme using this 
model in a microcapillary. The findings of the study will be compared with the 
present work in the next section. 
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5.3 Continuous flow kinetics in packed tube IEMR 
Determination of kinetic parameters of the continuous flow mode packed tube 
IEMR were conducted for both enzymes at flow rates ranging from 2-30 µL/min. 
For TK, the concentration of GA was varied from 10 to 50 mM while HPA was 
kept at 100 mM and for TAm, the concentration of ERY was varied from 50 to 300 
mM with MBA kept at 10 mM. The progression curve for each substrate 
concentration was shown to follow the standard TK and TAm reaction profile in 
solution-phase, with conversion yield increasing proportionately to substrate 
concentration (Figure 5.1). Data from these graphs were then used to plot the Lilly 
et al. (1966) kinetic model and determine the kinetic parameters for the continuous 
flow reaction (Figure 5.2). The slopes of the fitted lines were evaluated to give the 
Km(app) for each flow rate.  
 
From Figure 5.3, a pronounced effect of flow rate was observed on Km(app), where 
the values increased with lower flow rates. This can be explained by the presence of 
a diffusion layer surrounding the immobilised enzyme (Lilly et al., 1966). At high 
flow rates, the mass transfer effect is less pronounced as the diffusion layer around 
the bead gets thinner, while the effect is more significant at lower flow rates, which 
could be observed as an elevation of the Km(app) values. This diffusion layer theory 
fits the trend displayed in Figure 5.3, where an approximately linear decrease was 
seen for Km(app) between 2-10 µL/min, and then the values started to level-off 
between 10-30 µL/min. Toda (1975) addressed the problem of inter-particle mass 
transfer in connection with the overall kinetics of gel-entrapped enzymes packed in 
a fixed bed reactor. He suggested that the increase in the Km(app) value at a low flow 
rate is due to film diffusion or a liquid channeling factor. In addition, several 
experimental studies have shown similar flow dependency of Km(app) (Lilly et al., 
1966; Shiraishi et al., 1996; Ozdural et al., 2001). They explained the importance of 
mass transfer outside a solid catalyst with the fact that the apparent Michaelis 
constant determined in a packed column reactor varied with the flow rate of the 
liquid. On the contrary, Matosevic et al. (2011b) found an increase in Km(app) with 
increasing flow rate of substrate through a surface derivatised capillary containing 
immobilised TK enzyme. With lower operating flow rates of 0.33-3 µL/min and 
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reduced enzyme concentration compared to the packed tube reactor, the mass 
transfer effect observed was not as pronounced as in our system. 
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(a) 
 
(b) 
 
Figure 5.1: Bioconversions using different substrate concentration at flow rates ranging from 2 
µL/min-30 µL/min. (a) Continuous-flow TK-catalysed reaction at different GA concentration (10-50 
mM) with HPA concentration was kept at 100 mM (b) Continuous-flow TAm-catalysed reaction at 
different ERY concentration (50-300 mM) with MBA concentration was kept at 10 mM. 
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(a) 
 
(b) 
 
Figure 5.2: Kinetics determination using Lilly-Hornby model for continuous-flow mode reaction. 
Data to obtain these plots was taken from Figure 5.1. (a) TK-catalysed reaction and (b) TAm-
catalysed reaction. Solid lines fitted by linear regression. Values of Km (app) and C for the continuous 
flow reactions could be obtained from these plots. 
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Figure 5.3: Km (app) values for GA and ERY ranging from 2 µL/min-30 µL/min. Data to obtain this 
plot was taken from Figure 5.2. 
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The reactor capacity (C) values obtained were nearly constant for all experiments, 
with an average of 12.88±0.27 mM/min and 0.28±0.027 mM/min for GA and ERY, 
respectively. These values were then used to determine the turnover number, kcat 
which was 32 s
-1
 for TK and 0.058 s
-1
 for TAm. These values were approximately 3 
times less than kcat values in solution-phase (Section 3.2.5 and Section 3.3.6). This 
apparent loss in activity may be due to the inaccessibility of some enzyme 
molecules that were immobilised in the packed tube to the substrate molecules. The 
intrinsic compressibility of porous agarose beads resulted in highly compact 
packing, which created a barrier to the accessibility of the substrate to those enzyme 
molecules located within the beads packing. In addition, non-uniform enzyme 
distributions within the support would also affect the apparent kinetic parameters 
where the catalyst immobilised on the surface can render far greater enzyme 
utilization efficiency compared to the catalyst in the interior core configuration 
(Dalvie and Baltus, 1992; Juang and Weng, 1984). Finally, altered conformation of 
enzyme and steric hindrance could also contribute to the loss of activity of the 
immobilised enzyme (Krenková & Foret, 2004; Delouise & Miller, 2005; Kerby et 
al., 2006). 
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5.4 Effect of substrate residence time 
Characteristic operating parameters for continuous reactor is the dilution rate, D (h
-
1
) and the average residence time, + (h). These parameters are related as follows: 
 
 
In continuous reactor operation, the amount of material that can be processed over a 
given period of time is represented by the volumetric flow rate, Q (mL.h
-1
). 
Therefore, for a given throughput, the reactor size V (mL) and associated capital 
and operating costs are minimised when + is made as small as possible (Doran, 
2013).  
 
The average residence time is also known as a space time or holding time is 
inversely proportional to the dilution rate. At high dilution rate, conversion of 
substrate to product decreases. In the continuous flow of TK-catalysed and TAm-
catalysed reactions in the packed tube IEMR, the product formation was 
proportional to the space time (+) at the range of higher flow rates (10-30 µL/min) 
(Figure 5.4). This pattern started to level-off at higher space time (1-5 µL/min) 
which displayed similar trend as Km(app) on the flow rates (Figure 5.3). This situation 
can be explained by the presence of a diffusion layer surrounding the immobilised 
enzymes (Lilly et al., 1966). At higher flow rates, the mass transfer of the substrate 
and the product through the layer are improved which resulted in higher conversion 
of the substrate. This finding shows that the rate of enzyme reaction is highly 
affected by the diffusion rate presence in the immobilised enzyme system. 
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(a) 
 
 
(b) 
 
Figure 5.4: Analysis of space time with respect to the converted substrate in the continuous flow 
microreactor. (a) The relation of space time with HPA converted to erythrulose in TK-catalysed 
reaction, (b) The relation of space time with MBA converted to AP in TAm-catalysed reaction. Error 
bars represent one standard deviation about the mean (n = 3) 
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5.5 Summary  
In this chapter, the kinetic evaluation of transketolase and transaminase in 
continuous flow mode was successfully demonstrated using Lilly-Hornby (1966) 
kinetics model in the packed tube IEMR. Conversion yield shown to increase with 
the substrate concentration as seen in the standard TK and TAm reaction profile in 
solution-phase. Moreover, no significant inhibition by the products was observed 
within the substrates concentration range studied. 
 
The Km(app) for both enzymes showed to be a function of flow rate whereby the 
Km(app) decreases with increasing flow rate. The dependency of the Km(app) on the 
flow rate can be explained by the presence of the diffusion layer surrounding the 
immobilised enzyme and the effect was reduced at higher flow rates as displayed in 
Figure 5.3. In addition, the Km(app) values for both enzymes at the highest flow rate 
(30 µL/min) were found to be smaller than that for the soluble enzyme. This 
behaviour might be attributed to the increased affinity of the immobilised enzyme to 
the substrate, due to the reduced mass transfer effect at high flow rate. Furthermore, 
values of kcat calculated were three times smaller than those measured in free 
solution. There are several possible explanations for the reduced kcat obtained in the 
immobilised form, these include the imperfect immobilisation, non-uniform 
distribution of the enzyme and steric hindrance. 
 
The enzyme kinetics of transketolase and transaminase enzyme was successfully 
demonstrated in this chapter. The kinetic model system adopted in this analysis 
allows for the evaluation for any mass transfer effects that may be present and can 
alter the overall enzyme kinetics. Nevertheless, the findings showed that the 
apparent Michaelis Menten constant of both enzymes to be affected by the mass 
transfer effect which was also observed in many other studies (Lilly et al., 1966; 
Shiraishi et al., 1996; Ozdural et al., 2001). In conclusion, this packed tube IEMR 
system has a potential to be used to characterise kinetics of various biochemical 
reactions based on the simplicity of the system. The continuous flow operation 
eliminates dead time, improve mixing problem and the immobilised enzymes can be 
reused and easily recovered. 
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6 Multi-step enzymatic reaction in packed tube IEMR 
6.1 Introduction 
The production of complex organic compounds through integration of multi-step 
synthesis provides an attractive alternative for the creation of molecules with 
increased complexity and defined functions or properties. However, the traditional 
pathway for multi-step synthesis usually adopted the batch and iterative step-by-
step transformation of starting materials into desired product. Each synthesis step 
usually is completed with the product removal from the reaction mixture and 
purified to remove any undesired components that have adverse effect with the 
subsequent synthetic transformations (Webb & Jamison, 2010). This approach is 
considered time consuming and commonly wasteful and pose clear contradiction 
with the single-cell multi-step biosynthetic pathways found in nature (Dewick, 
2009). Alternatively, the multi-step syntheses can be performed by integrating 
multiple synthetic steps into a single and continuous flow operation without having 
to isolate the intermediate products. 
 
 
Figure 6.1: Multi-step synthesis strategies. Image reproduced from (Webb & Jamison, 2010). 
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The use of biocatalysts in product synthesis is well documented and has proven to 
be an extremely advantageous technology (Section 1.4). This approach is 
particularly appealing since biocatalysts are intrinsically “green” (biodegradable), 
highly selective and most importantly they are compatible with each other within 
certain ranges of operating conditions (Ricca et al., 2011). The cooperation of 
immobilised catalysts in the continuous flow system further extends the potential 
for revolutionizing the synthesis process (Section 1.5).  
 
The combination of transketolase and transaminase enzyme reactions in series has 
the potential to create chiral amino-alcohols from achiral starting compounds. This 
de novo designed pathway for the synthesis of optically pure amino alcohols 
comprises of the formation of asymmetric carbon-carbon bond catalyses by 
transketolase and subsequently the addition of the chiral amino group by 
transaminase. This model reaction was previously demonstrated by Ingram et al. 
(2007) using transketolase from E.coli and %-alanine: pyruvate aminotransferase (%-
A:P TAm) from Pseudomonas aeruginosa overexpressed in a single host for the 
biocatalytic synthesis of 2-amino-1,3,4-butanetriol (ABT) in a one-pot process in 
microwell format. The reaction however showed to be limited due to the low 
activity of the %-A:P TAm causing a low overall yield of the reaction. The two step 
synthesis of the ABT was further investigated by Rios-Solis et al. (2011) where 
they paired the wild-type E. coli TK with !-transaminase from C. violaceum that 
showed higher yields and stereoselectivities. The 87% mol/mol yield for ABT 
synthesis represented an improvement of 4-fold in yield in a quarter of the reaction 
time compared to the previous work (Ingram et al., 2007).  
 
Apart from the microwell format, the production of ABT through multi-step 
enzymatic reaction was also performed in a microreactor system. Matosevic et al. 
(2011b) exploited the advantages of microreactor system that is otherwise 
unachievable in a conventional microwell-based system. To demonstrate the 
feasibility of performing the continuous flow TK-TAm enzymatic reaction using 
immobilised enzymes, Matosevic et al. (2011b) derivatised the inner surface of a 
fused silica capillary (“open-tubular” reactor). The dual TK-TAm reaction reached 
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5% conversion over 1 hour at an initial MBA concentration of 10 mM. 
 
In this chapter, the synthesis of the ABT compound in a packed tube IEMR was 
performed using two model reaction systems. The first model system was a two-
enzyme route with sequential use of transketolase (pQR 791) and !-transaminase 
(pQR 801) as previously demonstrated (Matosevic et al., 2011b; Rios-Solis et al., 
2011). The first step of the dual reaction involved the reaction catalysed by 
transketolase (pQR 791) between hydroxypyruvate (HPA) and glycolaldehdye (GA) 
producing L-erythrulose (ERY), and subsequently transaminase (pQR 801) 
catalysed the second part by aminating ERY using S-methylbenzylamine (MBA) to 
produce the chiral amino alcohol product of ABT. Demonstration of the synthesis 
of ABT was executed by connecting single TK and TAm IEMR in series (Figure 
6.2). The second model reaction was the three-step enzymatic reaction through 
sequential use of !-transaminase (pQR 1021), transketolase (pQR 791) and !-
transaminase (pQR 1021). Instead of using HPA as the starting material that is a 
rather expensive substrate, serine (SER) and GA were used which were converted 
into HPA by TAm in the first part of the three-steps reaction. Subsequently, TK 
catalyzed the reaction between HPA and the remaining GA into ERY. The three-
step enzymatic reaction was completed by the reaction catalysed by the second 
TAm between ERY and SER to produce the chiral amino alcohol, ABT. Three 
single IEMRs were cascaded in series to allow the multi-step enzymatic reaction 
(Figure 6.3). 
 
Demonstration of the synthesis of the ABT product via the dual and three-step 
reaction and the monitoring of each component can provide a full profile of the 
bioconversion. In order to achieve this, the stability and reactivity of reaction 
components (substrates and products) in the presence of different enzymes were 
investigated to access any effect on the enzyme kinetics and aid in identifying the 
optimal parameters for the multi-step enzymatic reactions. 
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The key objectives of this chapter are: 
• Demonstration of the dual enzyme reaction involving TK and TAm 
immobilised in series to produce the chiral amino alcohol product, ABT. 
• Demonstration of the three-step enzyme reaction comprised of the 
sequential TAm, TK and TAm reaction conducted in three single IEMRs 
cascaded in series to synthesise ABT. 
•  
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Figure 6.2: Schematic diagram of continuous flow dual reaction kinetics. The dual reaction system consists of two packed tube IEMR connected in series. His6- 
transketolase (pQR 791) and His6-transaminase (pQR 801) are immobilised inside each of the IEMR. 
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Figure 6.3: Schematic diagram of continuous flow three steps enzyme reaction kinetics. The three steps enzyme reaction system consists of three packed tube 
IEMR connected in series. His6- transaminase (pQR 1021) and His6-transketolase (pQR 791) are immobilised inside each of the IEMR. 
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6.2 Dual TK-TAm reaction 
6.2.1 Setup of the dual microreactor system and immobilisation of enzymes 
The dual enzyme reaction was executed by connecting single TK and TAm IEMR 
(2x5 cm) in series that gives a total reaction volume of ~10 !L each (Figure 2.4). 
The immobilisation of both His6-TK and His6-TAm were performed separately on 
each IEMR before assembly following the procedure previously described (Section 
2.10.2.2). Immobilisation was performed with purified solutions of both enzymes 
preparations at a concentration of 0.2-2.0 mg/mL. Quantification of the immobilised 
enzyme was carried out based on the elution sample (Section 2.10.2.2) obtained 
once the reaction was completed. The measurement of the enzyme concentration 
was determined by absorbance measurement at 280 nm and validated via Bradford 
assay at 595 nm on a bench scale spectrophotometer (Section 2.2.3.2). 
 
6.2.2 Stability of TK and TAm reaction components in the dual enzymatic 
reaction 
The stability of each enzyme reaction component is paramount in the multi-step 
enzymatic syntheses. Thus, some compromises have to be made regarding the 
optimum conditions for each enzyme. One of the important factors to look at is the 
buffer condition. It was previously reported that the optimal buffer condition for TK 
and TAm were Tris-HCl (Hibbert et al., 2005; Cázares et al., 2010) and HEPES 
(Kaulmann et al., 2007; Smithies et al., 2009) buffer respectively. Stability of HPA 
towards HEPES buffer was found to be detrimental to the substrate (Matosevic et 
al., 2011b). Similar finding was also reported previously whereby HEPES buffer 
was found to greatly affect the stability of both substrates, HPA and GA (Chauhan 
et al., 1996). On the other hand, the stability of the transaminase substrate MBA in 
the presence of TK substrates was proved to be high in Tris-HCl (Matosevic et al., 
2011b). Based on these considerations and the preliminary data of enzymatic 
activity in a batch solution (Chapter 3), Tris-HCl buffer was selected for the dual 
TK-TAm reaction. 
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Moreover, the presence of TK cofactors (Mg
2+
 and TPP) did not pose any negative 
effect on the TAm bioconversion and likewise the effect of PLP on the TK 
bioconversion was minimal (Rios-Solis et al., 2011). In addition, the coupled 
reaction was performed at pH 7.5, which was previously shown to be suitable for 
both enzymes (Mitra et al., 1998; Kaulmann et al., 2007). 
 
6.2.3 Stability of MBA substrate in His6-TK immobilised microreactor 
 
The stability of the TAm reaction component MBA in Tris-HCl (pH: 7.5) buffer 
was investigated in TK packed tube IEMR. Reaction mixture of TK reaction (60 
mM GA and HPA, cofactors) with the addition of 6 mM MBA was continuously 
fed into the packed tube IEMR at various flow rates (1-30 µL/min). Another set of 
TK reaction with similar condition (without MBA) was also run as a control. The 
utilisation of MBA and ERY production were measured by HPLC at different flow 
rates. No observable depletion of MBA was observed which showed that there was 
no activity of TK towards MBA. In addition, the reaction profiles of ERY formation 
for both conditions displayed very similar results; the slight difference might be due 
to the experimental errors (Figure 6.4). This suggested that the presence of MBA in 
the TK reaction mixture does not pose any significant effect on the reaction. 
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Figure 6.4: Reaction profile of the transketolase reaction in the presence of the TAm substrate. Two 
sets of TK reactions were conducted; one in the presence of TAm substrate, MBA and a TK control 
reaction. This result showed that the presence of MBA in the TK reaction mixture does not have any 
effect on the TK reaction.   
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6.2.4 Demonstration of the dual model reaction 
In order to achieve the synthesis of the chiral amino alcohol ABT, the dual TK-
TAm reaction system via two packed tube IEMRs was performed directly from 
achiral substrates GA and HPA with MBA as the amino donor. The reaction was 
performed in the presence of both enzymes cofactors in Tris-HCl buffer at pH 7.5 
and room temperature. The reaction was monitored for ERY, AP and ABT 
production via HPLC analysis. 
 
Substrates mixture of both enzymes, with initial concentrations of 60 mM (GA and 
HPA, each) and 6 mM (MBA), were fed together in the presence of cofactors 
(Section 2.12.1). Higher initial substrate concentration of GA and HPA (10x more) 
compared to MBA were used which resulted in higher ERY formation to shift the 
equilibrium towards ABT production in the second step of the reaction. Substrate 
mixtures were loaded into the feed reservoir in a 1 mL syringe and dispensed via a 
syringe pump connected to the first IEMR. In the first part of the dual reaction, 
His6-TK catalysed the conversion of the achiral substrates HPA and GA to form 
ERY. The product of the first reaction was then continuously fed to the second 
IEMR containing the immobilised His6-TAm. The dual reaction was completed 
with the amination of ERY with MBA as the amino donor to produce the final 
target reaction product, ABT. This dual TK-TAm reaction was conducted in 
continuous flow mode at various flow rates ranging from 1-30 µL/min, which 
corresponds to residence times from 0.33 to 10 minutes per individual reaction step. 
 
6.2.4.1 Dual TK-TAm reaction in packed tube IEMR 
The profile of the dual TK-TAm reaction can be monitored by measuring the 
substrate and product composition at certain time period, which can give the 
complete mass balance of the reaction. However the target product of the dual 
reaction, ABT, cannot be quantified based on the formation of the by-product, AP, 
due to the presence of the side reactions between the residual TK substrates, HPA 
and GA in the transaminase-catalysed reaction (Chen et al., 2006; Kaulmann et al., 
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2007; Rios-Solis et al., 2011). Therefore the quantification of the ABT has to be 
performed via the derivatisation process (Section 2.8) prior to the HPLC assay.  
 
With an initial substrate concentration of 6 mM MBA, the coupled reaction reached 
approximately 83% conversion in 20 minutes at the lowest flow rate (Figure 6.5). 
This corresponds to a specific activity of 0.03 µmol/min/mgTAm . On the other hand, 
the formation of ABT was not increase proportionally with AP and the trend 
became more apparent at higher flow rates. This result was anticipated as higher 
residual concentrations of HPA and GA from the TK-catalysed reaction were fed 
into the second step, which resulted in more side reactions. Consequently, the 
formation of ABT was greatly reduced and the detection of the product became 
more error prone especially at flow rates between 10-30 µL/min. 
 
The production of the ABT in the final step of the TK-TAm reaction is dependent 
on the formation of ERY in the first part of TK-catalysed reaction. In order to 
estimate the conversion yield of GA and HPA to ERY in the first reaction, a 
separate experiment was conducted. A single IEMR was prepared with immobilised 
TK. Similar enzyme and substrate concentrations were used to match the condition 
in the coupled reaction. Based on Figure 6.6, the reaction reached a conversion of 
90% in 10 minutes at the lowest flow rate with a specific activity of 8.20 
µmol/min/mgTK. This suggested that a total of 54 mM ERY was fed to the second 
IEMR in the coupled reaction. Therefore, about 9% of the relative amount of ERY 
supplied by the TK step was aminated by TAm in the second reaction. Based on 
these results, it is apparent that the transketolase is more active than transaminase 
for the model reaction under the conditions investigated. A similar trend was also 
observed in the rates of catalysis of the two enzymes in batch solution as well as 
other studies reported elsewhere (Ingram et al., 2007; Matosevic et al., 2011; Rios-
Solis et al., 2011). Nevertheless, low specific activity of TAm was not only due to 
the slow amination rate of the enzyme but also due to the presence of side reactions 
with residual HPA and GA.  Kaulmann et al. (2007) reported that TAm has the 
affinity to catalyse the amination of both HPA and GA leading to the reduced 
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formation of ABT at higher flow rates when higher residual concentrations of HPA 
and GA from the TK-catalysed reaction were present.  
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(a) 
 
(b) 
 
Figure 6.5: Dual TK-TAm reaction in IEMR. Graph showing the formation of the ABT and by-
product AP in the TK-TAm dual reaction as a function of (a) flow rate and (b) residence time. Initial 
substrates concentration of 60 mM (GA and HPA each) and 6 mM MBA in 50 mM Tris!HCl buffer, 
pH 7.5 with cofactors thiamine pyrophosphate (TPP), 2.4 mM and MgCl2, 9 mM and 0.2 mM PLP at 
room temperature The concentration of immobilised enzyme was 1.1 ± 0.15 mg/mL for TAm and 
0.15 ± 0.006 mg/mL for TK. Error bars represent one standard deviation about the mean (n = 3). 
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(a) 
  
(b) 
 
Figure 6.6: Production of erythrulose in the first TK-catalysed step in the dual TK-TAm reaction. 
Graph showing the formation of the ERY in the first step of the TK-TAm dual reaction as a function 
of (a) flow rate and (b) residence time. Initial substrates concentration of 60 mM (GA and HPA 
each) and 6 mM MBA in 50 mM Tris!HCl buffer, pH 7.5 with cofactors thiamine pyrophosphate 
(TPP), 2.4 mM and MgCl2, 9 mM and 0.2 mM PLP at room temperature The concentration of 
immobilized TK enzyme was 0.15 ± 0.006 mg/mL. Error bars represent one standard deviation about 
the mean (n = 3). 
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6.2.4.2 Side reaction of HPA and GA towards TAm reaction 
The effect of the presence of GA and HPA in the second step of TAm-catalysed 
reaction was investigated. Several sets of reactions catalysed by TAm (constant 
enzyme concentration) were performed with variation in the substrate added in the 
reaction. The reactions were conducted in batch solution whereby the final 
concentration of each substrate was kept constant to allow direct comparison of 
their respective initial rate. The reactions were monitored for the formation of 
acetophenone by HPLC analysis. Results from Figure 6.7 confirmed that GA and 
HPA were reactive towards TAm as previously reported (Chen et al., 2006; 
Kaulmann et al., 2007; Rios-Solis et al., 2011). The GA appeared to be more 
reactive with an initial rate of 0.0239 mM/min compared to 0.0108 mM/min for 
HPA. Moreover, TAm showed higher affinity towards GA compared to ERY, 
which would explain the low formation of ABT at higher flow rates. Therefore, the 
key point for this TK-TAm reaction was to match the TK and TAm activity to 
reduce the HPA and GA side reaction by TAm, and ultimately to achieve the 
highest possible ABT yield.  
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Figure 6.7: Profiles of the TAm-catalysed reaction with various substrate conditions. Graph showing 
the production of acetophenone catalysed by TAm in batch solution. Different substrate conditions 
were tested and the initial rate of each condition was determined. Reaction conditions: 5 mM MBA, 
50 mM acceptor, 0.2 mM PLP, pH 7.5 in Tris-HCl buffer, 0.16 mg/mL TAm. Substrate mixture: [1] 
MBA+ERY, [2] MBA+ERY+HPA, [3] MBA+ERY+GA, [4] MBA+ERY+HPA+GA, [5] 
MBA+HPA, [6] MBA+GA. 
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6.3 Three step enzymatic reaction 
The synthesis of the chiral amino alcohol, ABT in this model system would require 
a three-step enzyme sequential reaction, consisting of !-TAm (pQR 1021)-TK 
(pQR 791)-!-TAm (pQR 1021) catalysed reaction conducted in series.  Preliminary 
studies were performed in our research group and identified !-TAm (pQR 1021) 
from Rhodobacter sphaeroides to be one of the possible catalytic candidates for the 
synthesis of HPA. This enzyme was also reported to have high affinity towards 
serine as amino donor and high reactivity towards aldehydes as amino acceptor 
(Villegas, 2013). Moreover, !-TAm (pQR 1021) showed to have better reaction 
rate on the amination of erythrulose compared to the !-TAm (pQR 801) (Villegas, 
2013). Therefore, this enzyme was chosen and incorporated into the three-step 
enzymatic reaction for the production of ABT (Figure 6.8). 
 
Standard activity of the !-TAm (pQR 1021) enzyme in solution was carried out to 
get preliminary data on the enzyme activity. !-TAm (pQR 1021) activity was 
demonstrated using serine (SER) and glycolaldehyde (GA) model substrates with 
the cofactor pyridoxal phosphate (PLP) to produce hydroxypyruvate (HPA) and 
ethanol amine. This model system represents the first step reaction for the 
production of the chiral amino alcohol, ABT (Figure 6.8). The reaction was 
conducted in glass vials with a total reaction volume of 300 µL at room temperature 
following the procedure in Section 2.7.3. The reaction was evaluated by quantifying 
the product of HPA by HPLC (Section 2.8).  
 
Based on Figure 6.9, the specific activity of TAm (pQR 1021) calculated was 
0.02±0.009 µmol/min/mg This value was approximately 7 times lower than the 
specific activity of TAm (pQR 801) calculated based on the investigated conditions 
(Section 3.3.2). The low value obtained showed that the amination rate of the amino 
acceptor was slow in spite of the high amino donor concentration employed to shift 
the equilibrium of the reaction thus obtaining a higher conversion yield. Therefore, 
further considerations have to be taken to compensate for the low reaction rate. 
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Figure 6.8: Reaction scheme for the synthesis of 2-amino-1,3,4-butanetriol (ABT) via the TAm-TK-
TAm enzymes pathway. The three-step enzyme reaction pathway showing the first TAm-catalysed 
production of hydroxypyruvate (HPA) followed by the TK-catalysed production of eryhtrulose 
(ERY) and the multi-step reaction is completed with the amination ERY into ABT by the second 
TAm enzyme. Substrates required for the second (glycolaldehyde) and third step (serine) were 
recycled from the initial substrates mixture supplied in the beginning of the reaction. 
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Figure 6.9: Reaction profile of His6-TAm (pQR 1021) in solution phase. The TAm reaction profile 
with model substrate of 100 mM serine (SER) and 10 mM glycolaldehyde (GA) in 50 mM Tris!HCl 
buffer, pH 7.5 with cofactor 0.2 mM pyridoxal phosphate (PLP) at room temperature. The purified 
enzyme was used with a concentration of 1.1 mg/mL.  
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6.4 Setup of the three step microreactor system 
The three step enzyme reaction was executed by connecting three separate packed 
tube IEMRs (2x10 cm and 1x5 cm) in series that gives a total reaction volume of 
~2x20 !L and 10 !L respectively (Figure 2.5). The immobilisation of both His6-TK 
(pQR 791) and His6-TAm (pQR 1021) were performed separately on each IEMR 
before assembly following the procedure previously described (Section 2.10.2.2). 
Immobilisation was performed with purified solutions of both enzymes preparations 
at a concentration of 0.2-3.5 mg/mL. Quantification of the immobilised enzyme was 
carried out based on the elution sample (Section 2.10.2.2) obtained once the enzyme 
assay was completed. The measurement of the enzyme concentration was 
determined by absorbance measurement at 280 nm and validated via the Bradford 
assay at 595 nm on a bench scale spectrophotometer (Section 2.2.3.2). 
 
6.4.1 Integration of Actipix online detection 
6.4.1.1 Absorptivity of TAm reaction components  
The monitoring of the first step reaction in the three-step enzymatic reaction was 
performed via the online UV detection system, Actipix. The production of HPA in 
this step was monitored at UV absorbance of 210 nm. It was previously reported 
that the product HPA absorbs UV light at 210 nm (Miller et al., 2007) while both of 
the substrates (SER and GA) and by-product ethanol amine have negligible 
absorbance at the same wavelength. In order to determine the absorbance of the 
species, measurements at 210 nm were initially carried out on a bench scale 
spectrophotometer at room temperature. Solution of substrates was prepared in 50 
mM Tris-HCl (pH: 7.5) and the reading confirmed low absorptivity at this 
wavelength. To eliminate background interference by PLP, absorbance readings 
were blanked with the initial absorbance of the PLP-substrates mixture. 
 
In order to validate the previous results, the substrate solutions were run through the 
Actipix detector and the reading was observed. Results obtained were in agreement 
as in the spectrophotometer. The detection of product through the Actipix detector 
was calibrated with solutions of standard HPA measured at different concentrations 
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(Figure 6.10). This calibration curve was used to quantify the HPA production in 
the first step of the TAm-catalysed reaction. 
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(a) 
 
(b) 
 
Figure 6.10: Actipix online detection of hydroxypyruvate at 210 nm. (a) HPA absorbance at various 
concentrations (1-5 mM). The absorbance values were used to construct the (b) calibration curve for 
the quantification of HPA product in the first reaction of the three-step enzymatic reaction in packed 
tube IEMR. 
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6.4.2 Operational stability of TAm pQR 1021 in packed tube IEMR 
The operational stability of TAm in the packed tube IEMR was investigated over 8 
hours in continuous mode reaction. This data is crucial to ensure no degradation of 
enzyme activity during the reaction that may compromise the obtained data. The 
operational stability of the immobilised His6-TAm was evaluated continuously at a 
flow rate of 5 !L/min. Samples were taken every hour to measure the conversion of 
SER and GA to HPA product. Immobilised His6-TAm was found to remain stable 
during the first 7 hours of reaction with 100% productivity (Figure 6.11). However, 
the activity of immobilised TAm started to decline slightly after 8 hours, which 
accounted for about 15% of the initial enzyme activity. Nonetheless, immobilised 
TAm (pQR 1021) in the packed tube IIEMR displayed an improved enzyme 
stability compared to immobilised TAm (pQR 801) as previously discussed 
(Section 4.3.2). 
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 Figure 6.11: Operational stability of !-TAm (pQR 1021) in a packed tube IEMR. The reaction was 
performed with 100 mM serine (SER) and 50 mM glycolaldehyde (GA) in 50 mM Tris!HCl buffer, 
pH 7.5 with cofactor 0.2 mM pyridoxal phosphate (PLP) at room temperature with enzyme 
concentration of 1.3 mg/mL. Error bars represent one standard deviation about the mean (n = 2). 
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6.4.3 Demonstration of the three step enzymatic reaction  
The production of chiral amino alcohol, ABT in the three-step enzymatic reaction 
was performed via three packed tube IEMRs using serine (SER) as the amino donor 
and glycolaldehyde (GA) as the amino acceptor. The reaction was performed in the 
presence of both cofactors in 50 mM Tris-HCl, pH 7.5 at room temperature. The 
reaction profile of this multi-step enzyme reaction was assessed separately by 
monitoring the production of HPA in the first step, ERY in the second step and the 
final product of ABT and HPA. The product analyses were performed via HPLC 
and online detection system Actipix (first step). 
 
Substrate mixtures with initial concentrations of 100 mM SER and 40 mM GA were 
fed together in the presence of cofactors (Section 2.12.2). In the first part of the 
three-step reaction, His6-TAm catalysed the conversion of the substrates SER and 
GA to form HPA. The product of the first reaction was then continuously fed to the 
second IEMR containing the immobilised His6-TK, which catalysed the reaction 
between HPA and GA into ERY. The multi-step reaction was completed with the 
amination of ERY by the second His6-TAm to produce the final target product, 
ABT (Figure 6.8). This three-step TAm-TK-TAm reaction was conducted in 
continuous flow mode at various flow rates ranging from 0.5-10 µL/min, which 
correspond to residence times from 1 to 100 minutes. 
 
6.4.3.1 Three-step enzymatic reaction in packed tube IEMR 
Based on the preliminary enzyme activity data in solution phase of TAm (pQR 
1021), this enzyme showed a lower activity in the enzyme model system 
investigated compared to the TAm (pQR 801). In this particular enzyme reaction, 
the residence time needs to be adjusted so that it is sufficiently long to provide 
detectable level of substrate-to-product conversion. Therefore, the dimension of the 
individual IEMR was modified whereby the reaction volume for TAm (pQR 1021) 
was increased to 20 µL. This reflects the length of the IEMR from 5 cm to 10 cm 
(Figure 2.5). Moreover, the residence time was also extended by supplying the 
substrate at a much lower flow rate of 0.5 µL/min. 
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With an initial substrate concentration of 100 mM SER and 40 mM GA, the three-
step reaction reached approximately 6% conversion of ABT production at the 
lowest flow rate (Figure 6.12). This corresponds to a specific activity of 0.9 
nmol/min/mgTAm in the final step reaction. The low conversion of the final step was 
anticipated by the presence of side reactions from the residual HPA and GA which 
was also shown in the dual enzyme reaction (Section 6.2.4.2). The effect of the side 
reactions was more pronounced at higher flow rates as a higher proportion of 
residual GA and HPA were fed continuously from the previous steps. As a result, 
the formation of ABT was greatly reduced and the detection of the product was only 
assessable at lower flow rates of 0.5-1 µL/min. The effect of the side reaction in the 
final step was further discussed in Section 6.4.3.2. 
 
Apart from the side reaction effect, the low production of the ABT in the final step 
of the TAm-TK-TAm reaction is highly dependent on the formation of ERY in the 
second step and subsequently the formation of HPA in the first step reaction. The 
conversion of SER and GA in the first step of reaction (TAm step) was monitored 
online via the Actipix detection system. The production of the HPA recorded was 
shown to be increasing with lower flow rates, which was expected as the residence 
time increases (Figure 6.13). The conversion of the first TAm-catalysed reaction 
reached ~27% which equates to ~11 mM of HPA at 0.5 µL/min. The HPA produced 
was then fed into the TK-catalysed reaction, which later reacted with GA to produce 
ERY. Based on Figure 6.13, about ~10 mM of ERY was produced, which suggested 
that almost 100% conversion was reached at 0.5 µL/min. These correspond to a 
specific activity of 0.013 µmol/min/mgTAm and 0.29 µmol/min/mgTK. Therefore, a 
total of ~10 mM ERY was fed to the final IEMR, whereby about 6% of the relative 
amount of ERY supplied by the TK step was aminated by TAm to produce ABT. 
 
The TAm-catalysed reaction showed a consistently lower level of activity compared 
to TK as previously reported in the dual TK-TAm reaction as well as other studies 
reported elsewhere (Ingram et al., 2007; Matosevic et al., 2011b; Rios-Solis et al., 
2011). While these systems were not directly comparable, these data showed the 
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importance of matching the rates of the two enzymes to achieve optimal conversion 
rates. 
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(a) 
 
(b) 
 
 
Figure 6.12: Three-step TAm-TK-TAm reaction in packed tube IEMR. Graph showing the formation 
of the ABT and by-product HPA in the final step of the TAm-TK-TAm reaction as a function of (a) 
flow rate and (b) residence time. Initial substrate concentrations of 100 mM serine and 40 mM 
glycolaldehyde in 50 mM Tris!HCl buffer, pH 7.5 with cofactors thiamine pyrophosphate (TPP), 
2.4 mM and MgCl2, 9 mM and 0.2 mM PLP at room temperature The concentration of immobilised 
enzyme was 3.0-3.3 mg/mL for TAm and 0.15 mg/mL for TK. Error bars represent one standard 
deviation about the mean (n = 3). 
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Figure 6.13: Product profile of the first and second reaction in the three-step enzymatic reaction in 
packed tube IEMR. Graph showing the formation of the HPA and ERY, which were the product of 
the first and second step respectively. Initial substrate concentration of 100 mM serine and 40 mM 
glycolaldehyde in 50 mM Tris!HCl buffer, pH 7.5 with cofactors thiamine pyrophosphate (TPP), 
2.4 mM and MgCl2, 9 mM and 0.2 mM PLP at room temperature The concentration of immobilised 
enzyme was 3.0-3.3 mg/mL for TAm and 0.15 mg/mL for TK. Error bars represent one standard 
deviation about the mean (n = 3). 
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6.4.3.2 Side reaction study in three step enzymatic reaction 
The risk of having multiple side reactions becomes more critical as the number of 
cascade reactions increases. This happens when the initial substrates serve more 
than one enzyme in the multi-step reaction or the product of the earlier step has 
affinity towards the subsequent enzyme step reaction. Particularly for the 
continuous three-step enzymatic reaction, the effect of the side reaction is more 
apparent at higher flow rates, which reflects on the higher proportion of the residual 
substrates from the previous steps. In the TAm-TK-TAm catalysed reaction, the 
side reactions effect is only present in the final TAm-catalysed reaction, where the 
enzyme shows reactivity towards GA and HPA. As discussed previously in Section 
6.2.4.2, GA and HPA were reported to serve as substrates, not just for TK but also 
for TAm (Chen et al., 2006; Kaulmann et al., 2007; Rios-Solis et al., 2011). The 
reactivity of GA and ERY towards TAm (pQR 1021) was investigated (Figure 
6.14). The amination rates of GA by TAm was shown to be approximately three 
times higher compared to ERY. This result was in line with the low formation of 
ABT, which suggested that the affinity of TAm towards GA was higher compared 
to ERY. Moreover, the reactivity of GA was expected to be higher as the 
concentration of the residual substrate was about 20 mM, which was two times 
more than the ERY available. 
 
Apart from HPA and GA, the presence of the by-product ethanolamine from the 
first step TAm-catalysed reaction was also investigated. Two sets of TAm reactions 
were run, one as a control and the other one with the addition of pure ethanolamine. 
No significant different in the TAm enzyme activity was observed, which showed 
that this compound was not reactive towards TAm (data not shown).  
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Figure 6.14: Reactivity of GA and ERY towards TAm (pQR 1021). Standard activity assay of TAm 
(pQR 1021) with GA and ERY as the amino acceptor in batch solution. Initial substrate 
concentration of 100 mM serine and 10 mM glycolaldehyde and erythrulose in 50 mM Tris!HCl 
buffer, pH 7.5 with cofactor 0.2 mM PLP at room temperature. 
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6.5 Summary 
In this chapter, the demonstration of the multiple enzyme reactions involving the 
immobilised transketolase and transaminase were successfully performed in the 
packed tube IEMR. Individual units of IEMRs were connected in series to allow for 
the dual and three step enzymatic reaction to synthesise 2-amino-1,3,4 butanetriol 
(ABT).  
 
In the dual enzyme reaction the production of ABT achieved approximately 83% 
conversion in 20 minutes at the lowest flow rate (Figure 6.5). Conversely, lower 
conversion yield was obtained in the three step reaction where the reaction only 
managed to achieved ~6% conversion at the lowest flow rate (Figure 6.12). The low 
production of the final product ABT in this reaction was due to the severe side 
reactions caused by the residual substrates. The low conversion rate of the !-TAm 
(pQR1021) further hampered the overall reaction rates in the three- step reaction. 
 
Investigations on the stability of the reaction components in free solution were 
performed. HPA and GA were found to be reactive towards both !-TAm enzymes, 
which explains the presence of the side reactions in both model systems. Due to the 
significant effect imposed by the side reaction on the yield of the final product, 
future consideration to overcome this constraint is very important. Apart from that, 
the final product yield was highly dependent on the previous bioconversion steps. 
As the reaction rate of TAm was much slower than that of TK, finding the best 
matching enzyme combinations would improve the final yield in the multi-step 
enzyme reaction.  
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7 Conclusions and Future Work 
7.1 Summary of project achievements 
In this thesis, the development and characterisation of prototype immobilised 
enzyme microreactors (IEMR) were successfully achieved. The development of the 
IEMR was accomplished using His6-tagged transketolase (TK) and transaminase 
(TAm) enzyme immobilised onto Ni-NTA agarose beads that were packed into 
tubes and work as a packed bed system. This microreactor system, based on the 
reversible immobilisation of His6-tagged enzymes was implemented for the 
quantitative evaluation of TK and TAm bioconversion kinetics. Ultimately, several 
IEMR units were connected in series to enable the synthesis of a chiral 
pharmaceutical intermediate, ABT. The ability to synthesise this compound in 
relatively short time proves this IEMR system as a powerful tool for the 
construction and evaluation of de novo pathways as well as for rapid determination 
of various enzymes kinetics. 
 
Initially in Chapter 3, the kinetics performance of both enzymes were evaluated in 
batch solution phase. The characterisation of the enzymes based on several 
parameters was also investigated. Data gathered from the specific activity for both 
enzymes showed that the conversion rate of TAm (Section 3.3.2) was relatively 
slower (~150x) compared to TK (Section 3.2.2) based on the investigated 
conditions. This preliminary data highlights the importance of matching the rates of 
the two enzymes to achieve optimal conversion rates in the multi-step enzymatic 
reactions (Chapter 6). 
 
Furthermore, the principle of continuous flow kinetics was successfully 
demonstrated on the TK (Section 4.2.2.3) and TAm (Section 4.4.2) individually. 
The catalytic performance of both enzymes displayed consistent dependency on 
substrate concentration and residence time. Moreover, the product formation 
showed to be proportional to the space time at higher flow rates and started to level 
off as the flow rate was reduced. This condition can be explained by the presence of 
a diffusion layer surrounding the immobilised enzymes (Section 5.4). In addition, 
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the application of online UV detection system (Section 4.4), Actipix was integrated 
with the TAm packed tube IEMR and was successfully demonstrated to detect the 
by-product, HPA, in the single enzyme system. 
 
In Chapter 5, the kinetic performance of TK and TAm in a continuous flow reaction 
was investigated using the Lilly-Hornby (1966) kinetics model in the packed tube 
IEMR. The findings showed the Km(app) for both enzymes to be dependent on the 
flow rates whereby higher Km (app) values were observed at lower flow rates and vice 
versa. A similar trend was also reported by other researchers, while factors of mass 
transfer and liquid channeling were believed to be the potential cause of this 
condition. Furthermore, the turnover number kcat calculated were approximately 3 
times less than kcat values in solution-phase (Section 3.2.5 and Section 3.3.6). This 
apparent loss in activity may be due to the inaccessibility of some enzyme 
molecules to the substrates, altered conformation of the enzyme and a steric 
hindrance factor. 
 
The versatility of the IEMR was further demonstrated in the multistep enzymatic 
reaction to synthesis the complex chiral aminodiol (Chapter 6). Two model systems 
were studied with the final target product of 2-amino-1,3,4 butanetriol (ABT). In 
the first model system the production of ABT achieved approximately 83% 
conversion in 20 minutes at the lowest flow rate (Figure 6.5). On the other hand, the 
bioconversion of TAm in the three-step reaction only managed to achieve ~6% of 
ABT production at the lowest flow rate (Figure 6.12). Reduced activity observed in 
the latter system was due to the severe side reactions coming from the residual 
substrates. While both of the model systems were not directly comparable, the 
production of the final product was highly dependent on the previous bioconversion 
steps. Therefore, finding the best matching enzyme combinations would improve 
the final yield in the multi-step enzyme reaction.  
 
This in vitro study of the multi-step enzymatic reaction however provides insight 
into the behaviour of de novo engineered pathway prior to cloning them into 
engineered whole cell biocatalysts. Besides that, there is a huge potential of this 
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system to be further developed to ensure improved yields are achieved. While this 
system has been proved to work and has produced reproducible results, there is still 
room for improvements to be made. Generally, the main issue faced here is the low 
final product yield in the three-step enzyme reaction, which directly related with the 
side reactions. This problem stemmed from the low conversion rate of the TAm 
(pQR 1021)-catalysed reaction and subsequently affects the overall conversion rates 
of the system. This suggests that future efforts to improve the performance would 
require a comprehensive approach using both enzyme engineering and 
microfabrication methods. 
 
7.2 Future work 
Whilst the overall aim of this project was achieved, future work is required to 
improve the multi-step reaction to further increase reaction yields, and to enable 
better integration of analytical techniques. The main setback in the multi-step 
enzymatic reaction was the low yield of ABT production. As discussed before, the 
rate of conversion for the TAm reaction was relatively low compared to TK, which 
in turn affected the overall conversion. A possible strategy to improve this condition 
is by having higher enzyme loading for the slower enzyme reaction, which in this 
case is the TAm-catalysed reaction. Modification on the IEMR by increasing the 
reactor volume can be obtained by either increasing the length or the diameter of the 
reactor. However, any changes made on the dimensions of the reactor have to be 
within the maximum limit of the pressure drop in the IEMR (Section 4.3.1) and 
factors such as channeling effect and blockage should be considered.  
 
Another approach aimed to improving the performance of the multi-step reaction is 
by reducing the effect of the side reaction (especially at high flow rate) that 
promotes unfavourable equilibria. In each case of the model system, the residual 
substrates (HPA and GA) need to be removed in order to overcome this constraint 
and hence increase the formation of the target product. One of the strategies to 
tackle this problem is by applying the in situ substrate removal technique (ISPR). 
This method not only helps improving the conversion rate but also provides further 
benefit for the subsequent downstream processing (Lye & Woodley 1999). Several 
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techniques of ISPR can be adopted which include ion exchange, complex formation 
and physical adsorption (Lye & Woodley 1999). Nevertheless, further study has to 
be performed to determine the suitable ISPR method, potentially using absorbent 
resins with binding selectivity that are easily incorporated in the IEMR system. This 
can be achieved by adding an additional packed tube containing the adsorbent resin 
next to the respected IEMR to remove the unwanted compound. 
 
Apart from the ISPR method, the excessive amount of the residual substrates could 
be recycled back into the system. This option offers a good prospect on the overall 
multi-step reaction where it utilises the most of the total substrate concentration 
feed in the beginning of the reaction. An additional connector (eg: shut-off valve 
from Presearch Ltd) can be added into the system to allow for the recycling mode. 
Alternatively, a chip based microreactor could be used while maintaining the Ni-
NTA beads as the immobilisation method. With various types of microfabrication 
available (Section 1.3.2), multiple channels can be easily constructed on a single 
chip with flexibility in the design that would fit with the intended biocatalytic 
model system. Moreover, the versatility of microfabrication would allow the 
channel dimension to be adjusted to suit the need of matching the activities of 
transketolase and transaminase to get optimum conversion rate in the multi-step 
enzyme reaction (Boehm et al., 2013). 
 
With the main target to achieve higher yields for the production of chiral 
aminodiols, a different set of substrates can be tested using the transketolase-
transaminase model pathway. Rios-Solis et al. (2011) reported that higher yields 
were achieved when using isopropylamine (IPA) as the amino donor compared to 
MBA. This compound showed to have negligible side reactions with transaminase 
and obtained 87% yield for ABT synthesis and 90% yield for 2-aminopentane-1,3-
diol (APD) and available at a relatively low price. Moreover, ongoing research to 
increase the size of TK and TAm libraries is significant to improve the performance 
of de novo design of synthetic pathway to create chiral amino alcohols that are 
useful in many industrial synthon. Protein engineering strategies could be applied to 
generate more stable biocatalysts with new substrate specificity or enzyme with 
improved affinity for existing substrates (Hibbert et al., 2007, 2008; Cázares et al., 
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2010; Payongsri et al., 2012). Apart from this, a genome-mining approach can also 
be adopted to find more stable homologues in the sequenced genome libraries that 
is available online (Liolios et al., 2006). Besides that, a mix-and-match of different 
combination of TK and TAm enzymes can be implemented to create wide range of 
amino alcohols (Ingram et al., 2007; Smith et al., 2009).  
 
Another important aspect to be addressed for future work is to improve the 
characterisation of the transaminase stability. Based on the results obtained in 
Section 4.3.2, the stability of TAm was found to be less stable in immobilised form 
compared to the enzyme in solution. Apart from the suggested reasons discussed, a 
study on enzyme degradation can be conducted to further investigate the effect of 
immobilisation on the enzyme stability. Several methods can be performed for the 
analysis, which include circular dichroism, mass spectrometry, SDS-PAGE and size 
exclusion chromatography. The enzyme required for the analysis can be easily 
recovered by treating the IEMR with elution buffer.  
 
Finally, it would be desireable to demonstrate the whole multi-step reaction (each 
individual step) integrated with direct analytical techniques. Apart from minimizing 
the dead time for analyzing the sample, this would allow for more efficient 
monitoring of the enzyme activities without having to analyze the individual step 
separately. This was partly demonstrated in the three-step enzymatic reaction 
(Section 6.4.1) where the UV online detection system was installed to monitor the 
production of HPA in the first reaction. However, this system was unable to be 
integrated in other bioconversion steps (dual system) due to the overlapping 
absorptivites of HPA and ERY. Alternatively, introducing different substrates as 
discussed previously can minimise this problem. In addition, the analytical assay 
could be performed directly by coupling the microreactor with the HPLC system, 
which would provide real time reaction data (Mark et al., 2010). 
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Appendix 1: HPLC Traces 
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Appendix 2: Enzyme Binding on Surface 
Fischer et al. (2004) showed that the average density for proteins of MW>20 kDa is 
approximately 1.4g/cm
3
. The MW of each TK unit is ~72.5 kDa. Avogadro’s 
constant, NA is 6.02 x 10
23
 mol
-1
. Therefore the radius each TK molecule can be 
estimated as follows: 
Protein volume  
Or,      
Rearranging and substituting, 
     
     
This gives r!0.0027 µm and the area occupied can be approximated to the circular 
area: 
    Protein Area, A =  
     
And, 
The surface area available on the capillary can be calculated by assuming area of 
cylinder with internal diameter (ID) of 200 µm and length of 40 cm that is 250 mm
2
 
= 250 x 10
6 
µm
2
. 
 
Finally, 
Protein molecules   
Moles of TK     
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Therefore, the mass of TK immobilized on the microcapillary surface can be 
estimated: 
Mass of TK  
